Mapping a balanced translocation t(1;11)(q42.2;q21) linked to schizophrenia by Evans, Kathryn L.
MAPPING A BALANCED TRANSLOCATION







a) that this thesis was composed by myself and
b) that the work is my own, except where otherwise stated.
ABSTRACT
This thesis describes progress towards the mapping and cloning of the
breakpoints of a balanced translocation t(1;11)(q42.2;q21) which is linked to
schizophrenia and other major mental illness in an extensive Scottish
pedigree. Schizophrenia is one of the principal forms of major mental illness;
the lifetime risk for the disorder is approximately 1%. Very little is known
about the aetiology of schizophrenia. The clustering of psychiatric illness
within families and the results of twin and adoption studies indicate that
major mental illness has a considerable genetic component. However the
localisation, by linkage analysis, of genes that are responsible for psychiatric
disorders is difficult. Mental illnesses exhibit genetic heterogeneity,
phenocopies, assortative mating, incomplete penetrance, unclear mode of
inheritance, uncertainties in diagnostic boundaries which all complicate
linkage analysis. The process of gene localisation is greatly simplified by the
presence of a chromosomal rearrangement. The balanced translocation
which segregates with major mental illness in this family is therefore a very
important, as well as a relatively rare, resource. In order to map the
breakpoints of the translocation a series of somatic cell hybrids has been
characterised by PCR and Southern analysis. This analysis has resulted in
the determination of flanking markers of the breakpoints on both translocated
chromosomes and in the production of a panel through which markers can
be mapped, at high resolution, with respect to the chromosome 11
breakpoint region. To generate new markers for the region, microdissection
and microcloning of the derived chromosome 1 was undertaken by others
and I undertook to map the clones generated in this way. In total I have
mapped 28 new microdissection markers, either to chromosome 1 or to a
series of intervals on chromosome 11 q. The markers which were found to
map immediately distal to the chromosome 11 breakpoint were used to
isolate YACs from that region. On the basis of co-hybridisation, fingerprint
and pulsed field gel electrophoretic analysis, the YACs were assembled into
a contig. Pulsed field gel electrophoretic analysis, of genomic DNA from an
individual carrying the translocation, compared with DNA from a control
individual, with a probe in the interval closest to the translocation breakpoint
identified differences in three restriction fragments. This data was consistent
with the translocation breakpoint being within approximately 550 kb of this
marker.
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This thesis describes progress towards the mapping and cloning of the
breakpoints of a balanced translocation t(1;11)(q42.2;q21) which appears to
segregate with schizophrenia and other major mental illnesses in a Scottish
pedigree.
Schizophrenia is one of the most common major mental illnesses, affecting
approximately 1% of the world's population at some point in their lives
(Gottesman and Shields, 1982). It is a disabling disorder which begins in
adolescence or young adulthood. The symptoms of schizophrenia have
been divided into those which characterise the acute phase of the disorder
(such as thought disorders, delusions, hallucinations, bizarre behaviour and
catatonia) which are known as the positive symptoms. The negative
symptoms, which tend to occur before and after the acute phase, include
lack of motivation, social withdrawal, emotional apathy and attentional
impairment (Michels and Marzuk, 1993).
Schizophrenia was defined as a distinct condition in the late 19th Century by
Kraepelin (1919). Kraepelin divided severe mental illness into manic
depressive insanity and dementia praecox. Dementia praecox was renamed
"the schizophrenias" approximately 20 years later by Bleuler (1950) who
argued that symptoms such as delusions and hallucinations were secondary
to primary symptoms of thought association problems, ambivalence, affective
abnormalities and autistic thinking (Gallant, 1990).
Currently there are a number of different diagnostic criteria for mental
illnesses. Three major ones are the Diagnostic and Statistical Manual of
Mental Disorders III, revised (DSM-III-R) of the American Psychiatric
Association, the International Classification of Diseases 9 (ICD 9) and the
Research Diagnostic Criteria (RDC). The diagnostic criteria for
schizophrenia differ between these systems and a recent survey on the use
of these by French and British psychiatrists found that different diagnostic
criteria were used to diagnose schizophrenia in the two countries (van Os et
al., 1993). Thus there is no consensus as to the precise definition of
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schizophrenia and there is no biological marker for external validation.
Consequently it is possible, if sufficient criteria are used, to produce a
narrow definition of schizophrenia, which will allow reliable diagnosis.
However, this will result in a high false negative rate.
The symptoms of schizophrenia are highly variable between individuals
(Gottesman and Shields, 1982). It seems likely therefore that the term
schizophrenia covers a group of disorders. Also, family (Baron et al., 1985;
Kendler et al., 1985) and adoption (Kety et al., 1971) studies have shown
that schizophrenia spectrum disorders (conditions which involve
considerable overlap of symptoms with schizophrenia) such as schizotypal
personality disorders, occur at high frequency in the relatives of
schizophrenics, suggesting a genetic relationship between these disorders
and schizophrenia. There is also doubt about the delineation drawn
between schizophrenia and the affective disorders. The term affective
disorders covers a group of illnesses which are characterised by
disturbance in mood. The main forms of major affective disorder are
unipolar major depression and bipolar disorder. In bipolar disorder (also
known as manic-depressive illness) affected individuals suffer episodes of
mania, as well as periods of depression. The controversy over whether
schizophrenia and the affective disorders are biologically distinct is due to
the existence of schizoaffective disorder, an illness which has features of
both schizophrenia and affective disorder, and to the reports of monozygotic
twins and triplets where one co-twin has been diagnosed as schizophrenic
and the other as suffering from an affective disorder (McGuffin et al., 1982;
Dalby et al., 1986; Farmer et al., 1987 and Lohr and Bracha 1992)
1.2 Epidemiological Aspects of Schizophrenia
1.2.1 Incidence
Schizophrenia is a very common disorder; the lifetime risk is approximately
1% (Gottesman and Shields, 1982). The incidence in males is slightly
higher than in females (Gottesman and Shields, 1982). Unlike many
diseases the prevalence of schizophrenia appears to be fairly similar world
wide. There is evidence for areas of slightly higher prevalence, for example
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in Northern Sweden, Western Ireland and Finland, but it is very difficult to
assess these data with accuracy as different diagnostic criteria have been
used in the different studies (Wyatt et al., 1988).
The incidence of schizophrenia is high considering that the fertility of
schizophrenics is reduced (estimated to be 70% of that of socio-
economically comparable unaffected individuals) (Wyatt et al., 1988). The
reasons for the higher than expected incidence of schizophrenia are
unknown. Hypotheses include a reproductive advantage to those who carry
the gene (in the case of a recessive mutation) or to those who have the
genetic predisposition but do not develop schizophrenia (in the case of a
dominant mutation). There is some evidence for increased fertility in
relatives of schizophrenics (Erlenmeyer-Kimling and Paradowski, 1966;
Carter and Watts, 1971).
It may not be necessary to invoke a positive advantage for mutations which
predispose to schizophrenia. It is possible that variable expression and lack
of full manifestation of mutant alleles will reduce the ability of natural
selection to remove these alleles from the population. Also the adult age of
onset of schizophrenia implies that a proportion of individuals will have
reproduced before the onset of schizophrenic symptoms. Finally, if there are
a number of genes which when mutated have the potential to cause
schizophrenia then, all other things being equal, the observed disease
frequency will be higher than if only one gene were involved (Ridley and
Baker, 1990).
1.2.2 Socio-economic Status
There is a higher than average incidence of schizophrenia amongst the
lower socio-economic classes of large urban areas (Kohn, 1977). There are
several possible explanations for this observation. These include
"downward drift" of affected individuals; that greater stress is encountered in
urban areas, which precipitates the disorder in susceptible individuals and
that the crowding found in these areas would facilitate spread of any
infectious causative agent (Wyatt et al., 1988)
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1.2.3 Course and Outcome
There is considerable variation between individuals regarding the course
and the outcome of the disorder (Michels and Marzuk, 1993). Some
individuals (estimated at 14-30 % of patients) have a single episode followed
by a full recovery. Most, however, have persistent or episodic
psychopathologic symptoms and vocational and social difficulties. A
proportion of these patients experience progressive deterioration. Females
tend to have a better prognosis than males (Castle and Murray, 1991).
There are suggestions that the initial clinical symptoms of schizophrenia can
be precipitated by stress (Wyatt et al., 1988). There is more substantial
evidence that relapses are related to stress and that decreasing stress,
particularly stress caused by the emotional atmosphere in the patient's home
can decrease relapse frequency (Wyatt et al., 1988). Negative emotions
such as criticism of the patient, over-involvement and hostility are measured
in the form of an index of expressed emotion (EE). EE values are measured
in close relatives of patients and it has been found that half of patients in
high EE homes suffered a relapse over a nine month period compared with
less than one quarter of patients in low EE homes. The highest levels of
expressed emotion are generally found in cities in the West while rural
communities in developing countries usually exhibit the lowest EE levels.
Correspondingly, clinical and social outcome tends to be better in
developing countries than developed ones (Leff et al., 1992).
The level of premorbid functioning (for example whether the person has a
job) appears to be an important factor in predicting outcomes of
schizophrenia (Eaton, 1991). Poor premorbid functioning tends to predict a
poor outcome.
1.2.4 Season of Birth
Examination of the date of birth of schizophrenics indicates that
schizophrenics are slightly more likely (7-15 %) to be born in late winter and
spring. Most of this excess occurs within schizophrenics without a family
history of psychiatric illness (Jones and Murray, 1991). The explanation for
this well-established phenomenon is unknown. Hypotheses include a higher
likelihood of in utero exposure to viral infections, which are known to vary
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according to season and an increase in conceptions in late spring or early
summer by parents predisposed to having schizophrenic offspring (Wyatt et
al., 1988). A number of studies have been carried out to test whether
prenatal exposure to influenza is likely to increase the risk of schizophrenia
in adulthood (for example Mednick et al., 1988; Kendell et al., 1989; Bowler
and Torrey, 1990 and O'Callaghan et al., 1991). These studies come to
conflicting conclusions.
1.2.5 Age of Onset
The vast majority of schizophrenia cases exhibit adult onset; 90% of cases
have an onset between 15 and 45 years of age (Roberts and Brunton, 1990).
The peak age of onset differs between the sexes. In males the peak occurs
between ages 18-25 whereas in females the peak is broader at 26-45 years
(Stromgren, 1988).
1.2.6 Association of Other Psychiatric Illnesses with Schizophrenia
Varma et al. (1992) compared psychiatric morbidity in 1018 first degree
relatives of schizophrenics to that found in the first degree relatives of a
similar number of control patients. It was found that the relatives of
schizophrenics were at a significantly increased risk. Psychiatric morbidity
was observed in 34.8 % of first degree relatives of schizophrenic patients as
compared to 9.2 % of first degree relatives of controls.
Kendler et al., (1985) studied psychiatric morbidity in 723 first degree
relatives of schizophrenics as compared with that found in the relatives of
controls. The following diagnoses were increased in the relatives of
schizophrenics versus controls: chronic schizophrenia (3.7 % versus 0.2 %);
schizoaffective disorder (1.4 % versus 0.1 %); paranoid disorder (0.9 %
versus <0.1 %) and atypical psychosis (2.5 % versus 0.3 %). A similar study
examined psychiatric morbidity in 376 first degree relatives of schizophrenics
as compared with that found in the relatives of controls (Baron et al. 1985).
The following diagnoses were increased in the relatives of schizophrenics
versus controls: chronic schizophrenia (5.8 % versus 0.6 %); schizotypal
personality disorder (definite) (14.6 % versus 2.1 %); schizotypal personality
disorder (probable) (12.1 % versus 6.5 %) and paranoid personality disorder
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(7.3 % versus 2.3 %). In a subsequent study, the relatives of schizophrenics
that had diagnoses of major affective disorder were examined to see if this
was associated with increased familial risk of schizophrenia and related
disorders (Baron and Gruen, 1991). It was found that the relatives of
schizophrenic patients with a family history of affective illness had a greater
risk of schizophrenia and schizophrenia-related disorders when compared to
the relatives of patients without such a family history.
Many groups have investigated the genetic relatedness of schizophrenia to
the affective disorders (reviewed in Taylor, 1992); it was found that
schizophrenia and affective disorders do co-occur in a proportion of families
with affected individuals.
The existence of schizoaffective disorder also indicates that the separation
of schizophrenia and affective illness may not be valid. There is
considerable variation between DSM-III-R, ICD -9, and RDC diagnostic
criteria for schizoaffective disorder (reviewed by Lapensee, 1992). It
appears that there are a number of different illnesses or subtypes
encompassed by the term (Lapensee, 1992). The relatives of patients with
schizoaffective disorder appear to be at a higher risk to both schizophrenia
and affective disorder (Lapensee, 1992).
Examples of identical twins who are discordant for psychiatric illnesses also
exist. McGuffin et al. (1982) reported identical triplets two of whom were
schizophrenic while the third had bipolar illness. Dalby et al. (1986) reported
a pair of monozygotic twins, one of whom was diagnosed as suffering from
schizophrenia and the other from mania. A similar case was reported by Lohr
and Bracha (1992). A larger twin study found that of 26 monozygotic twin
pairs where at least one co-twin was schizophrenic in five cases the co-twin
had been assigned to a DSM-III affective disorder category (Farmer et al.,
1987).
These studies clearly indicate that there is a genetic relationship between
schizophrenia and other psychiatric illness.
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1.3 Pathology of Schizophrenia
Post-mortem studies of brain weights of schizophrenic patients have found
that the disease is associated with a decrease in total brain weight and
length (Roberts and Brunton, 1990). Reductions were also suggested in
cerebral hemispheric and cortical volumes (Roberts and Brunton, 1990).
More consistently, studies find increases in ventricular size and reductions in
size of medial temporal lobe structures associated with schizophrenia
(Waddington, 1993).
Magnetic resonance imaging (MRI) and computed tomography (CT)
scanning are non-invasive in vivo methods which have been used in a
number of studies (summarised in Jones and Murray, 1991) to compare
brain structure in schizophrenics and matched controls. Many CT studies
have found that a large proportion of schizophrenics have enlarged cerebral
ventricles, although there is controversy over the proportion of cases and the
extent of the enlargements. It is clear however that any ventricular
enlargement is present at the onset of positive symptoms, is not related to
illness length and shows no evidence of progression on follow-up (up to 8
years).
MRI studies have confirmed the increase in ventricular size in a proportion of
schizophrenics. These studies also found that temporal lobe structures, in
particular the hippocampus, were reduced in size. One study reported that
the superior temporal gyrus was decreased in volume, particularly on the left
side (Barta et al., 1990). The reduction in size of this region, which is an
auditory association area, appeared to correlate with the severity of
hallucinations.
Where sex differences have been reported, usually greater deviations from
normal have been noted in males than in females (Jones and Murray, 1991).
Monozygotic twins discordant for schizophrenia have been shown to have
differences in ventricular volumes (Jones and Murray, 1991). Two studies
have found that in the majority of cases the schizophrenic twin had larger
cerebral ventricles. The second study also found that the volume of grey
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matter in the left temporal lobe was smaller in the schizophrenic twin than
the unaffected twin.
Schizophrenia-like symptoms occur at a higher than expected frequency in
temporal lobe epilepsy (Jones and Murray, 1991). Such findings prompted
studies of the limbic temporal lobe of schizophrenics. Decreases from
expected sizes were found, particularly in the hippocampus.
Three studies have examined the frequency of minor physical abnormalities
(MPAs) in schizophrenics versus controls (reviewed in Jones and Murray,
1991). MPAs are trivial abnormalities in ectodermal development, such as
abnormalities in hand morphology. All three studies found an increased
incidence of MPAs in schizophrenics relative to controls, the highest
frequency being found in familial schizophrenia cases. MPAs are indicative
of pathological processes in foetal life (Bracha et.al., 1991). The period of
ectodermal development affected can be deduced from the nature of the
ectodermal abnormalities. These studies suggest the influence of factors
during the fourth and fifth months of gestation (the first two thirds of the
second prenatal trimester) (Bracha et al., 1991). This is the period during
which neural migration to the cortex occurs (Bracha et al., 1991). A study of
23 pairs of monozygotic twins which were discordant for schizophrenia found
that, compared to the unaffected co-twin, affected co-twins had significantly
higher total scores of fourth and fifth month hand dysmorphologies (Bracha
et al., 1991). This may reflect differential in utero exposure to, for example
ischemic or toxic, insults which are known to affect ectodermal development
during this developmental period.
As mentioned above, decreases have been observed in hippocampal
volumes in a proportion of schizophrenics and lower hippocampal cell counts
have been observed in a proportion of schizophrenic patients (Jones and
Murray, 1991). This deficit could be caused either by neuronal degeneration
or by a developmental abnormality. This can be determined by examining
the brains of schizophrenics for gliosis. Gliosis is the term for the
proliferation of glial cells and increase in glial-associated proteins which
occurs in response to all types of disease processes which result in neuronal
damage (Roberts, 1990). Gliosis has not been found in the majority of
schizophrenic brains examined (Jones and Murray, 1993). This suggests
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that the observed deficit in hippocampal volume in schizophrenia is caused
by disturbances in brain development, rather than neurodegenerative
processes or destructive lesions. Post-mortem studies indicate that the
decreased cell volume may be due to a premature arrest of neuronal
migration into the hippocampus and parahippocampal gyrus (Jakob and
Beckmann, 1986; Falkai et al., 1988). This hypothesis is consistent with the
observation that the lesions seem to predate the onset of symptoms and do
not exhibit progression.
The results discussed above suggest that schizophrenia may be caused by
defects in brain development, in particular in defects in the development of
medial temporal lobe structures. Medial temporal lobe structures are
thought to play a crucial role in the integration and processing of information
from association cortex (Roberts, 1990). It is possible that defects in these
areas could cause symptoms such as those which make up the core of those
found in schizophrenia (Roberts, 1990) (although they could not account for
the all abnormalities found in schizophrenia). Possible causes of defects in
brain development are discussed in Section 1.4.
1.4 Aetiology Of Schizophrenia
1.4.1 Evidence for Genetic Predisposition
Family, adoption and twin studies have overwhelmingly established that
there is a major genetic component to schizophrenia. The various types of
studies indicate that the relatives of schizophrenics are at a higher risk of
developing schizophrenia than the 1% risk which applies to the general
population.
Family studies examine the family of a schizophrenic patient for psychiatric
illness. Pooled Western European life-time risks for definite and probable
schizophrenia in systematic family and twin studies, 1920-1987 (Gottesman
and Bertelsen, 1991) indicate that the risk of schizophrenia in children of
schizophrenics is 13 %, the risk to sibs is 9 % and the risk to parents is 6 %.
If one parent is schizophrenic then the risk of schizophrenia in a sibling of a
schizophrenic is 17 % and if both parents are schizophrenic then the risk of
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schizophrenia to offspring is 46 %. These figures indicate that
schizophrenia is familial, but they do not distinguish between genetic
influences and within family environmental influences.
Twin studies control for some of the shared environmental component of
schizophrenia. This is done by comparing concordance rates for
schizophrenia in monozygotic and same-sex dizygotic twins. A genetic
component of schizophrenia would manifest itself as a higher concordance
in monozygotic twins than dizygotic twins. Pooled Western European life¬
time risks for definite and probable schizophrenia in systematic family and
twin studies, 1920-1987 (Gottesman and Bertelsen, 1991) indicate that
concordance in dizygotic twins is 17 %, while in monozygotic twins it is 48 %.
An extension to a twin study was described by Gottesman and Bertelsen
(1989) who followed-up from, and confirmed the findings of, Fischer (1971).
They studied the incidence of schizophrenia in the adult offspring of
concordant and discordant monozygotic and dizygotic same-sex twin pairs.
The offspring of pairs of monozygotic twins are related to both co-twins as
first degree relatives while the offspring of dizygotic twins are related to the
other co-twin as second degree relatives. Thus the risks to offspring of the
same-sex dizygotic co-twins serve as controls for risks to first and second
degree relatives under the study conditions. When the twin pair is
discordant for schizophrenia, the offspring of the normal co-twin share little
or none of the exposure to a schizophrenic parent, thus controlling for this
within family environmental factor.
The study found that the risk of schizophrenia was 16.8 % in the offspring of
the affected monozygotic co-twin and 17.4 % in the offspring of the
unaffected monozygotic co-twin. The risk of schizophrenia was 17.4 % in
the offspring of the affected dizygotic co-twin and 2.1 % in the offspring of
the unaffected dizygotic co-twin. The difference in the risk for schizophrenia
in the offspring of the unaffected monozygotic and dizygotic co-twins
suggests that the genetic component to schizophrenia is high. The study
also suggests that when discordance is observed for schizophrenia in
monozygotic twins this is mainly due to a failure of expression of the genetic
predisposition to schizophrenia (Gottesmann and Bertelsen, 1989). This
study provides information about the possible mode of inheritance of
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schizophrenia, which is unclear. It suggests that, in at least a proportion of
cases, schizophrenia has a dominant mode of inheritance with reduced
penetrance.
Adoption studies have also been used to investigate whether schizophrenia
has a significant genetic component. The risk of schizophrenia in adopted
away infants with schizophrenic biological parents was compared with the
incidence in control adoptees who had unaffected biological parents
(Heston, 1966). An age-corrected rate for schizophrenia of 16.6 % was
found in the adoptees with a schizophrenic biological parent compared to a
rate of <2 % in control adoptees. A study into the rates of schizophrenia-
spectrum disorders in biological and adoptive family members of
schizophrenic adoptees found that 8.7 % of biological relatives had some
schizophrenic disorder, compared to 1.9 % of the adoptive family members
(Kety et al., 1971). Adoption studies therefore also indicate a significant
genetic component to schizophrenia.
1.4.1.1 Candidate Genes
There are many possible candidate genes for schizophrenia. As mentioned
above, defects in normal brain development may be responsible for
schizophrenia. Genes involved in the development of the brain are therefore
candidate schizophrenia causing genes. Likely candidates are genes which
are involved in development of the medial temporal lobe (in particular
hippocampal formation) possibly those which are involved in control of
neuronal proliferation and migration into the medial temporal lobe (Jones
and Murray, 1991).
Genes involved in dopaminergic function have long been proposed as
candidate schizophrenia genes. It was initially proposed that schizophrenia
was caused by a hyperdopaminergic state. The evidence for this hypothesis
is that the clinical effectiveness of the conventional neuroleptics is correlated
with their ability to block dopamine receptors. Also, drugs which increase
dopamine activity generally worsen the symptoms of schizophrenic patients
(Davis et al., 1991). There are however a number of facts which are
inconsistent with this hypothesis. Firstly, a substantial proportion of patients
are resistant to neuroleptic treatment which suggests that other
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neurochemical systems are involved in the disease in these patients (Davis
et al., 1991). If drugs which increase dopaminergic activity are given to non-
schizophrenics they do not develop schizophrenia-like symptoms (Davis et
al., 1991). Neuroleptics are only partially successful in alleviating the
negative symptoms of the disorder, suggesting that these symptoms can not
be fully explained by an excess of dopaminergic function (Davis et al., 1991).
There is evidence for hyperdopaminergic functioning in mesolimbic
neurones but post-mortem and cerebrospinal fluid studies of dopamine
metabolites do not indicate a homogeneous excess in dopamine metabolism
in schizophrenia and may be indicative of frontal lobe hypodopaminergia
(Davis et al., 1991). This has been suggested as an explanation for the
concurrent presence of positive and negative symptoms in schizophrenics.
Dopaminergic hyperfunction of mesolimbic neurones has been proposed as
a cause of the positive symptoms; and dopaminergic hypofunction of the
frontal lobe has been proposed as a cause of the negative symptoms of the
disorder (Davis et al., 1991; Waddington, 1993).
It is possible that the alterations in dopamine levels are a secondary effect of
the primary schizophrenic causing lesion. The fact that drugs which
increase dopaminergic activity do not induce schizophrenia-like symptoms in
non-schizophrenics (Davis et al., 1991) would support this. If this is the
case, then hypotheses as to the nature of the primary defect in
schizophrenia must account for the difference between schizophrenics, who
are sensitive to manipulation of dopaminergic neurotransmission, and non-
schizophrenics who do not develop schizophrenia-like symptoms when
administered drugs which augment dopamine activity (Davis et al., 1991).
A study of the dopamine D4 gene, which has a high affinity for clozapine
(Van Tol et al., 1991), an atypical neuroleptic which treats schizophrenic
symptoms without causing Parkinsonian side effects, revealed that the
receptor is polymorphic and that the different variants exhibit differences in
pharmacological properties (Van Tol et al., 1992; Lichter et al., 1993). The
authors suggest that such variation may result in differences in drug
response and/or differences in the susceptibility to the development of
psychiatric disorders. A recent study of post-mortem brains of
schizophrenics (Seeman et al., 1993) found that the number of D4 receptors
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was six-fold higher in the brains of schizophrenics relative to the brains of
controls.
The serotonin2 receptor can be considered a candidate gene for
schizophrenia, because of its affinity for the atypical neuroleptic clozapine
(Hallmayer et al., 1992). The serotonin2 receptor has been mapped to
chromosome 13 (Hallmayer et al., 1992). Linkage analysis was carried out
between the receptor, other chromosome 13 markers and schizophrenia in a
Swedish family (Hallmayer et al., 1992). The study ruled out involvement of
the serotonin2 receptor gene in schizophrenia in this family (Hallmayer et al.,
1992).
Polymorphisms at the porphobilinogen deaminase gene (PGBD) have been
studied in two sets of schizophrenics (Sanders et al., 1991; Owen et al.,
1992). One group of patients were found to have a higher than expected
frequency of a particular allele, indicating an association of that allele, or of
a closely linked gene with the disorder (Sanders et al., 1991). However this
finding was not replicated in the second group of patients studied (Owen et
al., 1992). The discrepancy in the outcome of the studies may be due to a
difference in the patient groups under study.
Sobell et al. (1993) tested 200 unrelated schizophrenics for the presence of
known mutations at the phenylalanine hydroxylase (PAH) locus (which cause
the autosomal recessive disease phenylketonuria, PKU). PAH was
considered as a candidate for a number of reasons (Sobell et al., 1993).
Firstly, individuals suffering from PKU, and their first degree relatives, are
reported to suffer from behavioural abnormalities, including psychosis.
Schizophrenic individuals have been observed to have elevated levels of
phenylethylamine (PEA) in their plasma and urine; excess PEA is a result of
absence of PAH activity. The structure of PEA is also very similar to
amphetamine, which can mimic some of the symptoms of schizophrenia, and
PEA and amphetamine cause the same behavioural abnormalities in test
animals (exaggerated motor activity and stereotypy). Finally, carriers of PKU
have only 10% of wild type PAH levels. This level of reduction in other
pathways, in the presence of environmental stress, often result in substantial
morbidity.
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When individuals suffering from schizophrenia were typed for these two
particular mutant alleles the mutations were not found in levels above those
expected. It is of course possible that other mutant alleles at this locus could
be responsible for a proportion of cases of predisposition to schizophrenia.
Jones et al. (1992) reported a nucleotide substitution, which was predicted to
cause an amino acid substitution, in the amyloid precursor protein (APP)
gene in a schizophrenic individual who also had cognitive deficits.
Mutations in the APP gene have been shown to be responsible for a
proportion of cases of familial Alzheimer's disease. Eighty-six
schizophrenics were subsequently tested for this substitution but no
positives were identified (Coon et al., 1993).
There have been reports of albinism and mental illness co-occurring in more
than one individual in a family. Baron (1976) reported a pedigree where five
individuals had oculocutaneous albinism (OCA) and schizophreniform
psychosis. One non-albino member of the pedigree had schizophrenia and
all others had neither albinism of mental illness. A family where two siblings
out of three have both schizophrenia and tyrosinase negative OCA has also
been reported (Clarke and Buckley, 1989). As tyrosinase mutations can be
responsible for OCA, tyrosinase,or a linked gene, has been suggested as a
candidate gene for schizophrenia.
Within the last two years expansions of trinucleotide repeats within genes
have been found to be responsible for at least four different diseases
(summarised in Mandel, 1993). These diseases exhibit anticipation, i.e.
increase in disease severity, decrease in age of onset and increased
frequency of affected individuals in successive generations, which largely
correlates with successive increases in the number of repeats present in the
mutated gene. The existence of anticipation in psychiatric disorders was
suggested as early as 1911 (Mott, 1911) and evidence supporting the
existence of anticipation in bipolar affective disorder has been published
recently (Mclnnis et al., 1993). Genes which contain trinucleotide repeats
which are susceptible to expansion may therefore be candidates for
schizophrenia.
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1.4.2 Evidence for Environmental Component
As described in section 1.4.1 there is clearly a significant genetic component
to schizophrenia. However, every study has found that the genetic
component cannot account for all of the variation observed between affected
and unaffected individuals. For example, while monozygotic twins clearly
exhibit a higher concordance for schizophrenia than dizygotic twins, this
concordance is only approximately 50%. This level of discordance in
genetically identical individuals is strong evidence for a non-genetic
component to the disorder. A major part of the non-genetic component is
likely to be environmental factors which affect individuals differentially and
which will therefore alter the likelihood of a genetically predisposed
individual becoming schizophrenic.
As mentioned previously, monozygotic twins discordant for schizophrenia
have been shown to have differences in ventricular volumes (Jones and
Murray, 1991). Two studies have found that in many cases the
schizophrenic twin had larger cerebral ventricles and the second study also
found that the volume of grey matter in the left temporal lobe was smaller in
the schizophrenic twin than the unaffected twin. The frequency of minor
physical abnormalities (MPAs) also differs between discordant monozygotic
co-twins (schizophrenic co-twins exhibiting a higher number of MPAs). This
may indicate that the co-twins differ in their exposure to environmental
factors in utero. Co-twins may also differ in their exposure to environmental
factors after birth. Possible examples of such environmental insults are
discussed in section 1.4.2.1.
Further evidence for an environmental component to schizophrenia comes
from the observation that schizophrenics, particularly those with no family
history of psychiatric illness, are slightly more likely to be born in late winter
and spring (Jones and Murray, 1991).
1.4.2.1 Candidate Environmental Factors
The environmental factors most consistently associated with schizophrenia
are obstetric complications (Jones and Murray, 1991). It has been found
that schizophrenics have had an excess of prenatal and perinatal problems
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when they are compared with controls and with patients suffering from other
psychiatric disorders. A number of reports have argued that obstetric
complications can cause disturbances in early brain development which
result in mental illness in adult life. However, an alternative hypothesis is
that obstetric complications may be an indicator of an earlier insult to the
nervous system, or even a secondary consequence of a genetic defect in
neural development.
As the pyramidal cells of the hippocampus are one of the cell types most
vulnerable to mild anoxia-ischemia this could cause damage preferentially to
this region of the brain (Jones and Murray, 1991). Other prenatal insults
which have been proposed as factors which may contribute to schizophrenia
include anaemia, toxic exposure, twin transfusion syndrome and exposure to
viral infections (Bracha et al., 1991).
As mentioned previously, it has been suggested that prenatal exposure,
during mid-pregnancy, to viral infections increases the risk of schizophrenia
in adult life (Wyatt et al., 1988). The mechanism by which viral infections
could cause an alteration in normal brain development is unclear. One
hypothesis is that neuraminidase-bearing viruses, e.g. influenza, which can
interfere with the adhesive actions of neural cell adhesion molecules, may
upset the migration of hippocampal cells (Conrad and Scheibel, 1987).
Immunological mechanisms of schizophrenia predisposition have also been
proposed. For example Wright et. al. (1993) have suggested that a mother's
genotype may cause her to produce a vigorous antibody reaction to viral
infection, and that during pregnancy, these antibodies cross the placenta
and the immature foetal blood brain barrier and cause neurodevelopmental
abnormalities in the foetal brain.
It has also been suggested that stress may cause schizophrenia in a
predisposed individual. The particular types of stress which appear to have
this effect have been studied (Leff, 1992). Life events, i.e. sudden discrete
events which occur in a person's life and require them to adapt
psychologically, such as death of a close relative or moving house, seem to
be clustered before an episode of illness. However, this has been found to
be true for a number of very different illnesses, for example heart attacks
and depression. Another form of stress which has been quantified is the
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emotional atmosphere in the home. This cannot, however, be used to judge
whether this type of stress precipitates an initial episode of schizophrenia.
1.5 Treatment of Schizophrenia
As the causes of schizophrenia are unknown, rational treatment is not
possible. The effectiveness of neuroleptic (or antipsychotic) drugs at
relieving the symptoms of schizophrenia were discovered by chance and
without any knowledge of their effects on brain chemistry.
Neuroleptic drugs block dopamine receptors and are effective, in many
cases, in treating the positive symptoms of the disorder (Johnstone, 1993).
However, about 30 % of patients show only limited improvement in acute
treatment trials and approximately 7 % have no response to neuroleptics
even when treated over a long period of time. Neuroleptics are partially
successful in the prevention of relapse but are of limited effectiveness
against the negative symptoms of the disorder. They also have the
disadvantage of producing short and long-term extrapyramidial side effects,
anticholinergic side effects, weight gain and tiredness (Johnstone, 1993).
Clozapine, which differs from the other dopamine blocking agents in terms of
its affinity for the different dopamine receptor subtypes (Van Tol et al., 1991),
produces fewer extrapyramidial side effects (Johnstone, 1993). This use of
this drug has however been curtailed because it causes agranulocytosis in a
small proportion of patients (Johnstone, 1993). Other antipsychotic drugs
which do not block dopamine receptors are occasionally used to treat
schizophrenia. These however are generally not as effective as the
neuroleptics (Johnstone, 1993).
Electroconvulsive therapy (ECT) has been used in controlled trials on
schizophrenic patients (reviewed in Johnston, 1993). Those patients who
were also being treated with neuroleptics responded to ECT treatment, but
this improvement had disappeared on follow-up 12 weeks after treatment.
Various treatments based on psychology have been used in attempts to
remove particular positive symptoms. These techniques seem to be only
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partially effective; some symptoms are lessened in some patients
(Johnstone, 1993).
In summary, schizophrenia is a relatively frequent, disabling disorder of
adolescence or young adulthood. It appears likely, at least in a proportion of
cases, that the disorder is caused by abnormal brain development.
Schizophrenia has a large genetic component but the expression of the
disorder is subject to environmental influence. Treatment of the disorder
tends to be only partially effective and the majority of sufferers remain
affected to some degree for the rest of their lives.
1.6 Positional Cloning of Monogenic Disorders
1.6.1 Introduction
The process of cloning genes solely by virtue of their position in the genome,
previously known as "reverse genetics", is now generally referred to as
"positional cloning". Most success in this field has been achieved for well
defined, but relatively rare monogenic disorders. Positional cloning of the
common polygenic disorders (for example psychiatric illness, cancer and
cardiovascular disease) is much more difficult (see section 1.7.1). Many of
the human polygenic disorders for which predisposing genes have been
successfully isolated have been those cancers which involve chromosomal
rearrangements (for example, isolation of the myeloid/lymphoid, or mixed
lineage, leukaemia (MLL) gene, Ziemin-van der Poel et al., 1991).
1.6.2 Linkage Analysis and Mapping
The first step in a positional cloning strategy is establishing either physical
or genetic linkage to the disease causing gene. This requires the collection
of families where the disease gene is segregating. In some cases a
chromosomal rearrangement, such as a translocation or a deletion, will be
observed to segregate with the disease. Such rearrangements can be
detected either by cytogenetics or Southern blotting. The detection of a
cytogenetically visible chromosomal rearrangement is the quickest way of
establishing such a linkage. The searches for most of the genes isolated by
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positional cloning to date have exploited rearrangements found to be linked
to the disease. Recently another type of rearrangement associated with
human disease has been characterised. Expansions of intragenic
trinucleotide repeats have been directly linked to X-linked spinal and bulbar
muscular atrophy, fragile X syndrome, myotonic dystrophy and Huntington's
disease. This results in an alteration of DNA structure which is readily
detectable by Southern analysis.
In the absence of a detectable rearrangement, co-inheritance of the disease
with arbitrary markers (usually of known chromosomal location) is studied.
Restriction length fragment polymorphisms (RFLPs) were the first class of
polymorphic DNA markers to be described. There are of two types of RFLP.
In the first, alterations in the DNA sequence create or destroy a site for a
particular restriction enzyme. Thus digestion with that enzyme, and
hybridisation with an internal probe, results in different size bands in
different chromosomes. This type of RFLP however, tends to have only two
alleles and consequently, many individuals are not informative (i.e. are not
heterozygous). The second type of RFLP is a consequence of minisatellite
arrays or variable number of tandem repeat sequences (VNTRs) which are
11-60 bp units repeated in tandem arrays. As the number of repeats varies
between alleles, digestion with a restriction enzyme which flanks the array,
followed by hybridisation with an appropriate probe, results in different sized
bands in different chromosomes. This RFLP system overcomes the problem
of insufficient allele number, as the number of repeat units is highly variable.
Similar to the minisatellites are the microsatellites. These loci are simple
sequence tandem repeats which consist of 1 to 6 bp units typically repeated
10-50 times. Microsatellites have three advantages over the minisatellites.
Whereas minisatellites are less common, are clustered near telomeres and
tend to be over 1 kb in length, microsatellites are more abundant (at least
one every 30 kb on average) and are more randomly distributed.
Microsatellites are also small enough to be amenable to amplification by the
polymerase chain reaction (PCR), removing the need for Southern analysis
which is more time consuming and requires a far larger quantity of DNA. In
PCR, oligonucleotide primers designed from unique sequence flanking the
repeat are used to direct cycles of enzymatic amplification of that locus.
This technique facilitates rapid allele characterisation, according to the size
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of the amplified product (which is determined by the number of repeat units
present).
Co-inheritance of the disease gene with particular alleles of a polymorphic
marker within a family or families indicates that the marker is very close to,
or linked to, the disease gene. The higher the proportion of affected
individuals in the family showing such co-inheritance, the closer the locus is
to the gene. This is because in general, the frequency with which
recombination separates two loci decreases with decreased distance
between them. The markers that show the lowest frequencies of
recombination with the disease are those which flank the disease gene. The
resolution of this type of data depends upon the number of meioses
available for study. In practice this rarely exceeds 100, limiting the
resolution to the equivalent of 1 % recombination. One percent
recombination is defined as a genetic distance of 1 centimorgan (cM). In
humans, 1 cM is approximately equivalent to 1 Mb, but this is not an exact
measurement as the relationship between recombination frequency and
distance varies between different regions of the genome and between the
sexes.
In some diseases it may be possible to further narrow down the region to
which linkage has been established. This is done by looking for the
existence of an association between a particular disease allele and
particular alleles at very tightly linked polymorphic loci. The particular
combination of alleles in a region is known as the haplotype. Detection of a
conserved haplotype allows increased mapping resolution as all the meiotic
events that have taken place since the occurrence of the mutation are taken
into consideration. Two approaches can be taken to detect such an
association. Affected sib pair analysis (see section 1.7.3) examines the
frequency of allele sharing between sibs, in order to detect that which occurs
at a higher frequency than is expected by chance. This method is
appropriate where many small families are available. Linkage disequilibrium
mapping aims to detect common haplotypes in affected individuals. This
method is more appropriate where a proportion of mutations have a common
ancestory and multigenerational pedigrees are available. Recently, linkage
disequilibrium mapping was successfully used to narrow down the
chromosomal region which was most likely to contain the gene responsible
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for Huntington's disease (Huntington's Disease Collaborative Research
Group, 1993).
If a mouse model of the human disease exists then this can be used to
identify potential locations of the human homologue. A mouse model of
human disease is defined as having similarities to the human in criteria
which relate both to the phenotype of the diseases (such as gross
appearance; affected tissue; biochemical/metabolic abnormalities;
behavioural defects and time of onset of the disease) and to genotypic
characteristics (such as mode of inheritance; pleiotropic effects; variable
penetrance; genetic heterogeneity and comparative mapping information)
(Darling and Abbott, 1992).
Mapping of genes is much easier in the mouse than in humans for a number
of reasons, which include the ability to set up a large number of specific
crosses, and the existence of recombinant inbred strains and interspecific
backcrosses in the mouse. Complex diseases, i.e. those diseases which are
polygenic and which are subject to influence of environmental factors are
very difficult to map in humans. However, genetic analysis of the mouse has
lead to the identification of susceptibility genes for complex disorders. For
example, ten murine genes which are involved in susceptibility to type I
diabetes in the non-obese diabetic (NOD) mouse have been mapped (Ghosh
et al., 1993).
Comparative maps of the mouse and human genomes can also be used to
help assign markers. The maps are based on the deduced evolutionary
relationships between the murine and human genomes. They indicate the
regions of the human genome which are homologous to each murine
chromosomal region. If a marker known to be linked to the disease gene
has been mapped in the mouse, then the comparative map can indicate
possible locations of the linked marker in the human genome. Conservation
of linkage between the species is increasingly likely with decreased distance
between the two loci. Loci which exhibit linkage in more than one species
are said to show conservation of synteny.
Once linkage of a disease gene to a particular chromosomal region has
been established then any known genes in that region can be considered as
21
candidates for the disease (see section 1.6.5). If this is unsuccessful then it
is necessary to identify new candidate genes. Often, the first step towards
this is the production of a physical map of the region. The estimated size of
the identified region will determine the number of markers required to
produce a comprehensive physical map. In many cases the generation of
new markers is required. One good source of new markers are somatic cell
hybrids.
Somatic cell hybrids are produced from the fusion of rodent and human cells.
The hybrid cell lines segregate the human chromosomes, facilitating the
assembly of a panel of hybrids each with different, stable human
chromosome complements (Weiss and Green, 1967). These cell lines are
one of the potential starting points for the production of lines which are
further reduced in human genomic complexity. The reduction is achieved by
exposing one cell line (the donor) to a lethal dose of ionising radiation
followed by fusion of these cells with a recipient cell line (Goss and Harris,
1975). The resultant hybrids can express markers from both parents but
most unselected fragments from the donor are eventually lost. Another
method of producing fragmentation hybrids is by chromosome-mediated
gene transfer (McBride and Ozer, 1973). A co-precipitate of donor
chromosome fragments and calcium phosphate is applied to recipient cells.
Independent clones, each bearing a chromosome fragment carrying a
suitable selectable marker, can then be isolated.
Pools of probes generated from such hybrids, for example by Alu-PCR
(Nelson, 1989) can be fluorescently-labelled and hybridised directly to
metaphase chromosome spreads. This technique is known as fluorescent
in-situ hybridisation (FISH). FISH can be used to determine the
chromosomal origin of the pool of probes (known as a chromosome "paint")
and to examine the pattern of integration of the human DNA in the rodent
cell line.
Markers can be produced from somatic cell hybrids again, for example, by
Alu-PCR amplification of the human component. Amplified fragments may
be used directly as probes, or may be converted, by DNA sequencing, into
sequence-tagged sites (STSs) which are short unique sequences of DNA
which can be amplified by PCR (Olson et al., 1989).
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Markers can also be produced from a precise chromosomal region by
microdissection. In many cases the region of interest is dissected from
banded metaphase chromosomes. This procedure can produce abundant,
region specific probes but they tend to be short (for example, average size of
350 bp) (Hadano et al., 1991) and consequently, difficult to work with. We
chose to follow protocols developed by Martinsson et al. (1989) to produce
clones from unbanded chromosomes (Muir et al., manuscript in preparation).
This procedure results in insert sizes which are approximately ten times
larger than those produced by dissection of banded chromosomes.
Although, in general, a smaller, more precise dissection can be made if
banded chromosomes are used, the larger clones produced by dissection of
unbanded chromosomes can be used simply and directly in a variety of
mapping and probing experiments.
Once markers have been generated they must be chromosomally and
regionally assigned. Somatic cell hybrids can be used for this. The DNA
content of a series of reduced complexity hybrids can be analysed by FISH
(see above) and by typing for markers of known chromosomal location. A
set of hybrids which define a number of intervals on a particular chromosome
can be assembled and used to regionally localise markers.
Complementary to the technique of hybrid mapping is pulsed field gel
electrophoresis (PFGE) (Schwartz and Cantor, 1984). This method allows
the separation of very large DNA fragments (up to 12 Mb) (Orbach et al.,
1988) and the construction of long range restriction maps. This allows
probes to be linked and ordered, accurate measurements of physical
distances to be made and chromosome breakpoints to be detected.
FISH is also important in the construction of physical maps. This technique
allows determination of relative order of probes along the length of a
chromosome. As mentioned previously, fluorescently labelled probes can be
hybridised directly to metaphase chromosomes. This allows determination
of the chromosomal origin of probes and reliable ordering of individual
probes, which are separated by at least 1 Mb, with respect to each other (or
with respect to a cytogenetic marker). When probes are closer together a
variety of other FISH techniques can be used to determine relative order
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(summarised in Buckle and Kearney, 1993). Probes can be hybridised to
interphase nuclei where the chromatin is less condensed but each
chromosome occupies a discrete region. This allows accurate ordering of
probes which are separated by 50-1000 kb. Interphase nuclei can be used
to prepare free chromatin in a two dimensional linear form. This type of
substrate provides mapping information in the 200-350 kb range. Resolution
can be achieved for probes separated by 10-200 kb by the preparation of a
"halo" of DNA loops around the nuclear matrix. With this technique probes
such as those derived from entire cosmids appear as a string of spots along
the length of the chromatin fibre. The most recently described FISH
technique is known as direct visual hybridisation (DIRVISH). The substrate
for this technique is prepared by stretching duplex DNA across a slide,
resulting in a stream of linear DNA strands. Like halo DNA, strings of signal
are produced, but results are possible with this technique with a probe of 5
kb, allowing a very fine resolution for mapping. The upper limit of this
technique has not been established, but a probe corresponding to a 700 kb
YAC recombinant has been hybridised, resulting in a signal of the expected
length (Parra and Windle, 1993).
1.6.3 Contig Mapping
Once markers have been generated and mapped they can be used to
generate a clone map of the region of interest. Various vectors for such a
map exist. Cosmids (Collins and Hohn, 1978) have the advantages of high
cloning efficiency and the availability of simple methods for isolation of large
amounts of purified insert DNA. However only -40-45 kb of DNA can be
cloned in cosmids. This was greatly improved upon with the development of
yeast artificial chromosomes (YACs) (Burke et al., 1987). Several hundred
kilobases of DNA could then be cloned as linear artificial chromosomes
which were propagated in the budding yeast Saccharomyces cereviseae.
This technology also provided a means for the stable cloning of chromosome
regions which had proved impossible to obtain from cosmid libraries
(Coulson et al., 1988). YAC recombinants with inserts of greater than 1 Mb
can now be produced, resulting in another substantial increase in the rate at
which a physical map can be produced. YACs however have some
disadvantages. These include low cloning efficiency and the lack of a simple
method for isolation of pure DNA. Another problem is that a proportion of
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YAC inserts originate from more than one chromosomal location. This is due
to co-cloning events and recombination between two YACs in one cell.
Some YACs also show deletions of some chromosomal regions. The recent
development of Bacterial Artificial Chromosomes (BACs), which appear to be
capable of insert sizes approaching those of YACs, may be free of some of
these problems (Shizuya et al., 1992). Cloning efficiency is increased, DNA
isolation is easy and the BAC is maintained at a single copy per cell,
reducing problems due to recombination between BACs. BACs appear to be
relatively stable over a large number of generations and co-cloning events
may occur less frequently than during YAC cloning.
Currently, the primary physical map of a particular region tends to be
generated in YACs. YACs are isolated, using markers mapped to the region,
and an overlapping series of clones, or contig is established from them. The
pattern of STSs present in the YACs and "fingerprints" of the YACs
(generated by hybridisation of a repetitive probe, such as an Alu element, to
a restriction digest of the YAC) are used to order YACs and to detect
overlaps between them. FISH and PFGE are also a important techniques in
building contigs. As described above, they can be used to order clones with
respect to each other and with respect to cytogenetic markers. Closing gaps
in the contig may require the isolation of the ends of a particular clone and
the use of these to select, or to "walk" to, the next clone. Smaller insert
clones, especially cosmids, tend to be used to bridge gaps in YAC contigs
and to sort out any ambiguities due to chimaeric or rearranged YACs.
Once a YAC contig has been established it is often used to isolate cosmids,
with a view to forming a corresponding cosmid contig. Cosmids are often
more practical than YACs for further experiments.
1.6.4 Gene Identification
Once a contig of the region of interest has been established it can then be
examined for the presence of coding sequences. The size of the region to
be searched will depend on how it was defined. For example, if a
chromosome translocation is associated with the disease, then the smallest
clone which spans this breakpoint is the starting point for the gene search.
However, if the disease region is genetically defined, then a large contig may
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have to be examined. In many cases cosmids are chosen as the starting
material for gene isolation. However, the size of the search region may
correspond to many YAC recombinants, making YACs a more practical
resource. A number of different methods are used towards gene
identification.
1. Clones can be examined for the presence of CpG islands. The
dinucleotide CpG occurs at one fifth of its expected frequency in vertebrate
DNA (Bird, 1986). This is because the cytosine in the majority of CpG
dinucleotides is methylated, and over evolutionary time these 5-methyl
cytosines are deaminated to a thymine. However, mammalian genomes also
contain clusters of unmethylated CpGs dinucleotides. These are known as
CpG islands and occur at the 5' ends of genes. Approximately 60 % of
genes are estimated to have islands at their 5' end. This can be broken
down into 40 % of tissue specific genes and most, if not all, housekeeping or
widely expressed genes (Larson, 1992). CpG islands can be detected in
genomic DNA by digestion with enzymes whose recognition sequences
contain more than one CpG and which only cut non-methylated DNA. Such
enzymes cut far more frequently in islands than in the majority of the genome
and correspondingly a cluster of such enzyme sites is indicative of an island.
Clones which are adjacent to CpG islands can be used as hybridisation
probes to identify cDNAs but, as mentioned previously, only 60 % of genes
have CpG islands. This technique has been used in the isolation of many
genes, for example, four new genes encoded in the Class II region of the
human major histocompatibility complex were detected in this way (Hanson
et al., 1991).
2. As many genes are conserved between species, the cloned DNA can be
examined for evolutionary conservation. The cloned material (cosmids or
smaller) is checked for cross-hybridisation to DNA from a number of different
species (using what is known as a Zoo Blot). This technique was used as a
first step in the isolation of candidate genes for Duchenne muscular
dystrophy (Monaco et. al., 1986).
3. Cloned material (cosmids or smaller) can be examined for expressed
sequences by hybridisation to mRNA obtained from a tissue or tissues that
are likely to express the disease gene. This technique, known as Northern
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blot analysis, can in some cases determine whether the gene identified is
that which is involved in the disease under study. If a probe picks up a
signal from a normal individual but shows either no signal or an altered
signal size in an individual suffering from the disease under study then it is
likely to be involved in the disease. An absence or alteration in the length or
stability of the transcript will occur when the disease-causing mutation
abolishes transcription or produces a truncated, novel or unstable transcript.
Limitations to this approach may be encountered if the gene under study is
expressed either at low levels or is subject to temporal control. It may also
be difficult to obtain samples of the appropriate tissue in which to study
expression. It is sometimes possible to overcome this by amplification of the
products of illegitimate transcription in more accessible tissues (reviewed in
Kaplan et al., 1992).
4. A number of techniques for physical selection of cDNAs have been
developed (Brookes and Porteous, 1991; Lovett et al., 1991; Parimoo et al.,
1991 and Korn et al., 1992). These methods are all based on the isolation of
sequences which are common to two different complex DNA sources,
namely a contig of a genomic region and a cDNA library. Among the
sequences which are coincident between the two resources will be the
genes encoded by the genomic contig. The different approaches vary in
technical details but all aim to isolate heteroduplexes, i.e. DNA duplexes
where one strand comes from the genomic clone and the other comes from
the cDNA source. Providing that the gene of interest is expressed in the
cDNA source under study, these techniques potentially allow the isolation of
transcripts which are expressed at low levels.
5. Isolation of transcribed sequences from particular genomic regions has
been achieved through the use of somatic cell hybrids with reduced human
DNA content, but containing DNA from the region of interest (Liu et al., 1989;
Corbo et al., 1989). In one method heterogeneous nuclear RNA is isolated
from a human-rodent cell line and a cDNA library is made from this material.
The cDNA library is then screened for the presence of human clones (Liu et
al., 1989). Another method uses human Alu repetitive sequences to direct
construction of human specific cDNAs. Where Alu sequences are present in
introns and in 3' untranslated regions of human genes, human cDNAs will be
amplified (Corbo et al., 1989). Thus this version of the method avoids the
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requirement for library construction and screening. These methods are most
useful when somatic cell hybrids containing a very limited amount of human
DNA are available. The techniques are limited to the isolation of genes
which are constitutively expressed and, in the case of the second method
described, to those genes which contain repeats in their introns.
6. Exon trapping and exon amplification are methods which identify genes by
selection for functional splice sites from cloned DNA. The original method of
exon trapping (Duyk et al., 1990) has largely been superseded by a second,
more straightforward, method called exon amplification (Buckler et al., 1991)
Further variation on the procedure has been described (Hamaguchi et al.,
1992). In essence, the vector contains an entire intron flanked by 5' and 3'
splice sites. Genomic DNA is shotgun-cloned into the intron, between the 5'
splice donor site and the branch site. This material is then transformed into
mammalian cells where it is transcribed. If the cloned DNA contains an
entire exon and flanking intronic sequences in the sense orientation then
splicing between these and the vector sites will occur. Mature mRNA can
then be isolated from the cells and reverse transcription PCR is used to
produce cDNA corresponding to the cloned sequences. The size of the
product obtained indicates whether the inserted genomic material has been
completely spliced out or whether an exon was present in the test DNA and
has been trapped. The presence of cryptic splice sites in the inserted DNA
may result in false positives and the small proportion of genes that do not
contain introns will not be identified by this system. However, it has the
advantage that detection is not dependent on the expression level of the
gene. Recently, this technique was used in the isolation of the gene which is
responsible for Huntington's disease (Huntington's Disease Collaborative
Research Group, 1993).
7. Direct DNA sequencing can also be used in gene identification. The gene
which causes Kallman's Syndrome was identified by one group (Legouis et.
al., 1991) using this technique; 67 kb of genomic DNA which corresponded
to an interval known to contain at least part of the gene was sequenced and
examined for potential exons. Computer programs were then used to
examine sequence for transcribed regions. These programs take account of
features such as consensus splice sites, open reading frames and
segmental similarities with known proteins and examine parameters such as
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codon usage and differential nucleotide hexamer compositions in order to
detect potential exons.
8. Many of the methods described above can be used to identify probes that
can be used to screen cDNA libraries. Complex probes such as entire YACs
have also been successfully used to directly screen cDNA libraries (Elvin et
al., 1990; Wallace et al., 1990). Such schemes may have limitations as the
larger the probe the less likely it is that a particular small region of it will pull
out a cDNA, especially if the corresponding cDNA is small. Repetitive
sequences may also cause a high false positive rate. Problems may also be
caused by low expression levels or restricted expression patterns of the
cDNA.
1.6.5 Testing Candidate Genes
Once a candidate gene has been identified by any of the above methods it
must then be shown to cause the disease under study. If a chromosomal
rearrangement segregates with the disease and interrupts the candidate
gene then this is good evidence that the correct gene has been isolated.
Other, less clear-cut evidence includes expression patterns that fit with the
disorder such as expression from the correct tissues at the correct time in
unaffected individuals along with alteration of expression in affected
individuals. It may not, however, be easy to obtain the necessary material to
carry out such analyses, as expression may be in a tissue which is difficult to
sample, or expression may occur during embryonic development. Finally,
screening affected individuals for consistent mutations (which are predicted
to result in loss or alteration of function) in the candidate gene provides good
evidence that the gene is responsible for the disease. There are a number
of methods for detecting previously unknown mutations in genes (reviewed
in Grompe et al., 1993). Large deletions and insertions (>1Mb) and
inversions can be detected by cytogenetics. Southern blot analysis can be
used to look for smaller deletions and inversions, and will also detect point
mutations, if a restriction site is altered by the mutation. Microdeletions can
also be detected by PCR. Multiplex PCR, of several sequences throughout
the gene can be carried out with the result that a large area of the gene can
be covered in a single analysis. Deletions are indicated by a failure of
amplification of a particular product (or products). In addition to these
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methods, a range of techniques exist for the examination of sequences for
point mutations. These are summarised in Table 1.1 (adapted from Prosser,
1993).
1.7 Positional Cloning of Polygenic Disorders
1.7.1 Problems Associated with Positional Cloning of Schizophrenia
Positional cloning strategies can also be applied to polygenic disorders. The
mapping of susceptibility genes for such disorders is however more difficult
than the mapping of genes responsible for monogenic disorders. A major
difficulty is in establishing the initial linkage.
The logarithm of the odds (LOD) score method is a commonly used method
for testing for linkage of marker loci to a disease gene which is believed to
segregate in a particular family or families. The frequency with which
recombination occurs between the disease gene and a marker (the
recombination fraction, 0) increases with increased distance between loci,
until they are sufficiently far apart that the probability of parental and
recombinant chromosomes is equal (as is the case when loci are on
separate chromosomes). When testing for linkage between two loci an
attempt is made to disprove the null hypothesis, that there is no linkage i.e. 0
= 0.5 (the alternative hypothesis is that linkage occurs at 0 < 0.5). This is
done by examining the ratio of probability of observing a particular
distribution of alleles under the hypothesis of linkage at 0 to the probability
under the hypotheses of no linkage. The decimal logarithm of the odds ratio
(LOD) is calculated. When the distance between two markers is unknown
then LOD scores are calculated at several values of 0 in order to find the
maximum value. A LOD score of three is equivalent to an odds ratio of
1000:1 that two loci are linked. This is the accepted minimum value required
to show linkage in the case of a monogenic disorder. Such a high ratio is
required because of the prior low probability that two loci are linked (for
example the prior probability that two loci lie less than 0 = 0.3 apart is only
~2 %). This low prior probability means that, for 0 = 0.3, a LOD score of 3
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The problems encountered when attempting to use this method of linkage
analysis to detect a susceptibility gene for schizophrenia are discussed
below.
Linkage analysis will only be possible if a gene of major effect is segregating
in at least a proportion of the families under study. In the case of a
Mendelian disorder the risk to relatives decreases by one half with each
degree of relatedness. If the risk decreases more rapidly than this then a
more complex genetic model is implicated. Schizophrenia falls into this
category but the precise genetic model is unclear and probably varies
between families (Levinson and Mowry, 1991).
Genetic heterogeneity will also greatly affect linkage analysis. Genetic
heterogeneity is the situation where different mutations at different loci can
give rise to the same disease phenotype. It seems likely that schizophrenia
is genetically heterogeneous. Genetic heterogeneity within a study family or
families will tend to obscure linkage rather than generate false linkages.
This is because individuals who should be classified as unaffected will be
classified as affected. If any of these individuals are recombinant at a locus
linked to the disease then linkage to the locus will be weakened or missed
completely.
Assortative mating may increase genetic heterogeneity by introducing
another set of schizophrenia causing genes into a family. Assortative mating
has been shown to occur in some psychiatric disorders, particularly in the
affective disorders and possibly in schizophrenia (Baron et al., 1990) If
assortative mating occurs without detection then the results of linkage
analysis will be affected in the manner described above.
Phenocopies of the disease, for example disease caused solely by
environmental factors, will tend to decrease LOD scores at linked loci. This
is again because individuals who should be classified as unaffected are
classified as affected. Conditions such as temporal lobe epilepsy, brain
injuries, early-stage Huntington's disease, amphetamine overdoses, thyroid
disease and porphyria can cause schizophrenia like symptoms (Lander,
1988).
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A gene that can cause a predisposition to schizophrenia may show variable
expressivity. In other words it may cause susceptibility to mental illnesses
other than schizophrenia. A disorder which can be caused by a gene which
predisposes to schizophrenia should occur at a higher frequency in close
relatives of schizophrenics than it does in the general population. The
possibility that a common environment may cause psychiatric illness in more
than one family member must be ruled out. This is achieved by comparing
the incidence and types of psychiatric illness in adopted relatives of
schizophrenics to that seen in adopted relatives of controls. One such
survey found that relatives of schizophrenics are subject to higher than
expected levels of schizotypal personality disorder and paranoid personality
disorder (Kety et al., 1971). The extent to which variable expressivity occurs
and the diseases to which individuals are predisposed may vary from one
disease causing gene to another. Hence defining affected status is very
difficult. False positives will decrease positive LOD scores, as described
above, while false negatives will be indistinguishable from non-penetrant
carriers and therefore, in small numbers, may be less important.
As mentioned above, schizophrenia has a complex mode of inheritance, it
exhibits incomplete penetrance or expressivity. When carrying out linkage
analysis of a disease which shows reduced penetrance only ill individuals
can be confidently counted as recombinants, as healthy individuals may be
non penetrant disease gene carriers. The result of this limitation is that even
very large pedigrees may not have enough recombination events to
sufficiently narrow down the region containing the disease gene.
Linkage analysis requires that the penetrance of the gene under study be
specified. The penetrance of the allele will depend on the genetic
background of each individual as well as the environmental factors that each
individual is exposed to. It is also likely that different genes which
predispose to schizophrenia will exhibit different penetrance values. Thus
determination of the penetrance of a particular gene is not possible and LOD
scores are generally calculated for a range of penetrance values.
The gene frequency (in the general population) must also be specified in
order to calculate LOD scores. Again, accurate determination of this value is
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not possible and LOD scores tend to be calculated for a range of gene
frequencies.
As mentioned above, schizophrenia exhibits a wide range of onset ages.
This leads to difficulties when attempting to assess the penetrance of the
disorder and when deciding which family members are affected and which
are unaffected. The age of onset will vary between disease causing genes
and between individuals with the same predisposing allele. Such variation is
likely to be due to variation in environmental factors experienced by different
individuals and by the different genetic background of each individual.
The result of such uncertainty is that different estimates of the various
parameters (e.g. penetrance values and diagnostic boundaries of affected
phenotype) are used to calculate a set of LOD scores. Because of this, it is
considered necessary by some authors to have a higher minimum LOD than
the score of 3 which is considered sufficient to define linkage of a monogenic
disorder to a marker (Risch, 1992).
1.7.2 Failure of a Previous Attempt to Map Genes for Schizophrenia by
Linkage Analysis
Following a report of an association between schizophrenia and a partial
trisomy of chromosome 5 (Bassett et al., 1988) linkage of schizophrenia and
other psychiatric illness to markers on the trisomic region of chromosome 5
was reported in seven British and Icelandic families (Sherrington et al.,
1988). LOD scores were used to detect linkage; a LOD of 6.49 was
achieved with the broad phenotype, which included disorders such as
alcoholism as well as schizophrenia spectrum disorders.
This finding has however been followed by a series of studies which have
failed to find evidence of linkage to that region of chromosome 5 (Kennedy et
al., 1988; St.Clair et al., 1989; Detera-Wadleigh et al., 1989; Aschauer et al.,
1990; McGuffin et al., 1990; Crowe et al., 1991 and Macciardi et al., 1992).
The study was extended, by the use of polymorphic microsatellite markers
which were more informative and increased the number of informative
meioses (O'Donovan and Owen, 1992). Once this analysis had been carried
out no evidence was found for linkage of chromosome 5 markers to the
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broad phenotype. Although when the phenotype was restricted to
schizophrenia and spectrum disorders it remained at approximately 3. The
study was also extended by the addition of new families. Once this had been
done no evidence for linkage remained (O'Donovan and Owen, 1992).
1.7.3 Possible Solutions to the Problems of Mapping Schizophrenia
Genes
The problems of reduced penetrance, difficulty in determining the mode of
transmission and definition of affected status, which are associated with the
LOD score method of linkage analysis, could be lessened if subclinical
characteristics (which were determined by a gene that predisposed to
schizophrenia, but which showed higher penetrance than the disorder) could
be used in the linkage analysis. Such characteristics are referred to as trait
markers. Trait markers should satisfy the following criteria: genetic control;
association with disease at the population level; state independence and co-
segregation with illness in the families of index cases (Gershon et al., 1990).
Of the proposed trait markers, smooth pursuit eye movement dysfunction
and abnormal P300 event related potential appear to meet these criteria
(Blackwood et al., 1991).
Alternatively, other methods of linkage analysis could be employed. The
affected-sib-pair (ASP) method examines the frequency with which the
members of affected sib pairs both inherit the same allele at a locus, with the
frequency at which this would be expected if the locus was unlinked to the
disease. As the prior probability that sibs will share an allele at a particular
locus is high (even when both parents are heterozygous at a locus there is
still a 50 % chance that the sibs will have a common allele at the locus) it is
easier to exclude than to include loci.
This method has the advantage that it does not require the specification of
genetic model of the disease (Nothen and Fimmers, 1993). However, one of
its most important disadvantages, with respect to its usefulness in detecting
linkage to schizophrenia, is that the power of the method is greatly affected
by genetic heterogeneity.
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Another method of linkage analysis is association studies. These examine
individuals for an association between DNA variants and disease. Often, a
candidate gene is selected and nearby polymorphic markers are used to
compare patients and controls for an association of the disease and
particular haplotypes (Nothen and Fimmers, 1993). An association will
occur when there is strong linkage disequilibrium between the loci or when
the marker contributes to the disease pathogenesis (Nothen and Fimmers,
1993). Linkage disequilibrium will only occur when there is either a low
mutation rate, very tight linkage or a selective advantage of the haplotype
which contains the disease gene (Nothen and Fimmers, 1993). Like the
ASP method, the effectiveness of this method will be reduced by the
presence of genetic heterogeneity. In addition there is the problem caused
by population stratification. To avoid differences in allele frequencies
patients and controls have to be carefully matched for ethnic, geographical
and social background. A possible solution is to carry out association
studies within families with the control sample corresponding to, for example,
the parental alleles not inherited by the proband (Nothen and Fimmers,
1993).
The easiest way to identify the position of a disease gene is to identify a
chromosomal rearrangement which segregates with the disorder.
Chromosomal rearrangements include inversions, where breaks have
occurred at two points on a chromosome and the segment has been inverted
before being rejoined; deletions, where a segment of a chromosome has
been lost and translocations, where breaks have occurred on two (or
occasionally more chromosomes) and rejoining has happened between the
wrong chromosome ends. Translocations can be balanced, where
rearrangement has occurred without loss or duplication of any chromosomal
material, or unbalanced, where duplications and/or deletions have occurred.
Balanced translocations are the most common de novo structural
chromosome rearrangements; estimates of their frequency range from 2.6-
14/10,000 live births (Giaclone and Franke, 1992).
Chromosomal rearrangements as well as pointing to the location of the gene
make it easy to determine when the appropriate region has been cloned.
Deletions may cover a large chromosomal region making subsequent
identification of the correct gene difficult. This may also be true in case of
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translocations and inversions, the gene may not be at one of the breakpoints
rather, the break may affect expression of a nearby gene or the
rearrangement may have prevented crossing over in the region, fixing the
rearranged chromosome as a marker for the disease gene.
Chromosomal rearrangements have a final advantage which is particularly
important when carrying out linkage analysis in diseases with complex
modes of inheritance, such as schizophrenia. The rearrangement allows all
individuals who have inherited the proposed causative mutation to be
identified. In the absence of a rearrangement this is not possible because of
the reduced penetrance associated with such disorders. This means that
when a rearrangement segregates with the disorder there is access to more
recombination events for linkage analysis (although, as mentioned above,
rearrangements may reduce the number of recombination events in that
region).
1.8 A Family Segregating A Balanced Translocation
t(1; 11 )(q42.2;q21)
As mentioned previously, a large Scottish pedigree has been reported where
a balanced translocation t(1; 11 )(q42.2;q21) appears to co-segregate with a
predisposition to schizophrenia and other major mental illnesses (St.Clair et
al., 1990). The family was identified by a survey carried out on the MRC
Cytogenetics Registry in Edinburgh. The Registry holds up to date clinical
data on 282 pedigrees, identified over a 20 year period, which have familial
autosomal abnormalities. These pedigrees were examined for any co-
segregation of mental illness with the chromosomal abnormalities. This
search resulted in the identification of pedigree K26. No phenotypic
abnormalities were reported in the original description of the family but
cumulative annual follow-up data from general practitioners indicated that
many members of the family had been treated for psychiatric illness. The
family was reapproached and the mental health of each family member was
re-evaluated. Seventy-seven individuals were included in the study, 58
living and 19 deceased. Twenty-three individuals from this family were
diagnosed as suffering from mental illness, as defined by the Research
Diagnostic Criteria for mental and/or behavioural disorders. These
diagnoses are three cases of schizophrenia, two of schizoaffective disorder,
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six of major depressive disorder, six of generalised anxiety disorder, one of
minor depressive disorder and three of alcoholism. Five of the family
members had received or were receiving treatment for adolescent
psychiatric disorders, three of whom now have a subsequent diagnosis. Of
the 23 cases, three individuals had attempted suicide and a further two had
achieved suicide. Twenty-one of these individuals could therefore be
karyotyped, along with 56 other family members. It was found that 34 of the
77 individuals carry the t(1;11)(q42.2;q21) translocation. Sixteen of these
had been diagnosed as suffering from a mental illness while, of the 43
without the translocation, only five were diagnosed as suffering from a
psychiatric disorder. None of these diagnoses was for a major mental
illness; there was one case of minor depressive disorder, three cases of
alcoholism and one of generalised anxiety.
LOD scores against chance linkage of the translocation to mental illness
were calculated. It was not known which mental disorders could potentially
be accounted for by the chromosomal rearrangement. LOD ratios were
therefore calculated for five definitions of affected phenotype. As gene
frequency and gene penetrance were also unknown, the LOD score for each
phenotypic model was calculated for a range of gene frequency and
penetrance values.
When the affected phenotype was defined as schizophrenia and
schizoaffective disorder the maximum LOD score was 2.19. Recurrent major
depression was included and the maximum LOD rose to 3.33. The third
model produced the highest maximum LOD score, 4.34, when the definition
of the affected phenotype was expanded to include adolescent conduct and
emotional disorder. The maximum LOD score fell to 1.37 and 1.73 when
generalised anxiety, minor depression and chronic alcoholism were added to
the second and third models respectively.
The psychiatric diagnoses that made up model II are commonly found
together in families with many cases of mental disorders. The adolescent
conduct and emotional disorders that were added to model II to form model
III are often found in people who develop recurrent mental illness in adult
life, as has been observed in this pedigree. They also tend to be found at a
higher than expected frequency among the offspring of adults with major
38
mental illness. It is not surprising therefore that inclusion of these diagnoses
in the definition of affected phenotype causes the maximum LOD score to
rise. It is also unsurprising that the addition of generalised anxiety, minor
depression and chronic alcoholism should cause LOD scores to fall. Such
diagnoses lack specificity and occur at relatively high frequencies in the
general population. These results therefore indicate a strong likelihood of
linkage of the translocation to mental illness in this family.
Mapping and cloning the regions of the translocation breakpoints would
therefore facilitate a search for a gene or genes (that may be located at or
near one or both of the translocation breakpoints) which may predispose to
schizophrenia and other mental illnesses.
The identification of a gene which predisposes to schizophrenia has many
implications. The same gene may be involved in mental illness in other
patients. This could be tested firstly by linkage analysis in families and by
mutational analysis of the gene in individuals. This would provide a
validating factor for diagnosis of mental illnesses and would provide
information on the genetic relationship between different diagnoses.
The advantages of identifying the gene predisposing to mental illness in this
family would not however depend on its involvement in other cases of mental
illness. Study of the gene and its product would provide information which
may give clues to the aetiology of the disorder and correspondingly to
possible treatments for the disorder. This information may also implicate
other proteins and genes (for example proteins involved in the same or in a
related pathway or homologous genes) in involvement in other cases of
mental illness.
The discovery and study of a gene which, if mutated, can cause a
predisposition to mental illness may increase our knowledge of normal brain
development. It may also provide clues as to the nature and the mode of
action of the environmental factors which are important in schizophrenia.
1.9 Objectives of this Thesis
The objectives of this thesis are as follows:
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1. To refine the position of both translocation breakpoints.
2. To establish relative marker order with respect to the chromosome 11
breakpoint.
3. To identify and map new markers in the region of the chromosome 11
breakpoint.
4. To isolate YACs from the region immediately distal to the translocation
breakpoint.
5. To identify a clone which crosses the breakpoint on chromosome 11.
To this end a number of resources were assembled and exploited. Of these
the following were key to the execution of my studies:
1. Somatic cell hybrids which segregate the translocation chromosomes.
2. Reduced chromosome hybrids which contain complimentary fragments of
human chromosome 11 in rodent backgrounds.
3. A microdissection library corresponding to a 30 Mb region surrounding the
translocation breakpoint of the derived chromosome 1.
4. Gridded YAC libraries.
5. Fingerprint analysis of YAC recombinants.
6. Marker segregation analysis of YAC recombinants.
7. Pulsed field gel electrophoretic analysis of normal and translocation
chromosomes with microdissection clones.
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CHAPTER 2
2. Materials and Methods
2.1 Mammalian Cell Culture
2.1.1 Cell Lines
The following cell lines were analysed. Somatic cell hybrid lines which
segregate the reciprocal translocation chromosomes are MIS 7.4 (murine,
X63, background) and MAR 12 (murine, RAG, background), which carry the
derived 1 translocation chromosome, and MIS 39.8 and MAR 1 which carry
the derived 11 translocation chromosome (each in the absence of any
normal chromosome 1 or 11 material). Segregation of the translocation
chromosomes was achieved by cell-surface marker selection strategies
(Fletcher et al., 1993). Four X irradiation hybrids, WJX 3.4, WJX 5.4, WJX
7.4 and WJX 11.2, which contain fragments of chromosome 11 in the
background of a Chinese hamster ovary cell line, WG3H, were also
analysed. These fragmentation hybrids were produced by X irradiation of a
chromosome 11-only hybrid J1CI4 (Jones et al., 1984), followed by rescue of
the fragments produced, by fusion with WG3H cells and finally, cell surface
marker selection to isolate those cell lines which retained fragments of
chromosome 11 (Fletcher et al., 1993). Two additional chromosome 11
fragmentation hybrids, E67.1 and E67.4, were studied. These were derived
by transfer of metaphase chromosomes from a human EJ bladder carcinoma
cell line to the murine C127 cell line. This was followed by selection for
HRAS 1 mediated transformed growth, in addition to selection for the HRAS
locus and other markers on 11 p (Porteous et al., 1986). E67.1 and E67.4,
had been analysed previously for 11 p markers (Porteous et al., 1987) and a
limited number of 11 q markers (Spurr et al., 1988). Two additional
translocation cell lines were analysed. PG48 has a translocated
chromosome 11 which lacks 11 q22-11 qter (and a number of other human
chromosomes) in a, a23, hamster background (McConville et al., 1993).
CF52 has a well characterised t(11;16)(q13;p11) translocation chromosome
as its sole human component in the background of a murine cell line, A9
(Koeffler et al., 1981).
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MAFLI, which is a permanent B lymphoblastoid cell line established from a
patient with schizophrenia and bearing the t(1; 11 )(q42.2;q21) translocation
(Fletcher et al., 1993), and J1CL4, see above, (Jones et al., 1984), were
positive controls. Cell lines WG3H, X63 and RAG (see above) were
negative controls.
In a few assays, a number of other cell lines were studied: MIS 39.5 is a
hybrid cell line which contains a rearranged chromosome 11, in addition to
the derived chromosome 11 translocation chromosome (Veronica van
Fleyningen, personal communication). CF37 (Mohandras et al., 1980) is a
hybrid cell line which contains a translocated chromosome 11, whose
chromosome 11 breakpoint is at a similar position to that of the translocated
chromosome 11 present in CF52. M11X is a hybrid which has a
t(X;11)(q26;q23.2) as its sole human component (Chiang et. al., 1984).
MIS 7.4, MIS 39.8, X63, MAR 1, MAR 12, CF52, PG48, CF37, MIS 39.5,
M11X and RAG were all grown in Veronica van Heyningen's laboratory.
They were obtained in the form of frozen cell pellets, from which DNA was
isolated (see section 2.2.1). Similarly, E67.1 and E67.4 were obtained as
frozen cell pellets from David Porteous. J1CI4, WG3H, WJX 3.4, WJX 5.4,
WJX 7.4, WJX 11.2, and MAFLI were obtained from Veronica van
Heyningen in the form of liquid nitrogen stocks and were cultured as
described below.
2.1.2 Maintenance of Cells in Culture
All cell culture was carried out under sterile conditions in a Lamina flow
hood. Cells were maintained in Dulbecco's modified Eagles medium
(DMEM) (Flow Laboratories) supplemented with heat inactivated 10 % foetal
calf serum (FCS) (Gibco). Penicillin and streptomycin (Gibco) were added to
cultures at 100 units/ml and 100 pg/ml respectively. Cultures were grown at
37°C in 25 cm2, 75 cm2 (Nunclon) and 175 cm2 (Falcon) tissue culture flasks
in a 10 % C02 atmosphere.
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2.1.3 Reviving Frozen Cells
Cells which had been previously frozen and stored under liquid nitrogen
were rapidly thawed by placing the vial in a beaker of water warmed to 37°C.
Once the cell suspension had completely liquefied, the storage medium was
diluted with 5 ml culture medium and the cells were pelleted by
centrifugation at 1000 rpm for 5 minutes. The pellet was then resuspended
in a small volume of culture medium and the cells were transferred to a
25 cm2 culture flask, which contained 10 ml culture medium.
2.1.4 Harvesting Cells
The culture medium was removed by aspiration, and the cell monolayer
rinsed in a small volume of Dulbecco's phosphate buffered saline (PBS)
(approximately 2 ml/25 cm2 flask, 5 ml/75 cm2 flask, 8 ml 175 cm2 flask) to
remove traces of serum. The PBS was then removed and the same quantity
of 10 % trypsin in versene was added (versene is 12 ml 0.2 % phenol red
(Flow laboratories); 10 Dulbecco tablets (Oxoid Ltd.) and 0.4 g EDTA). The
flasks were briefly incubated at 37°C, to activate the trypsin, facilitating
loosening of the cells. The cells were then harvested into a 50 ml centrifuge
tube (Corning) and the flask was rinsed out with a small amount of medium
(to maximise the harvest). The tube was filled with medium, to dilute and
inactivate the trypsin, and the cells were pelleted by centrifugation at
1000 rpm for 5 minutes.
2.1.4.1 Harvesting Cells for the Expansion of Clones
The cells were harvested as described in section 2.1.4. The cell pellet was
resuspended in the appropriate volume of medium and added to new flasks.
2.1.4.2 Harvesting Cells for Storage at -70°C
Cells were harvested as described in section 2.1.4. The cell pellet was
resuspended in 2 ml of ice cold freezing mix (FCS containing dimethyl
sulphoxide (DMSO) at a final concentration of 10 %). Approximately 1 ml of
this cell suspension was stored in each of two freezing vials (Nunc) which
had been previously chilled on ice. The vials were initially placed at -70°C in
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a cotton wool padded box (to slow the freezing process). After a minimum of
16 hours the vials were transferred to liquid nitrogen storage.
2.1.4.3 Harvesting Cells for Preparation of DNA
The cells were harvested as described in section 2.1.4. The cells were then
washed, by resuspension in 20 ml PBS, followed by centrifugation at
1000 rpm for 5 minutes. This procedure was repeated twice to remove all
traces of medium. Pellets were stored at -70°C, prior to DNA preparation
(see section 2.2.1).
2.1.4.4. Harvesting Cells for Preparation of Agarose Plugs
The cells were harvested as described in section 2.1.4. The cells were then
washed by resuspension in 20 ml PBS and centrifugation at 1000 rpm for
5 minutes. This was repeated twice in order to remove all traces of medium.
The pellet was then resuspended in approximately 5 ml PBS, prior to
agarose plug preparation (see section 2.2.2).
2.2 Preparation of DNA from Cultured Cells
2.2.1 Isolation of Genomic DNA from Cultured Cells
This method was adapted from van Heyningen (in press).
Frozen cell pellets were allowed to thaw before being resuspended in 0.5 ml
TNE (10 mM Tris, pH 8.0; 1 mM ethylenediaminetetra-acetic acid (EDTA);
150 mM NaCI). The cells were maintained in suspension and lysed by the
addition of 2.5 ml lysis buffer (0.5 % sodium dodecyl sulphate (SDS);
150 mM NaCI; 100 mM Tris.HCI, pH 8; 100 mM EDTA). RNA was digested
by the addition of 300 pg RNase A (Sigma) and incubation at 37°C for 15
minutes. Proteins were digested by the addition of Proteinase K (Boehringer
Mannheim) at 0.5 mg/ml with incubation overnight at 50°C. An equal volume
of water saturated phenol was then added to the extracts, they were mixed
thoroughly and centrifuged at 3000 rpm for 5 minutes. The aqueous layer
was removed and extracted, as described above, with an equal volume of
firstly 1:1 phenol/chloroform and secondly chloroform. The DNA was
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precipitated from the aqueous layer with 0.5 volumes of 7.5 M ammonium
acetate and 2 volumes of ethanol. The DNA was spooled out of the solution
onto a glass rod. It was allowed to air dry, was washed in 75 % ethanol and
again allowed to air dry. The DNA was then dissolved in 200 pi TE (10 mM
Tris.HCI pH7.5; 1 mM EDTA).
2.2.2 Preparation of Plugs for Pulsed Field Gel Electrophoresis
This method was adapted from van Heyningen (in press).
The cells were harvested and washed as described in section 2.1.4. The
pellet was then resuspended in approximately 5 ml PBS. A drop of the
suspension was taken and the number of cells per ml estimated using a
haemocytometer. The cells were centrifuged at 1000 rpm for 5 minutes and
resuspended in equal volumes of PBS and 1 % low melting temperature
agarose (Gibco BRL) such that the final concentration of cells was ~107 /ml.
After thorough mixing the solution was quickly dispensed in 100 pi aliquots
into plug moulds and allowed to set on ice. Once solidified the plugs were
ejected into 20 ml 1 % NDS solution (0.45 M EDTA; 10 mM Tris.HCI pH 9;
1 % SDS) containing proteinase K at a final concentration of 1 mg/ml. The
plugs were then incubated at 50°C for 24 hours. The solution was then
replaced with fresh 1 % NDS/Proteinase K solution and a second 24 hour
incubation carried out. The plugs were then stored in 20 ml 1 % NDS,
without Proteinase K, at 4°C.
2.3 Yeast Cell Culture
2.3.1 Media and Additives
All media was sterilised by autoclaving.
AHC Broth and Agar
AHC is a rich, selective medium which lacks uracil and tryptophan. It was
used for selective growth of YAC recombinants prior to production of plugs
and isolation of DNA.
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1.7 g yeast nitrogen base (without amino acids and ammonium sulphate)
(Difco), 5 g ammonium sulphate, 10 g casein hydrolysate-acid (low salt)
were added to 1 litre distilled water. The pH was adjusted to 5.8. 17-20 g of
Bacto agar (Difco) per litre broth was added at this stage for AHC agar.
After autoclaving and allowing to cool, 50 ml filter sterilised 40 % glucose
and 10 ml 2 mg/ml sterile adenine sulphate solution were added to the broth
(or agar).
YPD Broth And Agar
YPD medium was used for growing yeast cultures.
20 g bactopeptone (Difco), 5 g yeast extract (Difco), 5 g sodium chloride
were added to 1 litre distilled water. 1.5 % agar was added at this stage for
YPD agar. After autoclaving and allowing to cool, 50 ml sterile 40 % glucose
was added to the broth or agar.
2.3.2 The ICI YAC Library
The ICI YAC library (Anand et al., 1990) was screened by Southern
hybridisation (Southern, 1975) (see section 2.11.4). The library consists of
approximately 35,000 YAC recombinants gridded at a high density on 23
filters of 8 cm x 12 cm. The average insert size is approximately 350 kb and
the theoretical complexity of the library is therefore >3.5 genome
equivalents. The percentage of chimaerism of the library is estimated at
approximately 15 %. The ICI YAC library was obtained through the Human
Genome Mapping Project (HGMP) Resource Centre, London.
2.3.3 Yeast Strains
Saccharomyces cereviseae strains YP148 (Jones et al., 1989) and AB972
(Link and Olson, 1991) were used as size markers for pulsed field gel
electrophoresis. Table 2.1 lists the sizes of the chromosomes of the two
strains.
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2.4 Manipulation of YAC DNA
2.4.1 Yeast DNA Preparation
This method was adapted from Hoffman and Winston (1987).
10 ml yeast cultures were grown to saturation and the cells collected by
centrifugation at 3000 rpm. The cells were resuspended in 500 pi dH20,
transferred to an eppendorf tube and collected by a brief centrifugation at
13000 rpm. Most of the supernatant was removed and the pellet was briefly
vortexed. 200 pi lysis buffer (2 % Triton X-100 (Sigma); 1 % SDS; 100 mM
NaCI; 10 mM Tris.HCI, pH 8; 1 mM EDTA, pH 8), 400 pi phenol/chloroform
and 0.3 g 0.4 mm glass beads (BDH) were added to the cells, which were
then vortexed for 4 minutes. This process results in cell lysis and separation
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of the nucleic acids, which remain in the aqueous layer, from the cell debris
which remains in the organic layer. After vortexing 200 pi TE (10 mM
Tris.HCI pH7.5; 1 mM EDTA) was added and the tubes were centrifuged at
13000 rpm for five minutes. The supernatant was decanted to a fresh tube
and 1 ml cold ethanol was added to the supernatant (in order to precipitate
the DNA). The tubes were inverted and centrifuged at 13000 rpm for 2
minutes. The pellet obtained was dried and resuspended in 40 pi TE. RNA
was digested by addition of 30 pig RNaseA (Sigma) followed by a 5 minute
incubation at 37°C. The DNA was precipitated by addition of 10 ml 4 M
Ammonium Acetate and 1 ml ethanol (at -20°C). The tube was inverted and
centrifuged at 13000 rpm for 2 minutes. Once dry the pellet was
resuspended in 50 pi TE.
2.4.2 Preparation of Agarose Plugs for Pulsed Field Gel Electrophoresis
This method allows the extraction of intact yeast chromosomes, including
yeast artificial chromosomes (YACs), from cells. It was adapted from Maule
(in press).
A 100 ml yeast culture was grown, with shaking, at 200 rpm, from a single
colony, at 30°C for 24 hours, or until the number of cells per ml was ~108.
The culture was chilled on ice for 15 minutes. The cells were then
harvested, by centrifugation at 4000 rpm, for 10 minutes at 4°C. The
supernatant was discarded and the pellet dispersed in 50 ml chilled 50 mM
EDTA pH 7.5. The cells were harvested, resuspended in fresh EDTA and
harvested again, as described above. The pellet was resuspended in 3 ml
chilled 50 mM EDTA, pH 7.5 and warmed to 37°C. Cell walls were disrupted
by addition of 1.2 ml freshly prepared cell wall digestion solution (2 ml SCE,
pH 8 (1 M sorbitol; 0.1 M sodium citrate; 60 mM EDTA); 100 pi
2-mercaptoethanol (Sigma); 2 mg zymolyase (ICN Biomedicals). 6 ml 1 %
low melting temperature agarose (Gibco), in 0.125 M EDTA pH 7.5, at 50°C
was added to this. After thorough mixing 100 pi aliquots of the solution were
quickly dispensed into plug moulds and allowed to set on ice. Once
solidified, the plugs were ejected into 25 ml ETM solution (0.45 M EDTA;
10 mM Tris.HCI pH 8; 7.5 % 2-mercaptoethanol) and placed in a 37°C
waterbath for 24 hours. The ETM was replaced with 20 ml 1 % NDS solution
(0.45 M EDTA; 10 mM Tris.HCI pH 9; 1 % SDS) containing proteinase K
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(Boehringer Mannheim) at 1 mg/ml and the plugs incubated at 50°C for
24 hours. This step was repeated with fresh 1 % NDS solution. Finally, the
plugs were stored in 20 ml ETM at 4°C.
2.5 Bacterial Cell Culture
2.5.1 Media and Additives
All media was sterilised by autoclaving.
L-Broth and Agar
2.46 g MgS04, 10 g tryptone (Difco), 5 g yeast extract (Difco) and 10 g NaCI
were added per litre of distilled water. 15 g agar (Oxoid Ltd) was added per
litre broth for L-agar.
Terrific Broth
12 g tryptone, 24 g yeast extract, 4 g glycerol were added per 900 ml of
distilled water. After autoclaving, 100 ml autoclaved phosphate solution
(0.1 M KH2P04 and 0.72M K2HP04) was added.
Ampicillin
Ampicillin was added to agar and broth in order to select for bacteria
carrying plasmids which confer resistance to this antibiotic. A stock solution
of ampicillin (Sigma) was made up at a concentration of 50 mg/ml. This
solution was filter sterilised and stored at -20°C. It was added to broth and
agar to give a final concentration of 50 (ig/ml.
Kanamycin
Kanamycin selection was required for growth of 021, the cosmid containing
the human OMP gene. A stock solution of kanamycin (Sigma) was made up
at a concentration of 10 mg/ml. This solution was filter sterilised and stored
at -20°C. Kanamycin was added to broth and agar to give a final
concentration of 10 pg/ml.
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5-Bromo-4-Chloro-3-lndolyl (3-D-Galactopyranoside (X-gal)
X-gal (Sigma) acts as a substrate for p-galactosidase. It was added to agar
for the growth of plasmids carrying blue/white colour selection (see section
2.5.3). A stock solution of X-gal was made up at a concentration of
20 mg/ml in dimethyl sulphoxide (DMSO) (Sigma) and stored, protected from
light at -20°C. It was added to agar to give a final concentration of 40 pg/ml.
Isopropyl p-D-Thiogalactopyranoside (IPTG)
IPTG is an derepressor of the Lac operon. It was added to agar for the
growth of plasmids carrying blue/white colour selection (see section 2.5.3).
A stock solution of IPTG (Sigma) was made up at a concentration of 100 mM
and stored at -20°C. It was added to agar to give a final concentration of
0.5 mM.
2.5.2 Bacterial Strains
DH10B genotype: F-, araD139. Afara. Ieu)7697. AlacX74. galU. galK. mcrA
A(mrr- hsdRMS- mcrBC) rpsL, dor. <})80dlacZAM15. endA1, nupG. recA1.
This bacterial host strain was used for the growth of Bluescribe (pBS)
plasmid (see section 2.5.3).
2.5.3 Bacterial Vectors
Bluescribe (pBS) (Stratagene) is a plasmid vector based on pUC19
(Yanisch-Perron et al., 1985). The plasmid contains an ampicillin resistance
gene which allows selection of transformed bacterial cells and the bacterial
origin of replication allows attainment of high plasmid copy number. The
vector has a blue/white colour selection system which allows colonies
containing recombinant plasmids to be distinguished from those containing
non-recombinant plasmids. The polylinker is inserted into the p-
galactosidase (lac Z) gene. Correspondingly, plasmids without inserts have
an active lac Z gene and produce a produce a blue indolyl derivative when
grown on plates containing X-gal and IPTG. Colonies containing
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recombinant plasmids have an interrupted, non-functional lac Z gene and
are white.
2.5.4 Preparation of Competent Cells for Electro-Transformation
A sterile loop was used to streak out a bacterial host strain (DH10B) from a
frozen glycerol stock onto an agar plate. The plate was grown at 37°C
overnight. A single colony was then inoculated into 5 ml L-broth and
incubated overnight at 37°C with shaking at 250 rpm. The following day,
500 ml of prewarmed L-broth was inoculated with the overnight culture and
incubated overnight at 37°C with shaking at 250 rpm. The cells were grown
to an absorbance (measured at 600 nm) of 0.5-1.0, transferred to a chilled
flask and incubated on ice for 15-30 minutes. The suspension was then
divided between ten chilled 50 ml centrifuge tubes and centrifuged at 4°C for
15 minutes at 3500 rpm. Each pellet was resuspended in 50 ml of treated
water at 4°C. The water had previously been de-ionised, UV-sterilised, and
autoclaved in bottles with no trace of detergent. This treatment was carried
out as is very important that the water does not contain any impurities (which
will alter its pH from 7.0), or any detergents. The suspension was then
centrifuged, as described above, and the supernatant was carefully
removed. Each pellet was resuspended in 25 ml of treated water, containing
glycerol at a final concentration of 10 %. The cells were pelleted as
described above and the supernantant carefully removed leaving the pellet
in as small a volume as was possible. The pellets were pooled and
resuspended in 10 % glycerol to give a final volume of 1 ml, resulting in a
final cell concentration of approximately 3 X 1010. 40 pi aliquots of the
suspension were dispensed into Eppendorf tubes, which had previously
been placed in a dry ice/ethanol bath. Finally, the pellets were stored at
-70°C. The competence of the cells produced by this method ranged from
107 to 109colony forming units/pg pUC19.
2.5.5 Electro-transformation of Competent Cells
40 pi aliquots of competent cells (~108 colony forming units/pg pUC19) were
thawed at room temperature and placed on ice. 1-2 pi of the ligation
reaction (see sections 2.7.5 and 2.7.6) was added to the cells. The cell
suspension was mixed and incubated on ice for approximately 1 minute. It
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was then transferred to a chilled electroporation cuvette (Flowgen) and
subject to a 2.5 kV pulse, using a Bio Rad Gene Pulser. 1 ml L-broth was
quickly added to the cell suspension. The cells were transferred to an
Eppendorf tube and incubated at 37°C for approximately 45 minutes. After
this time, a fraction of the cells were spread on an agar plate containing the
appropriate antibiotic selection and incubated at 37°C overnight.
2.6 Preparation of plasmid DNA
2.6.1 Small Scale Plasmid DNA Preparation
This method is adapted from Jones and Schofield (1990).
A single bacterial colony was picked into 4 ml of "terrific broth" with
appropriate antibiotic selection and incubated overnight at 37°C, with
shaking at 250 rpm. 1.5 ml of the culture was decanted into an Eppendorf
tube and the cells pelleted by centrifugation at 13000 rpm for 1 minute. The
supernatant was decanted from the pellet and the tube allowed to drain for
several minutes to remove any remaining fluid. The pellet was resuspended
in 150 pi of GTE (50 mM glucose; 10 mM EDTA; 25 mM Tris.HCI pH 8.0,
which had been filter sterilised) by vortexing. 300 jllI of alkali solution (0.2 M
sodium hydroxide, 1% SDS) was prepared and added. The tube was
inverted several times to mix the contents and placed on ice for 5 minutes to
allow cell lysis to occur. 225 pil of ice cold, high salt solution (3 M potassium
acetate pH 4.8, which had been sterilised by autoclaving and stored at 4°C)
was added, in order to precipitate the, unwanted, bacterial DNA. The
solution was then mixed, by inversion of the tube, and placed on ice for
5 minutes. After this time the tube was then centrifuged at 13000 rpm for
5 minutes. The supernatant was decanted to a fresh tube and one volume of
ethanol was added. The tube was immediately centrifuged at 13000 rpm for
5 minutes. The pellet obtained was drained, washed in 70 % ethanol and
dried under vacuum for 5 minutes. It was then resuspended in 40 pi TE(10
mM Tris.HCI pH7.5; 1 mM EDTA).
The concentration of the DNA obtained was determined by measurement of
the optical density. The absorbance at 260 nm (ABS260)= 1 at 20 pg/ml
double stranded DNA.
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DNA obtained in this way was used in restriction endonuclease digests (see
section 2.7.1) and as template in double-stranded sequencing (see section
2.13.1)
2.6.2 Large Scale Plasmid DNA Preparation
This method was adapted from Sambrook et.al. (1989).
A single bacterial colony was picked into 4 ml of "terrific broth" with
appropriate antibiotic selection and incubated overnight at 37°C, with
shaking at 250 rpm. This culture was then used to inoculate 400 ml of
"terrific broth," containing the appropriate antibiotic selection, in a 1 litre
flask. This was incubated overnight at 37°C, with continuous shaking at
250 rpm. Cells were harvested, in two 200 ml Sorvall bottles, by
centrifugation at 6000 rpm for 10 minutes at room temperature. The
supernatants were decanted and both pellets were resuspended in 9 ml GTE
(50 mM glucose; 25 mM Tris pH 8.0; 10 mM EDTA pH 8.0, which had been
filter-sterilised). The two suspensions were then combined. 100 mg
lysozyme was dissolved in 2 ml GTE and added to the suspension which
was mixed and incubated at room temperature for 10 minutes (in order to
initiate cell lysis). 40 ml alkali solution (0.2 M sodium hydroxide, 1% SDS)
was prepared and added. The bottle was then swirled, to mix the contents,
and incubated on ice for 5 minutes (to allow cell lysis to go to completion).
20 ml of ice-cold high-salt solution (3 M potassium acetate, pH 4.8, which
had been sterilised by autoclaving) was then added to the bottle (to
precipitate the, unwanted, bacterial chromosomal DNA). After gentle but
thorough mixing, the solution was incubated on ice for 15 minutes. The cell
lysate was then centrifuged at 4000 rpm for 15 minutes at 4°C; the rotor was
allowed to stop without the brake to minimise dislodging of the pellets. The
supernatant was filtered through muslin, into a sterile measuring cylinder
and 0.6 volumes of isopropanol were added. The solution was mixed
thoroughly by shaking and incubated at room temperature for 10 minutes.
The precipitated plasmid DNA was recovered by centrifugation at 5000 rpm
for 15 minutes at room temperature. The pellet was drained, rinsed in 70 %
ethanol and dried under vacuum. The pellet was then resuspended 7.7 ml
TE(10 mM Tris.HCI pH7.5; 1 mM EDTA). To this was added 400 pi ethidium
bromide (10 mg/ml) and 9.2 g caesium chloride. The resultant solution was
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carefully pipetted into quickseal ultra-centrifuge tubes (Beckmann) and
centrifuged in a fixed-angle rotor at 100,000 rpm for 16-18 hours at room
temperature. The covalently-closed-circular plasmid DNA was visible as a
tight band about half way up the centrifuge tube. Bands were extracted from
the tube using a sterile 0.8 gauge hypodermic needle attached to a syringe.
The ethidium bromide was removed from the DNA by repeated extraction
with water-saturated butan-1-ol (extractions were carried out until no pink
colour remained in the organic phase). The DNA was then precipitated from
the caesium chloride-containing solution by addition of 2.5 volumes 70 %
ethanol. The solution was mixed and incubated at -70°C for 20 minutes. It
was then centrifuged for 10 minutes at 10,000 rpm. The pellet obtained was
drained, vacuum-dried and resuspended in 200 pi TE.
The ABS260 was measured in order to estimate the DNA concentration (see
section 2.6.1.
2.7 Enzymatic Manipulation of DNA
2.7.1 Restriction Endonuclease Digestion of DNA
Digestions with restriction endonucleases (Boehringer Mannheim) were
carried out in the appropriate buffer (supplied by the manufacturer) at the
recommended temperature. 1 pg DNA was digested in 5-10 pi, containing
1 /20th volume of 0.1 M spermidine (Sigma), with 1-2 units of restriction
enzyme, for 1 hour. Reactions were scaled up accordingly, except that the
amount of enzyme was reduced when longer incubation times were used.
When two different enzymes, both of which required the same buffer, were
used digests were carried out simultaneously. Otherwise, digestion with the
enzyme requiring the lower buffer salt concentration was carried out first.
The salt concentration was then altered by addition of the appropriate
amount of sodium chloride solution and the second digestion carried out.
Reactions were terminated by heating to 68°C or 80°C for 15 minutes,
according to the heat sensitivity of the enzyme (New England Biolabs
catalogue 1992), or alternatively by phenol/chloroform extraction of the
reaction. Restriction digests which were run on agarose gels were
terminated by the addition of 1/10th of their volume of "stop mix" (100 mM
EDTA, pH 8; 20 % Ficoll and orange G)
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2.7.2 Restriction Enzyme Digestion of Agarose Plugs
This method was adapted from Maule (in press).
Agarose plugs were soaked overnight on a shaker at room temperature in a
large excess of sterile TE (10 mM Tris.HCI pH7.5; 1 mM EDTA). The
following day they were soaked for 10 minutes in fresh TE before being
transferred to TE containing phenylmethylsulfonylfluoride (PMSF) (Sigma) at
40 pg/ml (PMSF was dissolved in isopropanol at 20 mg/ml, 2 pi of this was
added to each ml TE). The plugs were then incubated at 50°C for 30
minutes. They were transferred to fresh TE/PMSF and incubated at 50°C for
a further 30 minutes. The TE/PMSF was then replaced with 10 volumes of
the appropriate restriction buffer (Boehringer Mannheim) and shaken at
room temperature for 2 hours. The plugs were then digested in a 100 pi
volume which contained 1 X restriction buffer, 0.1 % Triton-X 100 (Sigma),
200 pg/ml bovine serum albumin (BSA) (Boehringer Mannheim), and 20
units of restriction enzyme. Incubation, at the appropriate temperature, was
carried out overnight. The following day the plugs were cooled on ice for 15
minutes and the liquid was removed. They were then rinsed in 1 ml ice cold
TE. The TE was removed, 200 pi "plug stop mix" (9.4 ml dH^O; 0.4 ml
EDTA, pH 8; orange G (Sigma); 0.25 ml TAE, see section 2.8.1) was added
and they were left on ice for 20 minutes. The plugs were then ready for
electrophoresis (see section 2.8.4).
2.7.3 Dephosphorylation of Linear Plasmid DNA
Dephosphorylation reactions were carried out in a 50 pi volume which
contained 7 mg of linear plasmid DNA, 0.1 unit of calf intestinal phosphatase
(CIP) (Boehringer Mannheim) and 5 pi 10 X CIP buffer (Boehringer
Mannheim). The reaction was incubated at 56°C for 30 minutes, another
0.1 unit CIP was added and incubation was continued for a further
30 minutes. The reaction was stopped by the addition of 1 pi 0.5 M EDTA
(giving a final concentration of 10 mM). The volume was increased to 150 pi
by the addition of TE (10 mM Tris.HCI pH7.5; 1 mM EDTA). The solution
was extracted twice with an equal volume of
phenol:chloroform:isoamylalcohol. This was followed by addition of an equal
volume of chloroforrmisoamylalcohol. The DNA was then precipitated, by
the addition of 1/10th volume 3 M sodium acetate and an equal volume of ice-
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cold ethanol. The solution was then incubated at -20°C for 30 minutes
followed by centrifugation at 15000 rpm for 15 minutes at 4°C. The pellet
was washed in 70 % ethanol, dried and resuspended in 10 pi TE.
2.7.4 Conversion of 5' Overhangs to Blunt-ended Molecules
The Klenow fragment of E.coli DNA polymerase I has a 5' to 3' polymerase
activity, and a 3' to 5' exonuclease activity (Sambrook et al., 1989). It was
utilised to 'fill in' recessed 3' ends of DNA molecules, to generate blunt-
ended molecules.
Approximately 5 pg of plasmid DNA, which had been previously linearised
generating a 5' overhang, was diluted in sterile water to give a final volume
of 28.5 pi. To this 1.5 pi 50 x dGTP, dCTP, dATP, dTTP mix (to give a final
concentration of 400 pM of each dNTP) and 3 units Klenow fragment
(Boehringer Mannheim, sequencing grade) were added. The reaction was
incubated at 37°C for 60 minutes, after which the enzyme was inactivated by
incubation at 68°C for 20 minutes.
2.7.5 Ligation of Blunt-ended Molecules
The optimal ratio of ends for such a ligation event is 3:1 vector:insert
(Cobinachi and Wilson, 1987). Typically, between 10 and 100 ng of vector
was used. Reactions were carried out in a volume of 10 pi which contained
1 pi 10 X T4 DNA ligase buffer (to give a final concentration of 20 mM
Tris.HCI pH 7.6; 5 mM magnesium chloride; 5 mM DTT; 50 mg/ml BSA)
(Sambrook et al., 1989), 30 mM potassium chloride, 10 mM ATP and 0.1 unit
T4 DNA ligase. Reactions were incubated overnight at 4°C. The enzyme
was then heat inactivated by incubation at 68 °C for 20 minutes.
2.7.6 Ligation of Sticky-ended Molecules
The optimal ratio of ends for such a reaction is 1:2 vector:insert (Cobinachi
and Wilson, 1987). Typically, between 10 and 100 ng of vector was used.
Reactions were carried out in a volume of 10 pi which contained 1 pi 10 X
ligase buffer (Boehringer Mannheim) (to give a final concentration of 50 mM
Tris.HCI pH 7.4; 10 mM magnesium chloride; 10 mM DTT; 1 mM spermidine;
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1 mM ATP; 100(ig/ml BSA) and 0.1 unit T4 DNA ligase (Boehringer
Mannheim). The reaction was incubated overnight at 16°C. The enzyme




1 M Tris, 20 mM EDTA and 1 M boric acid pH 8.3.
20 X TAE
0.8 M Tris, 20 mM EDTA, pH 8 and 0.4 M acetic acid.
10 X DNA Loading buffer ("stop mix")
20 % ficoll, 100 mM EDTA, orange G.
6 % Denaturing Polyacrylamide
57 g of acrylamide, 3 g of bis-acrylamide and 460 g of urea were
dissolved in 1 litre of 1 X TBE. This was stored at 4°C in foil covered
bottles. 60 ml of this 6 % acrylamide solution was used for each
polyacrylamide gel. 75pJ N,N,N,N'-tetramethylethylenediamine
(TEMED) (Sigma) and 0.5 ml 10 % ammonium persulphate were
added to this.
2.8.2 Agarose Gel Electrophoresis
DNA molecules were separated, according to size, in horizontal
agarose gels by electrophoresis. The percentage of agarose (Type II
medium EEO) (Sigma) in the gel was varied according to the range of
size separation required. Restricted genomic DNA was run in a
0.8 % or 1 % agarose gel. Smaller DNA fragments, such as plasmids
or PCR products (see section 2.14) were run on 1-2 % gels, with
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fragments smaller than 200 bp being run on either 2 % low melting
point agarose (Ultrapure LMP agarose, Gibco BRL) or 4 % 3:1
Nusieve agarose (FMC Bioproducts). All agarose gels were made
from and run in 0.5 X TBE. Ethidium bromide was added to all
agarose gels and buffer at a concentration of 1 pg/ml buffer. 1/10thof
the sample volume of 10 X "stop mix" was added to DNA samples
prior to loading on the gel. The size marker used was 1kb ladder
(Gibco BRL). Gels were run in Electro-4 gel boxes (Hybaid) generally
at 75-120 volts or at 15-30 volts overnight (genomic digests only).
DNA fragments were visualised on a UV transilluminator at 305 nm
and photographed using a video copy processor (Mitsubishi).
2.8.3 Preparative Agarose Gel Electrophoresis
DNA fragments were run in low melting point agarose gels (Ultrapure
LMP agarose) (Gibco BRL) in 0.5 X TBE. Gels were viewed on a UV
transilluminator at 305 nm and the required fragment was cut out of
the gel using a sterile scalpel blade. Care was taken to insure that the
minimum size of gel slice was excised.
DNA was isolated from the gel slice using agarase (Boehringer
Mannheim), according to the manufacturers instructions.
DNA fragments which were to be used only as hybridisation probes
were not isolated from the gel but prepared as follows. The gel slice
was weighed and 1-3 X the weight of water was added (such that
11 pi of diluted gel slice contained 25-50 ng DNA).
2.8.4 Polyacrylamide Gel Electrophoresis
Denaturing polyacrylamide gels were used to visualise DNA
sequencing reactions.
The glass plates were prepared by washing thoroughly with detergent
and rinsing with water and then 100 % ethanol. The front plate was
then coated in dimethyldichlorosilane solution and the back plate was
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coated in a solution of 10 ml 100 % ethanol; 30 \i\ acetic acid; 30 \i\
methacryoxypropyltrimethoxysilane. Spacers were placed on either
side of the back plate and the front plate was placed on top. The
plates were then taped together at the sides and the bottom. The
freshly prepared polyacrylamide was then poured between the plates,
a sharkstooth comb was inserted and clamps were applied. The gel
was allowed to set for at least 40 minutes at room temperature.
Gels were run in 1x TBE on vertical slab gel apparatus (Scotlab) at
30 volts for 1.5-4.5 hours.
After electrophoresis the tape and the front plate were removed. The
gel was placed in fix solution ( 10 % methanol; 10 % acetic acid ) for
15 minutes. It was then rinsed in dH,0 for 15 minutes and placed at
68°C until dry. The gel was then exposed to film (see section 2.11.4).
2.8.5 Pulsed Field Gel Electrophoresis
The agarose plugs were loaded into the wells of a 1 % agarose, 0.5 X
TAE gel and the wells were sealed with 0.5 % LMP agarose. The gel
was placed into the apparatus (made by John Maule) (Maule and
Green, 1990) which contained sufficient buffer such that the gel was
submerged 3 mm below the buffer. The buffer had previously been
cooled and was kept at a constant temperature of 10°C (by circulation
of the buffer through a cooling unit).
Pulsed field times depended on the size of the DNA fragments which
were being separated.
After electrophoresis, the DNA was visualised by staining in buffer
containing ethidium bromide at 5 (ig/ml for 40 minutes.
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2.9 Transfer of DNA to Membranes
2.9.1 Southern Transfer Protocols
DNA which had been run on agarose gels was transferred onto nylon
membranes by capillary blotting. This method was adapted from Southern
(1975).
Gels were photographed next to a ruler to allow future sizing of DNA
fragments.
An additional step was included when blotting pulsed field gels. To aid the
transfer of the large yeast chromosomes and YACs, pulsed field gels were
UV irradiated on a transilluminator (at 305 nm) for 5 minutes, after being
photographed.
The DNA was denatured by gentle shaking of the gel in denature solution
(0.5 M NaOH, 1.5 M NaCI) for 45 minutes. The gel was then neutralised by
gentle shaking in neutralising solution (1 M Tris.HCI; 2 M NaCI, pH 5.5) for
45 minutes. A large strip of 3 MM filter paper (Whatman) was soaked in
20 X SSC (3 M NaCI, 0.3 M Na3C6H507.2H20, pH 7) and placed on a board.
The ends of the paper were placed into a reservoir of 20 X SSC, generating
a wick. The gel was placed on top of the wick and a piece of nylon
membrane (Hybond-N, Amersham), which had been cut to the size of the gel
and prewetted in 2 X SSC, was placed directly onto the gel, avoiding
bubbles. On top of this was placed two pieces of 3 MM blotting paper, also
cut to size and prewetted in 2 X SSC, followed by two dry pieces of 3 MM
paper. Any exposed wick was covered in Saran-wrap (Dow Chemical
Company) and a 12 cm stack of paper towels and a weight (approximately
1 kg) were placed on top of the gel.
The length of blotting time varied according to the size of fragments which
were being transferred. Pulsed field gels were blotted for two days, genomic
digests for 4-16 hours and smaller fragments for 4 hours.
The membranes were then rinsed briefly in 2 X SSC and baked at 80°C. The
DNA was then cross-linked to the filter by exposure to UV on a
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transilluminator (at 305 nm) for 3.5 minutes. Nylon membranes were stored
in Saran-wrap (Dow Chemical Company) at room temperature.
2.9.2 Transfer of Plasmid DNA from Bacterial Colonies to Membranes
This method was used to screen large numbers of bacterial colonies for
recombinant plasmid.
A bacterial culture was spread onto a gridded nitrocellulose filter which had
been placed on a L-agar plate. The plate was incubated at 37°C until
colonies were visible. A second filter was then briefly placed on top of the
first, before being transferred to another plate (colony side uppermost). Both
plates were incubated at 37°C to allow colony growth. One plate, designated
the master plate, was stored at 4°C. The filter was carefully removed from
the second plate and floated, colony side up, on a solution of 0.5 M NaOH;
1.5 M NaCI. After 10 minutes the filter was briefly transferred to a piece of
Whatman 3MM paper to remove excess solution. The filter was then floated
on a solution of 0.5 M Tris.HCI pH 7.4; 1.5 M NaCI for 5 minutes. It was then
transferred to a solution of 0.5 M Tris.HCI pH 7.4; 1.5 M NaCI; 100 pg/ml
Proteinase K for 30 minutes. The filter was then rolled between two 3MM
sheets in order to remove bacterial matter and excess moisture. The filter
was floated on chloroform for 30 seconds before being allowed to air dry. It
was then baked at 80°C for 1.5-2 hours under vacuum.
2.10 Radiolabelling of DNA
2.10.1 Random Priming of DNA Probes
Probes were labelled with [a-32P] dCTP by random priming from
hexadeoxyribonucleotides with the Klenow fragment of E. coli DNA
polymerase I (Feinberg and Vogelstein, 1983 and 1984).
25-50 ng DNA (either in the form of a gel slice or in solution), in a
volume of 11 pil was denatured by incubation at 100°C for 10 minutes.
If the DNA was in solution the reaction was cooled rapidly on ice or, if
a gel derived probe was used, the reaction was cooled to 37°C. A
Boehringer Mannheim Random Priming kit was used to label the
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probe. 2 pi of 10 X reaction buffer, 1 pi each of dATP, dGTP and
dTTP (0.5 mM), 2 units of Klenow and 30 pCi [oc-32P] dCTP were
added to the probe which was then incubated at 37°C for a minimum
of 45 minutes. After this time the level of [a-32P] dCTP incorporation
was measured by trichloroacetic acid precipitation (Sambrook et al.,
1989). Once a sufficiently high level of incorporation (at least 50 %)
had been achieved unincorporated nucleotides were removed from
the probe. The nucleotides were removed by running the probe
through a Nick column (Pharmacia). The storage buffer was removed
from the column which was then equilibrated with 1 ml TNE (10 mM
Tris.HCI, pH 8; 1 mM EDTA, pH 8; 0.2 M NaCI). The probe was then
added to the column in a volume of 100 pi. 300 pi TNE was added
and the probe was eluted in a further 400 pi. 500 pg denatured
sonicated salmon sperm DNA was added to the eluate and this
mixture was denatured at 100°C for 10 minutes. After this time the
probe was chilled on ice, to prevent reannealing, before being added
to the hybridisation mix.
2.10.2 Preannealing of Repetitive Sequences
Probes which contained repetitive sequences were annealed, after
labelling, to repeat containing DNA. This was carried out in order to
prevent the repetitive element of the probe taking part in the
hybridisation reaction. This procedure was adapted from Sealey et
al. (1985).
The probe was labelled and incorporation tested, as described in
2.10.1, but the probe was not put down a Nick column. After
incorporation had been checked the probe was incubated at 100°C,
with 1 mg sonicated human DNA, for 10 minutes. The probe was
then incubated, in a prewarmed lead pot, at 68°C for 30-45 minutes.
After this time the probe was added to the hybridisation mix.
2.10.3 End Labelling of DNA Oligonucleotides
Oligonucleotides were labelled by the transfer of the 32P-labelled 7-
phosphate from Py-32P] ATP onto the terminal 5'-OH group.
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30 ng oligonucleotide was labelled in a 20 pi volume which contained
1 X polynucleotide kinase (PNK) buffer (5 mM Tris.HCI, pH 8; 1 mM
MgCI2; 0.5 mM DTT) (Boehringer Mannheim), 10 units of
polynucleotide kinase (PNK) (Boehringer Mannheim) and 30 pCi of
[7-32P] ATP (Amersham). Reactions were incubated at 37°C for 30-




6 X SSC, 10 % dextran sulphate, 0.1 % sodium pyrophosphate,
0.5 % SDS; 4 X Denhardts solution (100 X Denhardts solution is 2 %
BSA; 2 % polyvinylpyrrolidone; 2 % ficoll; 1 mM EDTA, stored at
4°C).
Oligo Hybridisation Mix
5 X SSC, 0.05 % BSA, 0.05 % ficoll, 0.1 % sodium dodecyl sulphate,
0.05 % polyvinylpyrrolidone, 0.1% sodium pyrophosphate.
2.11.2 Pre-hybridisation Protocols
Pre-hybridisation of filters was carried out in oligo hybridisation mix at
5°C below the Tm of the oligonucleotide (see section 2.14.1) (end
labelled oligonucleotides) and in hybridisation mix at 68°C (random
primed probes). Filters were placed between two gauze sheets in a
hybridisation bottle (Hybaid). 10 ml of hybridisation mix was used
with the small bottles and 20 ml with the larger bottles. Bottles were
placed in a Hybaid hybridisation oven with a rotating spindle for at
least 1 hour (end labelled oligonucleotides) and at least 4 hours
(random primed probes). Denatured sonicated salmon sperm was
added to the hybridisation mix at a concentration of 100 pg/ml.
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2.11.3 Hybridisation and Washing Protocols
End labelled oligonucleotide hybridisations were carried out for
4-16 hours at 5°C below the Tm of the oligonucleotide. Filters were
then removed from the bottles and washed three times for 5 minutes
each at room temperature in 4 X SSC, 0.1 % SDS, heated to the
same temperature as the hybridisation reaction.
Random primed hybridisations were incubated for 16 hours at 68°C.
Filters were then washed in the hybridisation bottles with 2 X SSC,
0.1 % SDS for 20 minutes at 68°C. They were then removed from the
bottles and washed with increasing stringency to 1 X SSC, 0.1% SDS;
0.5 X SSC, 0.1% SDS or 0.1 X SSC, 0.1% SDS at 68°C.
2.11.4 Removal of Hybridisation Signal
Probes were removed from Southern blots
manufacturer's instructions. A solution of 0.1 %
and boiled. This solution was then poured onto
allowed to cool to room temperature.
2.12 Detection of Hybridisation
2.12.1 Autoradiography
Filters were exposed to Kodak X-OMAT film in cassettes with
intensifying screens. Filters hybridised to 32P labelled probes were
exposed at -70°C and 35S reactions at room temperature. Films were
exposed for a period of 30 minutes to 2 weeks (depending on the
signal strength) before being developed, using an automatic x-ray film
processor RGII (Fuji).
2.12.2 Phosphorimaging
A Molecular Dynamics Phosphorlmager was also used for detecting
and quantifying hybridisation. Filters were exposed on a phosphor





scanned on the Phosphorlmager, where a laser beam converts the
radioactive signal into a digital image, with variations in the pixel
values proportional to the amount of radioactivity present. The image
was displayed on a grey scale, the upper and lower limits of which
were adjusted to give good image visualisation. The image was then
printed out on a grey scale laser printer.
2.13 Sequencing of DNA
2.13.1 Sequencing of Double Stranded DNA
Adapted from Sanger et al. (1977).
Template plasmid DNA was prepared according to section 2.6.1. RNA was
digested by the addition of 1 pi of RNase A (50 mg/ml) to 7 pi of the template
DNA and incubation at room temperature for 15 minutes. 1 pi of sequencing
primer (see section 2.15.2) (at 10 ng/ml) and 1 pi of 1 M sodium hydroxide
were then added, and the mixture was incubated at 68°C for 10 minutes (this
is to allow denaturation of the template DNA in the presence of the primer).
The primer was then annealed to the template by addition of 4 pi of TDMN
(0.3 M TES (Sigma); 0.05 M DTT; 80 mM magnesium chloride; 0.2 M sodium
chloride; 1 % chloroform; pH 1.6, stored at 4°C) and incubation at room
temperature for 10 minutes. The reaction was then placed on ice until
required. To this reaction 1 pi 0.1 M DTT, 0.4 pi 5 X Sequenase labelling mix
(7.5 mM each dGTP; dCTP; dTTP) (USB) , 2.1 pi LoTE (3 mM Tris.HCI,
pH 7.5; 0.2 mM EDTA), 0.5 pi [a35S] dATP (Amersham) and 2 pi diluted T7
DNA polymerase (Sequenase) (USB) (enzyme had previously been diluted
1:7 with enzyme dilution buffer) were added. This extension reaction was
incubated at room temperature for 3 minutes. The extension reactions were
then terminated by addition of 4 pi of the reaction to 2.5 pi of the four
dideoxynucleotide termination mixes (containing either ddATP, ddGTP,
ddTTP or ddCTP, USB), which had previously been warmed at 37°C for
5 minutes. The termination reactions were incubated at 37°C for 10 minutes
after which time 5 pi STOP mix (USB) was added. The reactions were then
stored at -20°C prior to polyacrylamide electrophoresis.
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2.14 Amplification of DNA by the Polymerase Chain Reaction
(PCR)
PCR (Saiki et al., 1985; Mullis and Faloona, 1987) is an enzymatic
amplification technique which permits the cyclic amplification of a specific
DNA sequence. The sequence specificity is provided by a pair of
oligonucleotide primers which direct amplification. The primers are
complimentary in sequence to the 5' ends of sequence to be amplified and
are annealed to the template DNA under conditions where they hybridise
only to their exact compliment. The PCR reaction is a series of cycles, each
of which consists of three steps. The first step is a high temperature step,
which causes denaturation of the template. This is followed by a reduction
in temperature (to that which is optimum for precise annealing of the
primers) and finally an extension step at 72°C (which is the optimum
temperature of the thermostable polymerase).
2.14.1 PCR from Genomic DNA
Reactions were carried out in a 50 pi volume which contained 5 pi
10 X buffer (50 mM KCI; 100 mM Tris.HCI pH 8.4; 1 % Triton X-100)
(Promega), 3 pi 25 mM MgCI2 (Promega), 1 pi of each primer at 250 ng/pl,
1 pi of 50 X dNTP stock where each dNTP at 10 mM (Pharmacia), 100 ng of
template DNA and 1 unit of thermostable DNA polymerase (Promega or
Perkin Elmer Cetus). Reactions were overlaid with mineral oil (Sigma).
PCRs were carried out on various machines; a Perkin Elmer Cetus DNA
Thermal Cycler, Hybaid Thermal Reactors and a Hybaid Omnigene. The
temperature and length of the different steps were varied according to the
primer pair, the machine and the length of the fragment to be amplified.
When published PCR conditions were available these were used as the
basis of the initial reaction. If no information was available, as was the case
for example for primers designed from published sequence information, then
initial conditions were determined as follows. Each set of conditions always
had an initial cycle with a longer denaturation step at a higher temperature
(generally, 94°C for 3 minutes- Perkin Elmer Cetus DNA Thermal Cycler,
93°C for 2 minutes- Hybaid machines). This cycle was followed by a series
of cycles, the number of which was dependent on the efficiency of
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amplification (generally 30 cycles were performed initially). This series of
cycles consisted of a denaturation step (generally, 92°C for 45 seconds-
Perkin Elmer Cetus DNA Thermal Cycler, 91 °C for 30 seconds- Hybaid
machines) followed by an annealing step. The annealing temperature used
was that which was 5°C lower than the melting temperature (Tm) of the
primers. This was determined by the equation Tm, at 1M Na+ concentration, =
4(G+C) + 2(A+T). Annealing was generally carried out for 1 minute- Perkin
Elmer Cetus DNA Thermal Cycler and for 30 seconds- Hybaid machines.
Annealing was followed by extension at 72°C for approximately 1 minute/kb
to be amplified- both machines. The final cycle had an increased extension
step of 5 or 10 minutes depending on the size of the amplified fragment. In a
number of cases the initial conditions required modification, in order to
promote optimum amplification. Changes were made to the annealing
temperature and the number of cycles of amplification. Formamide has been
reported to enhance the specificity of PCR reactions (Sarkar et al., 1990).
Formamide (BDH) was added to PCR reactions to a final concentration of
5 %. "Touchdown" PCR (Don et al., 1991) has also been reported to
enhance the specificity of PCR reactions. In "touchdown" PCR the
annealing temperature of the first cycle (or the first two cycles) is
approximately 10°C higher than the theoretical annealing temperature. Over
subsequent cycles the temperature is lowered by 1 or 2°C every one or two
cycles until the theoretical temperature is reached. The cycles which are
carried out at the stringent conditions provided by higher temperatures
should promote amplification of the correct template molecules, rather than
aberrant amplification from partially mismatched template. Thus, by the time
the temperature is at that which allows mispriming, the correct product has
an advantage over aberrant products.
10 pi I of the PCR product was visualised on an ethidium bromide-stained
agarose gel (see 2.8.1).
2.14.2 PCR from Bacterial Colonies
This method was adapted from Taylor (1991).
The reaction was set up essentially as described in 2.14.1, except that a
sterile toothpick was used to add a small amount of a bacterial colony to the
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reaction (in the place of the genomic template). Reaction conditions were
determined as described in 2.14.1 except that the initial cycle denaturation
time was increased (to 5 minutes- Perkin Elmer Cetus DNA Thermal Cycler
and to 3 minutes- Hybaid machines).
2.14.3 Primer Design
Where published primers were not available primers were designed from
published sequence or, in the case of D11S388 from sequencing of an
appropriate clone (see section 2.16.2). Primers were designed either by
eye, or by the Oligo4 programme (Hybaid).
2.15 Oligonucleotides
2.15.1 Oligonucleotide Synthesis
Oligonucleotides were synthesised, in the form of ammonium stocks, on an
Applied Biosystems 381A oligonucleotide synthesizer.
Oligonucleotides were precipitated from stocks by the addition of 1/10th
volume 3 M sodium acetate and 2.5 volumes ethanol followed by a 1 hour
incubation at -20°C. They were pelleted by a 15 minute centrifugation at
1300 rpm, washed twice in 80 % ethanol and dried under vacuum. The
pellet was resuspended in 200 pi TE. The concentration of the DNA
obtained was determined by measurement of the optical density; where the
absorbance at 260 nm (ABS260) =1 at 25 pg/ml single stranded DNA.
2.15.2 Sequence of oligonucleotides
The oligonucleotides which were used in PCR analysis of chromosome 1
and chromosome 11 markers are described in section 2.16.1.
The following oligonucleotides are complementary to sequences in the
cloning vector pBS (Stratagene) (see section 2.5.3).
5' CAG GAA ACA GCT ATG AC 3'
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5' GTA AAA CGA CGG CCA GT 3'
These oligonucleotides were used individually to sequence (see section
2.13.1) inserts contained in pBS. They were used together to promote PCR
amplification (see section 2.14.2) of inserts contained in pBS. The PCR
conditions used with these primers are described bellow. One cycle of 94°C,
5 minutes; 52°C, 30 seconds; 72°C, 1 minute. Thirty cycles of 91 °C,
30 seconds; 52°C, 30 seconds; 72°C, 1 minute. One cycle of 91 °C,
30 seconds; 52°C, 30 seconds; 72°C, 5 minutes.
2.16 Details of Marker Assays
This section describes the details of the assays for published chromosome 1
and chromosome 11 markers.
2.16.1 Details of PCR primers
The primer sequences, conditions of amplification, the size of the fragment
amplified and source references are described in Table 2.2. In the case of
the TYRLI assay the PCR primers amplified from both the TYRLI locus and
the TYR gene (Giebel et al., 1991). A restriction digestion step was
necessary after the PCR reaction, in order to distinguish between the
products of amplification of the two loci (Giebel et al., 1991). The products
were digested with Mspl, giving rise to fragments of 120 bp and 140 bp from
the TYR locus and fragments of 29 bp, 91 bp and 140 bp from the TYRLI
locus.
2.16.2 Development of a PCR assay for D11S388
The cosmid CJ52.4, which corresponds to the D11S388 locus (Julier et al.,
1990) was subcloned in a two step procedure. The first step was the
identification and cloning of subfragment which contained a (CA)n repeat.
This clone was then itself subcloned, in order to identify a fragment which
both contained the (CA)n repeat and which was small enough to allow
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The cosmid was digested with EcoRI and BamHI (see section 2.7.1). The
digested cosmid was run on a 0.8% gel (see section 2.8.2) and the DNA
transferred to a nylon membrane by Southern blotting (Southern, 1975) (see
section 2.9.1). The blot was hybridised with an end-labelled (CA)15
oligonucleotide (see section 2.10.3 and 2.11). DNA corresponding to the
band which hybridised most strongly to this oligonucleotide was obtained by
preparative agarose gel electrophoresis (see section 2.8.3). Vector DNA
pBS (Stratagene) (see section 2.5.3) was prepared in parallel and was also
digested with EcoRI and BamHI. Digested plasmid DNA was purified by
preparative agarose gel electrophoresis (see section 2.8.3). An equal
volume of water saturated phenol was then added to both DNAs. They were
mixed thoroughly and centrifuged at 13000 rpm for 5 minutes. The aqueous
layer was removed and extracted, as described above, with an equal volume
of firstly 1:1 phenol/chloroform and secondly chloroform. The DNA was
precipitated from the aqueous layer with M20*1 volumes of 5 M NaCI and
three volumes of cold ethanol. The DNAs were then placed at -20°C for
one hour and then centrifuged at 13000 rpm for 15 minutes. The pellets
were then washed in 70 % ethanol, dried and resuspended in a minimal
volume of sterile distilled water. A ligation reaction was then set up (see
section 2.7.6). The ligation reaction product was used to transform an
aliquot of competent DH10B cells (see sections 2.5.4 and 2.5.5) which were
plated out on L-agar plates containing ampicillin, X-gal and IPTG (see
section 2.5.1). DNA from the resultant colonies was transferred to
nitrocellulose filters (see section 2.9.2). The filters were hybridised with the
same end-labelled (CA)15 oligonucleotide. Plasmid DNA was prepared from
a subset of the hybridising colonies (see section 2.6.1). This DNA was
digested with EcoRI and BamHI and run on an agarose gel, in order to check
that the correct size band was obtained. A Southern blot was also prepared
from this gel. This blot was hybridised with the end-labelled (CA)15
oligonucleotide, in order to check that the correct fragment had been cloned.
This fragment was too large (4 kb) for sequence analysis. It was therefore
digested with Hinfl, the digest was run on a 1 % gel and the DNA was
transferred to a nylon membrane. The blot was hybridised with the end-
labelled (CA)15 oligonucleotide, identifying a -500 bp fragment. DNA
corresponding to this band was obtained by preparative agarose gel
electrophoresis. The recessed 3' ends left by this enzyme were converted to
blunt-ended molecules (see section 2.7.4). Vector DNA was prepared in
74
parallel; pBS was digested with Smal and subject to phenol/chloroform
extraction and precipitation (see above). The DNA was then
dephosphorylated (see section 2.7.3). Both vector and insert DNA were
then subject to phenol/chloroform extraction and precipitation (see above)
and a ligation reaction was set up (see 2.7.5). The ligation reaction product
was transformed, colonies were obtained and screened as described above
resulting in the identification of clones which contained the appropriate
insert. Plasmid DNA from these clones was sequenced, using primers
complementary to vector sequence (see section 2.13.1). The sequence
obtained was used to design PCR primers (see section 2.14.3) which
promoted amplification, of an appropriate sized band, from human genomic
DNA, as well as for the cosmid CJ52.4.
2.16.3 Details of Assays carried out by Southern Blotting
2.16.3.1 Assaying D1S8
The lambda probe corresponding to the D1S8 locus (Royle et al., 1988) was
obtained from ICI Diagnostics, Cheshire . The 5.9 kb insert was released by
digestion with Sau3A (see section 2.7.1). The appropriate band was excised
from a 1 % LMP gel and used directly as a hybridisation probe (see section
2.8.3).
2.16.3.2 Assaying ADROA2
PCR primers corresponding to plasmid sequence were used to amplify a
-550 kb insert from a plasmid containing an insert corresponding to part of
the ADROA2 locus (Libert et al., 1989 and 1991) (the plasmid was obtained
from Gilbert Vassart, Universite de Bruxelles, Brussels). The DNA was
excised from a 1 % LMP gel and used directly as a hybridisation probe (see
section 2.8.3).
2.16.3.3 Assaying OMP
PCR primers derived from the sequence of the rat OMP gene were used to
amplify an exonic fragment from the equivalent human locus. This DNA was
excised from a 1 % LMP gel for use as a hybridisation probe (see section
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2.8.3). This fragment was initially used to probe a Southern blot of digested
somatic cell hybrid DNA, in order to localise the locus on a hybrid mapping
panel. This probe, however hybridised to both human and rodent
sequences. The human specific signal was insufficiently intense to allow
unambiguous scoring. The human exonic fragment was therefore used as a
probe to screen a human cosmid library (the library screening was carried
out by Craig Simpson). This cosmid was digested with Pstl (see section
2.7.1). The digested cosmid was run on a 1 % gel (see section 2.8.2) and
the DNA transferred to a nylon membrane by Southern blotting (Southern,
1975) (see section 2.9.1). The blot was hybridised (see section 2.11) with
the exonic fragment described above. DNA corresponding to the band which
hybridised to this probe was obtained by preparative agarose gel
electrophoresis (see section 2.8.3). Vector DNA pBS (Stratagene) (see
section 2.5.3) was prepared in parallel. It was digested with Pstl and subject
to phenol/chloroform extraction and precipitation (as described in section
2.16.2). The DNA was then dephosphorylated (see section 2.7.3). Both
vector and insert DNA were then subject to phenol/chloroform extraction and
precipitation and a ligation reaction was set up (see section 2.7.6). This
ligation reaction product was used to transform an aliquot of competent cells
(see sections 2.5.4 and 2.5.5) which were plated out on L-agar plates
containing ampicillin, X-gal and IPTG (see section 2.5.1). The inserts in
white colonies were examined by PCR amplification (see section 2.14.2)
which was directed by primers corresponding to vector sequences (see
section 2.15.2). This indicated inserts of the appropriate size. A Southern
blot of the PCR products was then hybridised with the human exonic
fragment described above, confirming the identity of clones which contained
the appropriate insert. DNA prepared from clones identified in this way was
digested with Pstl. The digested DNA run on a 1 % LMP gel, the insert was




3. Marker Analysis of Hybrid Cell lines
3.1 Introduction
It was decided to focus primarily on the cloning of the chromosome 11
translocation breakpoint. The chromosome 11 translocation breakpoint was
chosen, because of the established chromosome 11 resources available in
the laboratory. These included chromosome 11 derived somatic cell hybrids
and assays for markers of known location on this chromosome. The
existence of two other balanced translocations which appeared to segregate
with schizophrenia, and which involved chromosome 11 q (Smith et al., 1989;
Holland and Gosden, 1990) (the breakpoints were not accurately defined)
also prompted this focus.
A set of hybrid cell lines was analysed for chromosome 1 and chromosome
11 markers, by PCR and Southern blot analysis. This was carried out firstly,
to produce a chromosome 11 mapping panel, which could be used to
regionally localise markers on chromosome 11, thus defining the location of
the chromosome 11 breakpoint at high resolution. Secondly, this analysis
was carried out to determine the location of chromosome 1 markers with
respect to the t(1;11)(q42.2;q21) translocation breakpoint. Details of the
marker assays and source references are described in section 2.16.
The hybrid cell lines which constituted the mapping panel were as follows.
Somatic cell hybrid lines which segregate the reciprocal translocation
chromosomes are MIS 7.4 (murine, X63, background) and MAR 12 (murine,
RAG, background) which carry the derived 1 translocation chromosome and
MIS 39.8 and MAR 1, which carry the derived 11 translocation chromosome
(each in the absence of any normal chromosome 1 or 11 material) (Fletcher
et al., 1993). Four X irradiation hybrids, WJX 3.4, WJX 5.4, WJX 7.4 and
WJX 11.2, contain fragments of chromosome 11 in the background of a
Chinese hamster ovary cell line, WG3H (Fletcher et al., 1993). Two
independent HRAS 1-selected chromosome mediated gene transformants
(CMGT), E67.1 and E67.4, which carry single fragments of chromosome 11
material, in the background of a murine, C127, cell line were also analysed
(Porteous et al., 1986). PG48 has a translocated chromosome 11, which
lacks 11 q22-11 qter, as well as a number of other human chromosomes in a,
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a23, hamster background (McConville et al., 1991). CF52 has a well
characterised t(11; 16) (q13;p11) translocation chromosome as its sole human
component in the background of a murine cell line, A9 (Koeffler et al., 1981).
MAFLI, which is a permanent B lymphoblastoid cell line established from a
patient with schizophrenia and bearing the t(1;11)(q42.2;q21) translocation
(Fletcher et al., 1993), and J1CL4, which is a hybrid cell line which contains
an intact chromosome 11 as its sole human component (Jones et al., 1984),
were positive controls. Cell lines WG3H, X63 and RAG (see above) were
negative controls.
Cytogenetic analysis of the translocation chromosomes had suggested that
the translocation breakpoints occurred at 11 q21 and 1q42.2 (St.Clair et al.,
1990). The chromosome 11 markers which were analysed were largely
chosen on this basis. A few short arm markers and markers spaced down the
length of the long arm were included, but the emphasis was on those markers
from the 11 q13-11 q23 region. Chromosome 1 markers could only be
mapped relative to the translocation breakpoint. Markers thought to map in
the region of 1q41-43 were analysed in order to determine whether they were
proximal or distal to the chromosome 1 translocation breakpoint.
A few markers were assayed by Southern blot analysis, but the majority were
PCR assays. In the case of the tyrosinase like gene (TYR LI), the PCR
primers amplify from both the TYR LI locus and the tyrosinase (TYR) gene. A
restriction digestion step was necessary after the PCR reaction in order to
distinguish between the products of amplification from the two loci (Giebel et
al., 1991) (see section 2.16.1).
Most of the loci which were localised using the hybrid mapping panel were
already known to map to chromosome 11. The exception to this was
olfactory marker protein (OMP). OMP is of unknown function. It is found in a
wide variety of vertebrates and is expressed predominantly in mature,
functioning olfactory receptor neurones where it is present as a highly
abundant cytoplasmic protein (Farbman and Margolis, 1980; Rogers et al.,
1987 and Danciger et al., 1989). In the mouse, OMP maps to a region of
mouse chromosome 7 which exhibits conservation of synteny with several
human chromosomal regions, including 11 q and 11 p (Rinchik et al., 1992).
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OMP was assayed by Southern hybridisation, using a subclone of a cosmid
corresponding to this locus. The development of the OMP assay is described
in section 2.16.3.3.
A number of chromosome 11 brain expressed sequence tags (ESTs)
(Polymeropoulos et al., 1992; Durkin et al., 1992 and Polymeropoulos et al.,
1993) were regionally localised on chromosome 11. The ESTs had been
derived from partial sequencing of brain cDNAs and were formatted for PCR
typing.
3.2 Development of PCR Assays
3.2.1 Preliminary PCR Assays
Initial PCR conditions were devised as explained in section 2.14.1. Selected
examples of the results of preliminary PCR reactions are shown in Figure 3.1
(the cell surface marker thy 1, THY1), Figure 3.2a (fibroblast growth factor,
FGF4) and Figure 3.3a (D11S533). The initial conditions of the TFIY1 assay
resulted in amplification of extra bands, as well as the target band. However,
scoring of the correct band was still possible. The initial conditions of the
FGF4 assay resulted in unreliable amplification of the predicted band and
amplification of many spurious bands. The initial conditions of the D11S533
assay did not promote amplification.
3.2.2 Modification of PCR Assays
It can be seen in Figure 3.3a, which shows D11S533 amplified under
published conditions, that the conditions which result in optimum amplification
vary from laboratory to laboratory. It is likely that this is due to variation
between PCR machines, variation in buffer constituents and variation in the
type of enzyme used. Often, when primers were designed from published
sequence (as described in section 2.14.1) the initial amplification conditions
also required modification (see Figure 3.2a). In assays where specific
amplification was not initially obtained the PCR conditions were modified in
the following ways. The annealing temperature was raised, the number of
cycles of amplification were altered, "touchdown" PCR (Don et al., 1991) was
carried out and formamide (BDH) was added to a final concentration of 5%
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The cell lines are described in section 2.1.1. The size marker is the 1 kb
ladder (Gibco BRL). Aliquots of somatic cell hybrid DNA were assayed by
PCR (see section 2.14.1) for the presence of the THY1 locus. Positive
signal is marked, at 342 bp. The results demonstrate that THY1 maps distal
to the t(1;11)(q42.2;q21) translocation breakpoint (as MIS 7.4 is positive).
This result, together with the segregation pattern in the fragmentation
hybrids means that THY1 can be placed close to D11S351, consistent with
the data of Richard et al., (1993) who place this marker distal to D11S351
(see Table 3.2a). PCR products, other than the predicted fragment of 342
bp are present. It is likely that these products are caused by mispriming.
The aberrant amplification does not, however, affect the ability to score the
locus specific band.
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Figure 3.2a
The cell lines are described in section 2.2.1. The size marker is the 1 kb
ladder (Gibco BRL).
Aliquots of somatic cell hybrid DNA were assayed by PCR (see section
2.14.1) for the presence of the FGF4 locus. The conditions of amplification
were designed as described in section 2.14.1. A positive result for the FGF4
assay is indicated by a PCR product of 542 bp. Signal was not present in
the positive control hybrid J1CL4 (which contains an intact human
chromosome 11 as its sole human component) and, in many of the tracks,
PCR products other than the predicted band of 542 bp, are present. It is
likely that these products are caused by mispriming.
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Figure 3.2: PCR Analysis of Segregation of FGF4 in the Hybrid Panel
Figure 3.2b
The cell lines are described in section 2.1.1. The size marker is the 1 kb
ladder (Gibco BRL). The hybrids were re-assayed for FGF4, following
sequential modification of the amplification conditions, as described in Table
3.1. Positive signal is now present at the expected size. The results of this
segregation analysis place this marker in a new interval, which is proximal to
the translocation breakpoint of CF52, at 11 q 13 (Koeffler et al., 1981). This
result, in conjunction with the results obtained in the fragmentation hybrids,
and with published information (FGF4 is distal to Bcl1 (Petty et al., 1993)
and Bel 1 is distal to ADROA2, Szepetowski et al., 1993), can be used to
localise this marker (see Table 3.2a).
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Figure 3.3a
The cell lines are described in section 2.1.1. The size marker is the 1 kb
ladder (Gibco BRL).
Aliquots of somatic cell hybrid DNA were assayed by PCR (see section
2.14.1), using published conditions, for the presence of the polymorphic
marker D11S533. Positive signal was expected within the range of 300-900
bp. There are a few faint bands in some of the tracks but the conditions of
amplification are clearly suboptimal.
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Figure 3.3: PCR Analysis of Segregation of D11S533 in the Hybrid Panel
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The cell lines are described in section 2.1.1. The size marker is the 1 kb
ladder (Gibco BRL).
The hybrids were re-assayed for D11S533, following sequential modification
of the amplification conditions, as described in Table 3.1. Positive signal is
now present in the expected size range. The results of this segregation
analysis place this marker in an interval which is proximal to the
t(1; 11 )(q42.2;q21) translocation breakpoint, but distal to the translocation
breakpoint of CF52, at 11 q 13 (Koeffler et al., 1981). This result, in
combination with the results obtained in the fragmentation hybrids and
published information (D11S533 maps to 11 q 13.5 (Eubanks et al., 1991) and
is very closely linked to D11S527, Li et al., 1992) can be used to localise this
marker (see Table 3.2a).
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(see section 2.14.1). Successful modification of the initial conditions was
often possible and examples of this are shown in Figures 3.2b and 3.3b.
Figure 3.2b shows the results of sequential modifications to the FGF4 assay.
The addition of formamide to this assay resulted in specific amplification.
Figure 3.3b shows the results of sequential modification of the D11S533
assay. In this case a lower annealing temperature, "touchdown" PCR and
increased number of cycles were necessary to promote specific amplification.
Table 3.1 describes the modifications which were made to the PCR assays of
all the initial markers.
3.3 Scoring of PCR assays
Where possible, markers were ordered relative to each other taking
published information into account and assuming the least number of
independent blocks of human DNA in the various hybrids.
3.4 Marker Analysis of the Hybrid Cell Lines
Tables 3.2a and 3.2b describe the results of initial marker analysis. This
analysis resulted in the determination of flanking markers of the translocation
breakpoints. Tyrosinase (TYR) was found to be proximal and fibroblast
collagenase (CLG) was found to be distal to the translocation breakpoint on
chromosome 11 (Table 3.2a). D1S8 was found to be distal to the
translocation breakpoint on chromosome 1 (Table 3.2b). D1S8 (Royle et al.,
1988) was mapped by Southern blotting. This result is shown in Figure 3.4.
Susan Maguire determined that D1S103 (Weber et al., 1990) maps proximal
to the translocation breakpoint on chromosome 1. This result is also
described in Table 3.2b.
Genetic analysis of members of pedigree K26 was carried out prior to this
work (Fletcher et al., 1993). RFLP and microsatellite analysis with
chromosome 11 markers found recombination events amongst the ten
translocation individuals with the distal marker D11S97 (Jeffreys et al., 1988)
and the proximal marker D11S35 (Litt et al., 1990). Two intervening (by
genetic analysis in CEPH pedigrees) markers, TYR and D11S388, did not
detect any recombinants. On chromosome 1, no recombinants were found
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Table 3.1 Modification of Initial Chromosome 11 PCR
Assays




HBB Sub-optimal, but scoring
possible
None
D11S87 Sub-optimal, but scoring
possible
None
TYR LI Faint bands, of correct
size, in a few tracks
Increased cycle number
PGA Spurious bands and
strong band, correct size
Raised Ta
Reduced cycle number
MDU1 Faint bands, of correct
size, in a few tracks
Increased cycle number
GST PI Many spurious bands Raised Ta
Touchdown PCR
FGF 4 Many spurious bands Formamide added
D11S527 Worked None
D11S533 Few faint bands Lowered Ta
Touchdown PCR
Increased cycle number
TYR Many spurious bands Raised Ta
CLG Spurious bands and
strong band, correct size
Raised Ta
Reduced cycle number
STMY1 Many spurious bands Raised Ta
Formamide added
D11S385 Many spurious bands Raised Ta
Formamide added
NCAM Many spurious bands Raised Ta
DRD2 Many spurious bands Raised Ta
Increased cycle number
D11S351 Many spurious bands Raised Ta
Formamide added
THY1 Sub-optimal, but scoring
possible
None
Table 3.1: Ta= annealing temperature (of PCR reaction).
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Figure 3.4: Southern Analysis of Segregation of D1S8 in the Hybrid
Panel
The cell lines are described in section 2.1.1. DNA (~5 ng/track) was
digested with Alul and separated in a 0.8 % agarose gel (see sections 2.7.1
and 2.8.2). The fragments were transferred to a nylon membrane and
hybridised, at 68°C, with a radio-labelled probe corresponding to D1S8 (see
sections 2.9.1, 2.11. 2.10.1 and 2.16.3.1). The blot was washed to
0.5 X SSC and, after exposure for 2 days, hybridisation was detected by
autoradiography (see sections 2.11.3 and 2.12.1).
Human specific hybridisation is at -6.5 kb. The results of this segregation
analysis place this marker distal to the t(1;11)(q42.2;q21) translocation
breakpoint, on chromosome 1 (see Table 3.2b).
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with the proximal marker D1S103, but several were found with the distal
marker D1S8.
FISH analysis , also carried out prior to this work, identified TYR as being
proximal and D11S388 as being distal to the translocation breakpoint on
chromosome 11 (Fletcher et al., 1993).
The results obtained from the mapping panel, genetic analysis and FISH
analysis are in agreement. However, D11S388 had been defined as a
flanking marker by FISH analysis, but satisfactory Southern hybridisation
mapping results could not be obtained with the corresponding cosmid, even
after suppression hybridisation. The RFLP detected by this probe was also
relatively uninformative. It was therefore decided to clone and sequence a
band, which hybridised to a (CA)15 oligonucleotide, from the cosmid, in an
attempt to design a PCR assay which could be used to map D11S388 on the
hybrid panel and which was more informative than the available RFLP assay
(for use in linkage analysis). This procedure (described in section 2.16.2)
resulted in the production of a PCR assay, although the CA repeat amplified
was too short to be sufficiently polymorphic for use in linkage analysis. The
analysis of the hybrid cell lines for D11S388 places it closer to the
translocation breakpoint than the previous flanking marker, CLG.
The marker analysis of the hybrid cell lines suggests that the panel has
sufficient resolution to separate quite closely linked markers such as the
neural cell adhesion molecule (NCAM) and the dopamine receptor D0 (DRD2)
(which hybridise to the same 500 kb pulsed field gel fragment) (McConville et
al., 1990). Also, glutathione S-transferase n (GSTPI) and the adenosine
receptor 2 (ADROA2), which are within 290-360 kb (Szepetowski et al.,
1993), are separated by the panel. However, markers which are known to be
very close together, such as CLG, stromelysin 1 (STMY1) and D11S385
(which are known to be on the same 135 kb pulsed field fragment)
(Formstone et al., 1993), are not separated by the mapping panel.
Figure 3.5 shows the results of hybridisation of a subclone of a human OMP
cosmid to the hybrid mapping panel (this result is described in Table 3.2a).
The localisation of OMP to 11 q was somewhat surprising when its
chromosomal location in the mouse is taken into consideration. Comparative
90
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The cell lines are described in section 2.1.1. DNA (~5 pg/track) was
digested with Bglll and separated in a 0.8 % agarose gel (see sections 2.7.1
and 2.8.2). The fragments were transferred to a nylon membrane and
hybridised, at 68°C, with a radio-labelled probe corresponding to the locus
OMP (see sections 2.9.1, 2.11, 2.10.1 and 2.16.3.3). The blot was washed to
1 X SSC and, after exposure for 24 hours, hybridisation was detected by a
Molecular Dynamics Phosphorlmager (see sections 2.11.3 and 2.12.2).
Human specific hybridisation is at -1.6 kb, while rodent specific hybridisation
is at -5 kb. The results of this segregation analysis place this marker in an
interval which is proximal to the t(1; 11 )(q42.2;q21) translocation breakpoint,
but distal to the translocation breakpoint of CF52, at 11 q 13 (Koeffler et al.,
1981). This, in conjuction with the results obtained in the fragmentation
hybrids, indicate that this marker lies between TYR and D11S533 (see Table
3.2a).
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studies with genes on mouse chromosome 7 have established extensive
homology to human chromosome 19q, 11 p and 11 q and to a lesser extent
15q (Darling and Abbott, 1992). The murine gene Mod-2 is exceptional in
that the human homologue, ME2, maps to 6p (Kompf, 1985). Genetic linkage
studies indicate that Omp lies on chromosome 7, 5.36 cM distal to Tyr and
1.2 cM proximal to Hbb. The mouse map of this region with the location of
the human homologue in parenthesis can be summarised as follows: Fes
(15q) - Tyr (11q21) - Mod-2 (6p) - Calc I / Hbb (11p15) (Rinchik et al., 1992).
This suggested that human OMP was most likely to map to 11 p15, or possibly
6p. However, the results of this analysis place OMP on chromosome 11 q,
flanked by TYR and D11S533 (Evans et al., 1993). Correspondingly, FISH
analysis (carried out by Judith Fantes) with a human OMP cosmid to
metaphase spreads, indicated that OMP maps to 11 q 13.5, centromeric to
tyrosinase. Genetic linkage to this region has recently been established for
Usher Syndrome Type I (Kimberling et al., 1992). Usher Syndrome Type I is
an autosomal recessive disorder characterised by profound congenital
deafness, vestibular areflexia and progressive retinitis pigmentosa. In the
mouse, Omp maps within 200 kb of the mouse mutant shaker I (Brown et al.,
1992). Shaker I is an autosomal recessive deafness mutant which shows
associated circling and head-tossing behaviour and hyperactivity (Green,
1989). It is possible that Usher Syndrome I and the shaker I defect are
caused by mutations in the same gene and that OMP causes both disorders.
This hypothesis is now under test by others in the group and elsewhere.
Five ESTs which had been assigned previously to chromosome 11
(Polymeropoulos et al., 1992 and Durkin et al., 1992) were regionally mapped
using the hybrid mapping panel. Each of the five ESTs define a new interval
on the hybrid mapping panel. ESTs 109, 501, 532 have been assigned to
11 p. Further analysis, using cell lines which define more intervals on 11 p,
will be required for more specific localisation of these markers. EST 111 and
EST 16 have been localised to chromosome 11 q. This is described in
Table 3.3. EST 16 maps to an interval either directly proximal or directly
distal to the previous translocation breakpoint flanking marker D11S388.
The mapping of another set of ESTs which have also been assigned
previously to chromosome 11 (Polymeropoulos et al., 1993) was extended by
Euan Slorach (Slorach et al., manuscript in preparation). Table 3.4 describes
92
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the results of those mapped to chromosome 11 q using the hybrid mapping
panel. This analysis has resulted in the localisation of an additional nine
brain ESTs on chromosome 11 q and has resulted in the definition of three
new intervals on the hybrid mapping panel.
A number of new markers became available during the course of this work
and were mapped using the hybrid panel. For the sake of completeness this
analysis is described in this section, but it should be emphasised that it was
carried out subsequent to the mapping of the microdissection clones
described in Chapter 4.
The results obtained are described in Table 3.5a. Firstly D11S873 and
subsequently, D11S931 were found to map to an interval directly distal to the
chromosome 11 translocation breakpoint. D11S901 was placed between
TYR and OMP. Genetic analysis indicates that the distance between
D11S901 and D11S931 is ~8 cM (Weissenbach et al., 1992) and that
D11S901 is -8.5 cM from D11S873 (Litt et al., 1993). This tentatively
suggests that D11S931 is 0.5 cM proximal to D11S873, but this has yet to be
confirmed by mapping both markers on the same set of individuals.
Several chromosome 1 markers have been mapped relative to the
translocation breakpoint on chromosome 1 (described in Table 3.5b). The
closest flanking marker below the breakpoint is D1S179, as it is the most
proximal of the three new markers, D1S169; D1S179 and a-actinin 2
(ACTN2), which this analysis places distal to the translocation breakpoint.
D1S103, which is 6 cM from D1S179 (Engelstein et al., 1993), and D1S251
are both proximal to the translocation breakpoint. The relative order of these
two markers is not known.
Having established the power of the mapping panel, but exhausted the
available markers, the next step was to generate many more markers in a
region close to the translocation breakpoint.
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CHAPTER 4
4. Mapping of Microdissection Clones to the Hybrid
Mapping Panel
4.1 Introduction
New markers in the region of the breakpoint were produced by
microdissection of a -30 Mb region surrounding the derived chromosome 1
translocation breakpoint (Muir et al., manuscript in preparation). The
dissected DNA was digested and cloned, and each clone was individually
amplified by PCR (this was done by Susan Maguire and Tony Brookes).
4.2 Mapping of Microdissection Clones
PCR amplified inserts were run out on agarose gels, transferred to nylon
membranes and hybridised with Cot I human DNA (this was done by Susan
Maguire). The microdissection clones which were negative on Cot I
hybridisation and which were 0.5-2 kb in size were selected first for somatic
cell hybrid mapping. Initially microdissection clones were hybridised to
Southern blots of restriction digested total human DNA, in order to determine
whether they were suitable probes. Examples of this are shown in Figure 4.1.
Panels a-e represent mapping of five microdissection clones to human DNA.
In each case, a single band is observed, indicating that all of these clones
are suitable probes. Of eleven probes examined in this way nine were found
to be suitable. Due to this high success rate, this practise was abandoned
and probes were hybridised directly to Southern blots of restriction digested
hybrid DNA. A subset of the hybrid cell lines described in section 3.1 were
used to map the microdissection clones. The hybrids were MIS 7.4, E67.4,
CF52, WJX 5.4, WJX 11.2 and PG48. These hybrids were chosen as they
constituted the minimum set which defined the maximum number of intervals
distal to the translocation breakpoint on chromosome 11.
4.3 Scoring of Results
Hybridisation to MIS 7.4 was expected for every clone, as this cell line
corresponds to the chromosome which was dissected to produce the
microdissection library. Hybridisation to CF52 was expected for every clone
which originated from chromosome 11, as this hybrid contains chromosome
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Figure 4.1: Mapping of Microdissection Clones to Human DNA









Figure 4.1 shows representative examples of the results of mapping
individual microdissection clones to human DNA by Southern blotting
(Southern, 1975). MAFLI DNA (~5 pg/track) was digested with EcoRI and
separated in a 1 % agarose gel (see sections 2.7.1 and 2.8.2). The
fragments were transferred to a nylon membrane and hybridised, at 68°C,
with microdissection clone probes (see sections 2.9.1 and 2.11). Probes
were produced by PCR amplification of inserts of individual microdissection
clones, using primers corresponding to vector sequence (by Susan Maguire
and Tony Brookes). This material was digested, to remove vector sequence
and run on a 1 % LMP gel. The band corresponding to the insert was cut
out of the gel, labelled by random priming and used directly as a
hybridisation probe (see sections 2.8.3 and 2.10.1). Blots were washed to
0.1 X SSC and, after exposure for 7 days, hybridisation was detected by
autoradiography (see sections 2.11.3 and 2.12.1).
The labels on the panels indicate the probe used in each case: a) = MD 459,
b) = MD 437, c) = MD 431, d) = MD 429, e) = MD 273. The marker is the 1
kb ladder (Gibco BRL). The size of each of the signals obtained
corresponds to that of the particular insert, as the same enzyme was used
both to release the microdissection clone insert and to digest the target
DNA. These results demonstrated that all of these microdissection clones
are suitable for somatic cell hybrid mapping.
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11 q 13-qter material. Clones which hybridised to MIS 7.4 and not CF52 (or
any other hybrid cell line) were therefore provisionally assigned to
chromosome 1. Panel a of Figure 4.2 shows an example of such a result;
microdissection clone 459 (MD 459) hybridises only to MIS 7.4. Where
probes mapped to chromosome 11, the pattern of segregation in the hybrids
was used to localise them to a particular region of chromosome 11. Panel b
shows the results obtained with MD 283. This clone hybridises to MIS 7.4,
CF52, PG48, WJX 7.4 and E67.4, but not WJX 5.4. This localises MD 283 to
the closest interval to the translocation breakpoint. Panel c shows an
example of a microdissection clone which maps to the next interval down.
MD 128 hybridises to MIS 7.4, CF52. PG48 and E67.4, but not WJX 5.4 and
WJX 7.4. In the majority of cases, microdissection clones were placed in a
previously defined interval, but occasionally the pattern of segregation
introduced a new interval. In this situation markers were arranged in the
order which assumed the least number of independent blocks of human DNA
in the various hybrids. An example of a result which defined a new interval is
shown in panel d, MD 21 hybridises to MIS 7.4, CF52, PG48, WJX 5.4 and
E67.4, but not WJX 7.4.
4.4 Results of Microdissection Clone Mapping
The results of mapping the first set of microdissection clones to the hybrid
panel are shown, in part, in Table 4.1. Table 4.1 describes the results
obtained with the 18 probes which originate from chromosome 11. Two new
intervals on chromosome 11 q were identified in the process. A further 10
probes were found to originate from chromosome 1. This work was extended
by Sheila Christie, Euan Slorach and Susan Maguire. Table 4.2 describes
the accumulated data for those markers which mapped to chromosome 11.
In total 86 microdissection clones have been successfully mapped. Forty-
nine of these clones originate from chromosome 11 and 37 originate from
chromosome 1.
4.5 Discussion
The microdissection clones have greatly increased the number of markers in
the regions distal to the translocation breakpoint on chromosome 11.
Although the intervals on chromosome 11 are not necessarily of a standard
102
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Figure 4.2: Mapping of Microdissection Clones to the Hybrid Panel
(continued)
Legend:
The cell lines are described in section 2.1.1. DNA (~5 |ig/track) was
digested with EcoRI and separated in a 1 % agarose gel (see sections 2.7.1
and 2.8.2). The fragments were transferred to a nylon membrane and
hybridised, at 68°C, with a microdissection clone (see sections 2.9.1, 2.11
and the legend to Figure 4.1). Blots were washed to 0.1 X SSC and, after
exposure for 24 hours, hybridisation was detected by a Molecular Dynamics
Phosphorlmager (see sections 2.11.3 and 2.12.2).
The marker is the 1 kb ladder (Gibco BRL). The size of each of the signals
obtained corresponds to that of the particular insert, as the same enzyme
was used both to release the microdissection clone insert and to digest the
target DNA.
The labels on the panels indicate the probe used in each case: a) = MD 459,
b) = MD 283, c) = MD 128, d) = MD 21. All clones should hybridise to
MIS 7.4, as this hybrid represents the microdissected chromosome. If no
other signal was obtained, clones were provisionally assigned to
chromosome 1. The pattern of hybridisation observed in the other hybrids
was used to assign each clone to an interval distal to the t(1; 11 )(q42.2;q21)
translocation breakpoint (see Table 4.1). For example, in panel b) MD 283
is positive in MIS 7.4, CF 52, PG48, WJX 7.4 and E67.4 and negative in
WJX 5.4. This localises MD 283 to the interval which is closest to the
translocation breakpoint.
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TABLE 4.1 Results of Initial Mapping of
Microdissection Clones
LOCUS MIS 7.4 CF52 PG48 WJX 7.4 WJX 5.4 E67.4 !
D11S931 + + + + - +
D11S873 + + + + - +
MD 104 + + + + - +
MD 283 + + + + - +
MD 220 + + + + - +
MD 128 + + + - - +
| MD 421 + + + - - +
I MD281 + + + - - +
EST 16 + + + - - +
MD 174 + + + - - -
D11S388 + + + - - -
MD 558 + + + - + +
MD 38 + + + - + +
MD 286 + + + - + +
MD 21 + + + - + +
CLG + + - - + +
STMY1 + + - - + +
D11S385 + + - - + +
MD 211 + + - - + +
MD 596 + + - - + +
MD 75 + + - - + +
MD 399 + + - - + +
MD 214 + + - - - +
NCAM + + - + - +
DRD2 + + - + - -
MD 54 + + - - + -
MD44 + + - - + -
D11S351 + + ND - + -
EST116 + + - - + -
EST652 + + - - + -
I THY1 + + ND - + ND
EST 111 + + - - - -
Table 4.1: The cell lines are described in section 2.1.1. Where possible,
the loci on 11 q distal to the t(1 ;11 )(q42.2;q21) translocation breakpoint are
arranged in their most likely order, taking account of published information
and assuming the least number of independent blocks of human DNA in the
various hybrids. + indicates the presence of the marker in the hybrid cell
line, - indicates its absence. ND indicates not determined.
(continued overleaf)
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Legend to Table 4.1 (continued)
The results obtained with the microdissection clones are shown in bold.
Eighteen microdissection clones were found to map to chromosome 11 q,
defining two new intervals. A further ten probes hybridised to MIS 7.4, but to
no other chromosome 11 hybrid. These were, therefore, provisionally
assigned to chromosome 1.
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Table 4.2 Results of Analysis of Complete Set of
Microdissection Clones
LOCUS MIS 7.4 CF52 PG48 WJX 7.4 WJX 5.4 E67.4
D11S931 + + + + - +
D11S873 + + + + - +
MD 104 + + + + - +
MD 122 + + + + - +
MD 176 + + + + - +
MD 412 + + + + - +
MD 471 + + + + - +
MD 437 + + + + - +
MD 282 + + + + +
MD 283 + + + + +
MD 220 + + + + +
MD 543 + + + + +
MD 128 + + + - +
MD 118 + + + - +
MD 310 + + + - +
MD 74 + + + - +
MD 130 + + + - +
MD 40 + + + - +
MD159 + + + - +
MD129 + + + - +
MD 377 + + + - +
MD 421 + + + - +
MD281 + + + - +
EST 16 + + + - - +
Continued Overleaf
Table 4.2: The cell lines are described in section 2.1.1. Where possible, the
loci on 11 q distal to the t(1 ;11)(q42.2;q21) translocation breakpoint are
arranged in their most likely order, taking account of published information
and assuming the least number of independent blocks of human DNA in the
various hybrids. + indicates the presence of the marker in the hybrid cell
line, - indicates its absence. ND indicates not determined.
The results obtained with the microdissection clones are shown in bold. In
total, forty-nine microdissection clones were found to map to chromosome
11 q. A further thirty-seven probes hybridised to MIS 7.4, but to no other
chromosome 11 hybrid. These were, therefore, provisionally assigned to
chromosome 1.
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Table 4.2 Results of Analysis of Complete Set of
Microdissection Clones (continued)
LOCUS MIS 7.4 CF52 PG48 WJX 7.4 WJX 5.4 E67.4
MD 174 + + + - - -
MD 139 + + + - - -
D11S388 + + + - - -
MD 558 + + + - + +
MD 330 + + + - + +
MD 173 + + + - + +
MD 38 + + + - + +
MD 286 + + + - + +
MD 21 + + + - + +
CLG + + - - + +
STMY1 + + - - + +
D11S385 + + - - + +
MD 63 + + - + +
MD 136 + + - + +
MD 27 + + - + +
MD 151 + + - + +
MD 509 + + - + +
MD 211 + + - + +
MD 116 + + - + +
MD 388 + + - + +
MD 596 + + - + +
MD 75 + + - + +
MD 399 + + - + +
MD 110 + + - - +
MD 453 + + - - +
MD 214 + + - - +
NCAM + + - + . +
DRD2 + + - + -
MD 96 + + - - +
MD 54 + + - - +
MD 162 + + - - +
MD44 + + - - +
MD 215 + + - - +
MD277 + + - - +
D11S351 + + ND - +
EST116 + + - -
+
EST652 + + - -
+
THY1 + + ND -
+ ND
EST 111 + + - -
-
For legend, see previous page.
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size, the number of clones in each interval tends to decrease with increasing
distance from the breakpoint. This is as expected, as it is likely that the
accuracy of the cut varied over the 100 chromosomes dissected, but the
region at the centre of the target area, i.e. the breakpoint, is most likely to be
included in the region removed on each occasion. In accordance with the
FISH painting analysis, approximately equal numbers of clones map to the
two chromosomes.
There are now twelve markers, ten of which are microdissection clones, in the
interval closest to the breakpoint. The genetic distance between D11S388
(which is distal to this interval) and TYR is estimated at 7.8 cM (NIH/CEPH
Collaborative Mapping Group, 1992). The corresponding physical distance
has been estimated at 4 Mbp, by FISH analysis of clones representing these
loci (Fletcher et al., 1993). This FISH analysis indicates that the
translocation breakpoint lies more or less mid-way between these markers.
Thus, the distance between D11S388 and the breakpoint can be estimated at
approximately 2 Mb. The proportion of this region which corresponds to the
interval closest to the breakpoint is not known, but it is likely that there is now




5. Screening of the ICI YAC Library
5.1 Introduction
Microdissection clones from the interval immediately distal to the
translocation breakpoint on chromosome 11 were used to screen the ICI YAC
library. The microdissection clones chosen were those which failed to
hybridise to Cot I DNA and which showed no evidence of repetitive content,
as judged by the results of hybridisation to genomic digests. These were
MD 122, MD 176, MD 220, MD 283, MD 471 and MD 543. A subclone (made
by John Brown) of a repeat containing microdissection clone (104) was also
used to screen the library.
5.2 Results of ICI YAC Library Screening
Examples of the results of screening the ICI YAC library are shown in
Figures 5.1-5.3. Figure 5.1 shows representative examples of the results of
hybridisation of the subclone of MD 104 to the 23 filters of gridded YACs.
The colonies indicated with arrows are those which were selected as
positives. Flowever, hybridisation of MD 104 to DNA from these YACs
indicated that these signals were all false positives. The same was true for
all of the YACs identified using MD 543. Figure 5.2 shows representative
examples of the 23 filters after hybridisation to MD 176, the colonies
indicated with arrows are those which were selected as positives. The large
arrows indicate those which were subsequently found to be true positives and
the small arrows indicate false positives. Approximately half of the YACs
selected with MD 122, MD 176 and MD 471 and 75 % of those selected with
MD 283 were found to be true positives. Figure 5.3 shows examples of the
23 filters after hybridisation with the MD 220, in this case all the YACs
selected as positives were subsequently found to be true positives.
5.3 Discussion
Of the markers which were successfully used in screening (i.e. those which
resulted in the isolation of at least one YAC) an average of four YACs were
isolated per marker. This is comparable to the estimate of the complexity of
the ICI YAC library (3.5 - 4 genome equivalents). Hybridisation with MD 543
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and with the subclone of MD 104 did not identify any positive YACs. It is
possible that one or both of these clones contained a repetitive sequence. In
retrospect, the Southern analysis with MD 543 shows a faint high molecular
weight smear indicative of repetitive content. It is also possible that the
genomic regions corresponding to these probes may not be represented in
the ICI YAC library.
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Figure 5.1: Screening of the ICI YAC Library with MD 104
Figure 5.1 shows representative examples of the results of screening of the
ICI YAC library (see section 2.3.2) with MD 104. The 23 filters were
hybridised, at 68°C, with radio-labelled probe (see sections 2.11, 2.10.1 and
the legend to Figure 4.1). Blots were washed to 1 X SSC and, after
exposure for 1 to 7 days, hybridisation was detected by autoradiography
(see sections 2.11.3 and 2.12.1). The arrows indicate YAC recombinants
which were identified as potential positives. Flowever, on further analysis
(see section 5.2) these were all determined to be false positives.
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Figure 5.2 shows representative examples of the results of screening of the
ICI YAC library (see section 2.3.2) with MD 176. The screening procedure is
described in the legend to Figure 5.1. The arrows indicate YAC
recombinants which were identified as potential positives. On further
analysis (see section 5.2) it was determined that those which are marked
with large arrows were true positives while those marked with smaller arrows
were false positives.
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Figure 5.3: Screening of the ICI YAC Library with MD 220
Figure 5.3 shows representative examples of the results of screening of the
ICI YAC library (see section 2.3.2) with MD 220. The screening procedure is
described in the legend to Figure 5.1. The arrows indicate YAC
recombinants which were identified as potential positives. On further
analysis (see section 5.2) it was determined that all of the recombinants
identified with this probe were true positives.
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CHAPTER 6
6. Assembly of YACs into Contigs and Pulsed Field
Gel Electrophoretic Analysis
6.1 Introduction
It was hoped that assembly of the isolated YACs into a contig would result in
identification of the YACs which correspond to the two ends of the cloned
region. The YACs identified in this way would then be localised with respect
to the translocation breakpoint. The first step in contig assembly was to
screen all the YACs with all the markers in the region, allowing detection of
overlaps between YACs. Fingerprinting of the YACs was also carried out to
confirm the overlaps between YACs. Briefly, restriction digested total yeast
DNA was hybridised with a Cot I DNA probe, which identifies human
repetitive sequences, producing a banding pattern for each YAC.
Overlapping YACs have related banding patterns. Pulsed field gel
electrophoretic (PFGE) analysis was used to provide estimates of the size of
the YACs. Resolved YACs were transferred to a nylon membrane and
detected by hybridisation with human Cot I DNA. PFGE analysis was also
used to compare the results of hybridisation of MD 122 to normal and
translocation chromosomes. DNA, contained in agarose plugs, from controls
and translocation carriers was restriction digested and resolved by PFGE
(control agarose plugs were a gift from John Maule). The fragments were
transferred to a nylon membrane and hybridised with MD 122. This was
carried out in order to determine whether this probe detected bands which
varied in size between controls and translocation carriers. Detection of a
variant band (or bands) would indicate that the probe hybridised to a genomic
region where restriction sites varied between translocation and non-
translocation individuals. It is likely that a translocation would cause such an
alteration of the location of restriction sites in the region. The sizes of the
altered fragments would indicate the maximum distance of a probe to the
translocation breakpoint.
6.2 Results of Screening the YACs with the Markers
Figures 6.1 and 6.2 are examples of screening the isolated YACs with
markers from the region closest to the translocation breakpoint. Figure 6.1
shows all the YACs from the region hybridised with MD 283, three positives
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Figure 6.1: Confirmation of MD 283 Positive ICI YAC Recombinants
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Figure 6.1 shows Southern blot analysis, with MD 283, of ICI YAC
recombinants which were identified by colony hybridisation (with MD 283
and with other markers mapped to the region closest to the translocation
breakpoint).
Yeast DNA (-200 ng/track) was digested with EcoRI and separated in a 1 %
agarose gel (see sections 2.7.1 and 2.8.2). The fragments were transferred
to a nylon membrane and hybridised, at 68°C, with a radio-labelled probe
(see sections 2.9.1, 2.11, 2.10.1 and the legend to Figure 4.1). Blots were
washed to 1 X SSC and, after exposure for 6-8 hours, hybridisation was
detected by a Molecular Dynamics Phosphorlmager (see sections 2.11.3
and 2.12.2).
The marker is the 1 kb ladder (Gibco BRL). The size of the signal obtained
corresponds to that of the particular insert, as the same enzyme was used to
both release the insert of the microdissection clone and to digest the target
DNA.
Three YAC recombinants were confirmed as positive for MD 283 and one
was found to be negative.
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Figure 6.2: Screening of the Isolated ICI YACs with MD 437
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Figure 6.2 shows the results of screening the blot described in Figure 6.1,
with MD 437.
Probe MD 283 was removed (see section 2.11.4) from the membrane, which
was then re-hybridised, as described in the legend to Figure 6.1, with
MD 437.
This analysis indicates that one of the three YACs which is positive for
MD 283 is also positive for MD 437.
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are identified. Figure 6.2 shows the same filter hybridised with MD 437, one
of the MD 283 positive YACs is also positive for MD 437.
Table 6.1 describes the results of screening all the YACs with all the markers
in the interval closest to the translocation breakpoint. It can be seen that in a
number of cases YACs are positive for more than one marker. YAC contigs
(described in Figure 6.7) can be assembled from this data. For example,
YACs 36IF5, 6DB11 and 14IA11 clearly overlap with 36IF5 extending beyond
the others at least one end (see Figure 6.7). In some cases, these results
also allow determination of the relative order of the markers. For example,
the three YACs mentioned above are all positive for MD 220 and MD 283.
However, only YACs 36IF5 and 6DB11 are positive for MD 282 and only YAC
36IF5 is positive for MD 437. This suggests that MD 220 and MD 283 are
closely linked with MD 437 at one end and MD 282 either between MD 437
and the other two, or at the other end of this contig. Thus this technique
allows rapid and simple determination of relative order of the markers in the
region as well as the assembly of YAC contigs.
6.3 Pulsed Field Gel Electrophoretic Analysis of YACs
PFGE analysis was carried out on a subset of the YAC clones in order to
obtain estimates of the sizes of the YACs. The results of this analysis are
shown in Figure 6.3. The analysis indicated that approximate sizes of the
YACs are as follows: 36IF5- -600 kb; 8AB2- -450 kb; 16GB9- -330 kb;
11BA9- -250 kb; 11EA9- -250 kb; 33EB11- -350 kb; 19EE2- -250 kb;
21BG4- -250 kb and 2AH11 -200 kb (data not shown for this YAC).
6.4 Fingerprinting of YACs
Low resolution fingerprinting of the YACs (such as that shown in Figure 6.4)
confirmed the overlaps between YACs. YACs which overlap should have
some bands in common, but independent recombinants should also have
unique bands. This can be seen in Figure 6.4, which shows low resolution
fingerprint analysis of the MD 122 and MD 176 positive YACs. In Figure 6.4,
the open circle indicates an example of a band which is present in all of the
YACs which are positive for MD 122, while the closed circle indicates an
example of a band which is present in all of the YACs which are positive for
118

































































































































































































































LO CXI < CD < CD LU
U_ CD LU CD CD LU LU
co <c -1— co i— co cd









Figure 6.3 shows the results of PFGE analysis of a subset of the confirmed
positive YAC recombinants. YAC DNA was resolved on a pulsed field gel
and transferred to a nylon membrane (see sections 2.8.5 and 2.9.1). The
membrane was then hybridised, at 68°C, (see section 2.11) with radio-
labelled (see section 2.10.1) Cot I human DNA probe (which hybridises to
human repetitive sequences and thus identifies the recombinant). The filter
was washed to 1 X SSC and, after exposure for 3 hours, hybridisation was
detected by autoradiography (see sections 2.11.3 and 2.12.1)
The approximate sizes of the YAC recombinants were determined by
comparison to the position of the known size of the yeast marker
chromosomes (see section 2.3.3). YAC 36IF5 is approximately 600 kb;
8AB2 is approximately 450 kb; 33EB11 is approximately 350 kb; 16GB9 is
approximately 330 kb and 11BA9, 11EA9, 19EE2 and 21BG4 are
approximately 250 kb.
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Figure 6.4: Low Resolution Fingerprint Analysis of YAC Recombinants
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Figure 6.4: Low Resolution Fingerprint Analysis of YAC Recombinants
(continued)
Legend:
Figure 6.4 shows representative examples of the results of low resolution
fingerprint analysis of the MD 122 and MD 176 positive YAC recombinants.
Yeast DNA (-200 ng/track) was digested with Pstl and separated in a 0.8 %
agarose gel (see sections 2.7.1 and 2.8.2). The fragments were transferred
to a nylon membrane and hybridised, at 68°C, with a radio-labelled Cot I
human DNA probe (see sections 2.9.1,2.11 and 2.10.1). Blots were washed
to 1 X SSC and, after overnight exposure, hybridisation was detected by
autoradiography (see sections 2.11 and 2.12.1).
The open circle indicates an example of a band which is present in all of the
YACs which are positive for MD 122, while the closed circle indicates an
example of a band which is present in all of the YACs which are positive for
MD 176. The arrow indicates an example of a band which is present in all of
the YACs in the contig and the arrowheads indicate examples of bands
which are unique to particular YACs. Note that YAC 33EB11 shares bands
with the other YACs which are also positive for MD 122, but it also has many
more unique bands than any other YAC (see text for discussion).
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MD 176. The arrow indicates an example of a band which is present in all of
the YACs in the contig and the arrowheads indicate examples of bands which
are unique to particular YACs. This technique gives confirmation of the
overlaps between YACs in this contig. Independent recombinants should
also have unique bands. This can be seen in many cases in Figure 6.4. This
technique also indicates YACs which are very different in content. For
example YAC 33EB11 shares bands with the other YACs which are also
positive for MD 122, but it also has many more unique bands than any other
YAC. This YAC is 350 kb in size whereas one other MD 122 positive YAC is
200 kb in size and the other four are 250 kb in size. The unique bands in this
YAC correspond to a region of the genome which is not represented in the
other YACs which are positive for MD 122. This means that this YAC either
extends beyond the ends of the others or, alternatively, this YAC may be
chimaeric and the unique bands, or least a proportion of them, may originate
from a separate chromosomal region.
Higher resolution fingerprinting such as that shown in Figure 6.5 can be used
to give a better indication of the overlap between YAC clones. For example,
two YACs which overlap by fingerprint analysis (although not by
microdissection analysis) are 11EA9 and 11BA9. These YACs have
approximately the same number of bands approximately half of which are
shared. The two YACs are approximately the same size, indicating that for
both of these YACs approximately one half overlaps with the other while the
other half is different.
6.5 Pulsed Field Gel Electrophoretic Analysis of Translocation
and Normal DNA
PFGE analysis, comparing a normal and a translocation carrying individual
was carried out. The results obtained after hybridisation with MD 122 are
shown in Figure 6.6. While this probe detects bands of the same size in the
translocation and non-translocation individuals in some restriction digests, in
others (Mlul, Sstll and BssHII), it detects bands which differ in size. The
smallest band which varies between the individuals, obtained in the Mlul
digest, is 300 kb. This may indicate that MD 122 hybridises to a 300 kb band
in normal individuals, which is interrupted by the translocation breakpoint in
carriers. Flowever, the 300 kb band is not present in the translocation cell
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Figure 6.5: High Resolution Fingerprint Analysis of YAC Recombinants
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Figure 6.5 shows the results of
high resolution fingerprint
analysis of a subset of the YAC
recombinants. The method
used is the same as described
in the legend to Figure 6.4, with
the exception that approximately
500 ng yeast DNA was digested
and this was run in a longer
agarose gel (20 cm as opposed
to 12 cm).
Higher resolution fingerprinting
can be used to give a better
indication of the overlap
between YAC recombinants,
than that provided by low
resolution fingerprint analysis.
Note that 11EA9 and 11BA9 are
not linked by microdissection
clone analysis, but that they
share approximately half of their
bands. The two YACs are of
indistinguishable size,
consistent with -50 % overlap.
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Figure 6.6 shows the results of PFGE analysis of restriction digested DNA
from a translocation carrier (M=MAFLI) and a control individual (F=FATO),
hybridised with MD 122. DNA contained in agarose plugs was digested with
a series of restriction enzymes and resolved by PFGE (see sections 2.2.2,
2.7.2 and 2.8.5). The fragments were transferred to a nylon membrane and
hybridised, at 68°C, with a radio-labelled probe (see sections 2.9.1, 2.11,
2.10.1 and the legend to Figure 4.1). The blot was washed to 1 X SSC and,
after exposure for 24 hours, hybridisation was detected by a Molecular
Dynamics Phosphorlmager (see sections 2.11.3 and 2.12.2).
Note that the probe detects bands of the same size in the translocation and
non-translocation individuals in some restriction digests, while in others
(Mlul, Sstll and BssHII) it detects bands which differ in size (see text for
discussion).
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line, despite the fact that this cell line has a normal chromosome 11, as well
as the translocated chromosome. This suggests that the differences
observed may be caused either by differences in methylation status of the
two cell lines, or by polymorphisms which result in a difference in restriction
sites between the two cell lines. The results obtained in the BssHII and the
Sstll digest are consistent with the karyotype of the cell lines. In the BssHII
digest, a large, unresolved, band is present in both cell lines, presumably
corresponding to the normal chromosome 11. A band of 550 kb is present
only in the translocation cell line. This suggests that MD 122 detects a band
of >1500 kb in normal chromosomes which is interrupted by the translocation
breakpoint in translocation chromosomes. This would indicate that MD 122
lies within 550 kb of the translocation breakpoint.
6.6 Discussion
Successful screening of the IC! YAC library with five of the twelve clones
resulted in three contigs which link all but three of the markers in the region
(see Figure 6.7). This suggests that there is a high density of markers in a
small region and that the YACs now cover a large proportion of the region.
The sizes of the YACs can be used to estimate the density of the
microdissection clones in the region. Three YACs (36IF5, 8AB2 and 16GB9)
total 1380 kb and contain nine independent markers between them. This
gives an estimate of one marker every approximately 150 kb and estimates
the size of the region, which contains twelve markers, at 1.8 Mb. This is
possibly an overestimate as it does not take into account overlap between
YACs, other than that which can be detected by marker hybridisation. The
figure of 1.8 Mb is compatible with our previous estimate of ~2 Mb for the
interval between D11S388 and the translocation breakpoint.
Fingerprint analysis of these contigs confirmed the overlaps between the
YACs. MD 122 detected an altered size restriction fragment in translocation
versus normal chromosomes. Fingerprint analysis of the MD 122 positive
YACs, along with the PFGE analysis which allowed determination of the size
of the YACs, indicated a YAC which may extend furthest towards the
translocation breakpoint. It is likely that higher resolution fingerprint analysis
126
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The Figure (which is not drawn to scale) shows a set of possible contigs
which can be assembled from the data described in Table 6.1. Boxed areas
indicate the extent of the cross hybridisation of YACs to microdissection
clones. The relative order of two groups of markers: 1) MD 471, D11S873
and MD 412 and 2) MD 220, MD 283, MD 282 and MD 437 remains to be
determined.
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of all of the MD 122 positive YAC recombinants would provide further
information on this important set of YACs.
Another YAC library (the ICRF YAC library obtained courtesy of Hans
Lehrach) was screened with MD 122, MD 176, MD 220 and MD 471 (this was
carried out by John Brown). The results of this screening are described in
Table 6.2 and incorporated into the contig of the region (see Figure 6.8).
YAC D485 is important, as it is positive for MD 104, MD 543 and D11S931,
for which there were previously no YACs. It also extends the contig which
previously consisted of the YACs which are positive for MD 220, MD 282,
MD 283 and MD 437. Similarly, D11155 links the contig of those YACs which
are positive for MD 122 and MD 176, to the contig which is positive for
MD 412, D11S873 and MD 471. This means that all twelve markers are now
localised to one or other of these contigs which between them are likely to
cover the entire region. When this information is used to re-estimate the size
of the region, a figure in line with the previous estimate, of -1.8 Mb, is
obtained.
The results of PFGE analysis of digests of total human DNA, hybridised with
microdissection clones provided more information which can be used to
assemble a contig of the region. When Sail digests of human DNA were
sequentially hybridised with MD 176, MD 471 and MD 543 the same band of
approximately 240 kb was identified (this work was carried out by John
Maule). This result potentially links the two contigs defined previously. MD
543 has been linked to MD 176 and MD 471 and if this 240 kb pulsed field
band is also positive for D11S873 and MD 412 then the contig described in
Figure 6.9 can be assembled. It is possible that these five markers do not all
hybridise to the same 240 kb fragment, but that they hybridise to two, or
more, fragments of indistinguishable size. MD 176, MD 412, D11S873 and
MD 412 have already been linked by YAC recombinants, suggesting that
these markers are indeed linked and either hybridise to the same pulsed field
fragment, or if they hybridise to different fragments, that there are two
adjacent 240 kb Sal I fragments. It may be possible to confirm or refute
linkage of MD 543 to the other markers by the study of hybridisation to
restriction digests of other enzymes and/or by analysis with end clones from
potentially overlapping YACs.
128
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Figure 6.8: Contig of the ICI and ICRF YAC Recombinants
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The Figure (which is not drawn to scale) shows two possible contigs which
can be assembled from the data described in Tables 6.1 and 6.2. Boxed
areas indicate the extent of the cross hybridisation of YACs to
microdissection clones. The relative order of two groups of markers: 1)
MD 471 and D11S873 and 2) MD 543, D11S931 and MD 104 remains to be
determined.
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Figure 6.9: Contig and PFGE Map of the ICI and ICRF YACs
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The Figure (which is not drawn to scale) shows a possible contig which can
be assembled from the data described in Tables 6.1 and 6.2 and from PFGE
analysis. The boxed areas indicate the extent of the cross hybridisation of
YACs to microdissection clones. A PFGE fragment of -240 kb hybridised to
MD 176, MD 471 and MD 543; MD 412 and D11S873 have yet to be tested
as PFGE probes. The relative order of two groups of markers: 1) MD 471
and D11S873; and 2) D11S931 and MD 104 remains to be determined.
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MD 122, while linked to MD 176, identifies a different size Sail fragment. The
results of PFGE analysis, which suggest that MD 122 lies within 550 kb of the
chromosome 11 translocation breakpoint, are consistent with the assembled
contig (see Figure 6.9) which suggests that MD 122 lies towards one end.
The relative orientation of the contig with respect to the translocation
breakpoint has also been determined by duel colour FISH analysis (carried
out by Yoshiro Shibasaki). FISH analysis has been carried out with the
following reagents.
1. Cosmids corresponding to microdissection clones MD 104, MD 220 and
MD 283 (isolated by David Baillie and John Brown from the ICRF cosmid
library which was obtained courtesy of Hans Lehrach).
2. A probe produced by catch-linker PCR from YAC 16GB9 (MD 122 and MD
176 positive) (produced by Tony Brookes).
3. Cosmids produced from YAC 16GB9 (produced by Yoshiro Shibasaki).
FISH analysis on metaphase chromosomes suggests that the cosmid
corresponding to MD 104 is proximal to those corresponding to MD 220 and
MD 283. Similarly, the analysis shows that MD 122 is proximal to MD 104.
Thus the results of FISH analysis are consistent with the contig described in
Figure 6.9.
The marker order described in Figure 6.9 is inconsistent with measurements
of genetic distances between D11S901 (which maps proximal to the
translocation breakpoint and TYR) and D11S873 and D11S931 respectively,
which suggest that D11S931 is proximal to D11S873 (see section 3.4). The
genetic distances from firstly, D11S931 and secondly, D11S873 to D11S901
are ~ 8 cM and -8.5 cM. However, as mentioned previously, these markers
have not yet been mapped on the same set of individuals and a difference of




7.1 Production of a YAC Contig Across the Chromosome 1
Translocation Breakpoint
This work is being carried out, in parallel with the chromosome 11 work, by
Benoit Arveiler. Pools of microdissection clones (from the library described in
Chapter 4) were used to screen the ICI YAC library. The YAC recombinants
isolated in this way were assembled into a sub-library, which was then
screened with the microdissection clones which had been assigned to
chromosome 1 (see section 4.4). Currently, the YACs isolated in this way are
being assembled into a contig. Contig assembly is being carried out by
fingerprint analysis of the YACs and by testing the YACs for co-hybridisation
of microclones. The sub-library and the ICI YAC library are also being
screened by PCR. This analysis is being carried out with the PCR markers





8. Summary and Concluding Remarks
8.1 Evolution of Experimental Strategy
This thesis describes progress towards the mapping and cloning of the
breakpoints of a balanced translocation t(1; 11 )(q42.2;q21) which segregates
with schizophrenia and other major mental illness in an extensive Scottish
pedigree.
No gene which predisposes to schizophrenia has yet been isolated. In fact,
attempts to establish genetic linkage to schizophrenia have so far been
unsuccessful. The same is true for attempts to establish linkage to the
affective disorders. It is likely that this reflects the difficulties of carrying out
linkage analysis on complex, polygenic disorders. A possible alternative
solution is to utilise a chromosomal rearrangement which segregates with the
disease to isolate the causative gene. The availability of a chromosomal
rearrangement greatly simplifies the search for a gene. Firstly, the
chromosomal region(s) to be cloned and examined for the presence of a
gene is immediately obvious. Secondly, it is very likely that the size of the
region(s) to be examined will be less than that which would be implicated by
linkage analysis. Therefore, a pedigree where a balanced translocation
segregated with schizophrenia represented an opportunity for identifying a
gene (or genes), at or near one of the translocation breakpoints, which is
responsible, at least within this family, for predisposition to schizophrenia and
other major mental illnesses.
Cytogenetic banding analysis of translocation chromosomes suggested that
the translocation breakpoints occurred at 11 q21 and 1q42.2 (St.Clair et al.,
1990). In order to refine the position of the translocation breakpoints genetic
linkage analysis was carried out (by various members of the group) with
polymorphic markers in these regions. Clones representing markers which
showed little or no recombination with the phenotype and the translocation
were used in FISH analysis (carried out by Diane Hanratty and John
Gosden), resulting in the definition of initial flanking markers (Fletcher et al.,
1993).
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We decided to focus primarily on the cloning of the chromosome 11
translocation breakpoint. The chromosome 11 translocation breakpoint was
chosen because we had already established a number of chromosome 11
resources in the laboratory. These included somatic cell hybrids and assays
for markers of known location on chromosome 11. The existence of two other
balanced translocations which appeared to segregate with schizophrenia and
which involved chromosome 11 q (Smith et al., 1989; Holland and Gosden,
1990) (the breakpoints were not accurately defined) also prompted this focus
on the chromosome 11 translocation breakpoint.
We wished to define the location of the chromosome 11 breakpoint at a
higher resolution, as part of a positional cloning strategy towards the isolation
of a clone (or clones) which spanned the translocation breakpoint. Positional
cloning of the chromosome 11 translocation breakpoint was a viable
proposition because, as well as the access to chromosome 11 markers, there
was considerable expertise in somatic cell genetics and molecular mapping
within the group.
High resolution characterisation of the translocation breakpoints required
firstly the segregation of the two translocation derived chromosomes into
separate somatic cell hybrids. Segregation of the translocation chromosomes
was achieved by cell-surface marker selection strategies (this was carried out
by Judy Fletcher and Veronica van Heyningen) (Fletcher et al., 1993). The
assembly of a panel of somatic cell hybrids, each of which contained
complementary segments of chromosome 11 was also required. Four
hybrids, containing fragments of chromosome 11 in the background of a
Chinese hamster ovary cell line (WG3H) were produced by Judy Fletcher and
Veronica van Heyningen. These fragmentation hybrids were produced by X
irradiation of a chromosome 11-only hybrid J1CI4 (Jones et al., 1984),
followed by rescue of the fragments produced, by fusion with WG3H cells and
finally, cell surface marker selection to isolate those cell lines which retained
fragments of chromosome 11. Two independent HRAS 1-selected
chromosome mediated gene transformants (CMGT), which carry single
fragments of chromosome 11 material in a murine background (Porteous et
al., 1986), and two other, unrelated translocation cell lines, PG48, which has
a translocated chromosome 11 which lacks 11 q22-11 qter, in a hamster
background (Gillett, et al., 1993) and CF52 which has a well characterised
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t(11; 16) (q 13;p11) translocation chromosome as its sole human component,
in the background of a murine cell line (Koeffler et al., 1981) were also
obtained. This was carried out with a view to using the cell lines to map
markers relative to the translocation breakpoints and to a series of intervals
on chromosome 11, as defined by the segments of chromosome 11 present
in the set of hybrids. This was the starting point of my PhD project. I initially
analysed the cell lines for the presence of markers whose chromosome 11
regionalisation and relative order was known. Subsequently, I analysed the
cell lines for chromosome 11 markers whose chromosome 11 regionalisation
was unknown. These markers were localised by comparison with those of
known chromosomal location.
Once the hybrid mapping panel had been established and characterised and
markers of unknown location had been mapped, it was obvious that new
markers would have to be generated from a region close to the chromosome
11 translocation breakpoint. This was achieved by microdissection of a
30 Mb region surrounding the translocation breakpoint in the derived
chromosome 1. The dissected material was digested with EcoRI and cloned
(Muir et al., manuscript in preparation). The microdissection clones
generated in this way were assigned to intervals on chromosome 11, using a
subset of the hybrid cell lines. This was done with the aim of identifying
those markers from the microdissection library which mapped to the interval
closest to the chromosome 11 breakpoint. The markers which mapped to this
critical region were used to isolate YACs. The analysis of these YACs, along
with PFGE analysis of the normal and translocated chromosomes (using
probes from the closest interval) and FISH analysis (with probes derived from
the isolated clones) were used to build up a YAC contig of the region.
8.2 Summary of results
This project has resulted in the determination of flanking markers of the
chromosome 1 and chromosome 11 translocation breakpoints and the
characterisation of a set of somatic cell hybrid lines. These somatic cell
hybrids have been used to regionally localise genes, ESTs, microdissection
clones and anonymous DNA markers on chromosome 11 q. My efforts have
resulted in the localisation of 13 genes, two ESTs, eight anonymous DNA
markers and 18 microdissection clones and, as a group, we have mapped an
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additional nine ESTs and 31 microdissection clones to a series of intervals on
chromosome 11 q. This hybrid mapping panel now defines 22 intervals on
chromosome 11 q. Thirty-seven microdissection clones have been localised
to chromosome 1 and six anonymous DNA markers have been mapped
relative to the translocation breakpoint on chromosome 1. The genetic
distance between the distal flanking marker and one of the potential proximal
flanking markers is estimated at 6 cM (Engelstein et al., 1993).
The microdissection clones were regionally localised on chromosome 11,
with the aim of identifying a number of new markers in the interval closest to
the chromosome 11 breakpoint. Ten microdissection clones were identified
as mapping to this interval. This, together with the fact that two anonymous
markers were subsequently localised to the same interval, means that there
are 12 markers in a region estimated at ~ 2 Mb. Five of these markers were
successfully used to screen the gridded filters of the ICI YAC library. This
resulted in the isolation of 16 YACs. Overlaps between the individual YAC
recombinants were detected by co-hybridisation of markers to the YACs,
allowing the assembly of three YAC contigs. These three contigs correspond
to nine of the twelve markers in the region under study. The validity of these
contigs was confirmed by fingerprint analysis, which demonstrated the
overlaps between YACs where they had been predicted. The contigs were
confirmed and extended by the analysis of a set of nine YACs isolated from
the ICRF YAC library (this work was carried out by John Brown and Susan
Maguire). This analysis allowed assembly of the markers into two YAC
contigs which covered all twelve markers in the region. The two contigs were
provisionally linked by co-hybridisation of markers from the two contigs to the
same pulsed field gel fragment (this work was carried out by John Maule).
The resultant contig of YACs was oriented relative to the translocation
breakpoint in two ways. Firstly, using MD 122 as a probe, I detected
differences in the length of PFGE restriction fragments in DNA from a
translocation carrier versus that obtained in normal DNA. This analysis
indicated that MD 122 is within 550 kb of the translocation breakpoint.
Secondly, duel colour FISH analysis (carried out by Yoshiro Shibisaki) was
carried out with a probe produced by catch-linker PCR (produced by Tony
Brookes) from YAC 16GB9 (MD 122 and MD 176 positive) compared to
cosmids corresponding to MD 104, MD 220 and MD 283 (isolated by David
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Baillie and John Brown). This analysis indicated that 16GB9 is proximal to
MD 104 which is in turn proximal to MD 220 and MD 283. It should be said
that this preferred order implies that D11S873 is more centromeric than
D11S931, a result which is at odds with published linkage analysis. There
appears to be a need to re-evaluate the genetic map of this region.
Thus the objectives of this thesis have been achieved in part. The position of
both translocation breakpoints have been refined, relative to the markers on
the two chromosomes. New markers have been identified in the region
immediately distal to the chromosome 11 translocation breakpoint. These
markers have been used to isolate YACs, which have contributed to the
assembly of a YAC contig of the region. It is necessary to confirm this contig,
and it may be necessary to extend it, before the chromosome 11 translocation
breakpoint can been cloned.
8.3 Future Directions
In order to confirm and complete the chromosome 11 contig a number of
experiments are being carried out, by various members of the group,
including myself.
1. End clones are being isolated from YACs. These clones are being used in
a number of ways. They are being hybridised to Southern blots of all the
YACs in the region, in order to detect all overlaps between the YACs and to
confirm the order of the clones and markers in the contig. End clones from
YACs at the end of the contig closest to the translocation breakpoint are
being hybridised to somatic cell hybrids, in order to determine which side of
the chromosome 11 breakpoint they map to. These clones are also being
used in PFGE analysis in an attempt to detect alterations in restriction
fragments sizes caused by the interruption of the chromosome by the
translocation breakpoint.
2. Probes are being isolated from YACs located at the end of the contig
closest to the translocation breakpoint, by catch-linker PCR. The probes
generated are being used in a number of different ways. They are being
used for FISH analysis, in order to determine whether any of the YAC
recombinants at the end of the contig which is closest to the chromosome 11
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translocation breakpoint, cross the breakpoint. In common with the end
clones, the individually cloned catch linkered probes are being hybridised to
Southern blots of all the YACs in the region, in order to detect all overlaps
between the YACs and to confirm the order of the clones and markers in the
contig. These probes are also being hybridised to somatic cell hybrids in
order to determine which side of the chromosome 11 breakpoint they map to.
Finally, individual clones are again being used in PFGE analysis, in an
attempt to detect alterations in restriction fragments sizes due to the
interruption of the chromosome by the translocation breakpoint.
3. YACs at the end of the contig which is closest to the translocation
breakpoint are being subcloned into cosmid vectors. These cosmids will also
be used in FISH analysis and as probes for hybridisation to Southern blots,
both of the YACs in the region and of the somatic cell hybrids.
If the experiments described above confirm the order of the clones in the
contig, but find that it does not extend to the translocation breakpoint, then it
will be necessary to walk from the nearest YAC recombinant, until a clone or
clones which cross the chromosome 11 translocation breakpoint have been
isolated. End clones and catch linkered probes generated from the closest
YAC will be used for this purpose.
A clone (or clones) which crosses the chromosome 1 translocation breakpoint
is also required. As discussed in section 7.1, experiments towards this are
currently underway. It may also be possible to isolate clones from the region
of the translocation breakpoint on chromosome 1 using a probe adjacent to
the chromosome 11 breakpoint. For example, where a probe detects
restriction fragments of altered size in translocation chromosomes these
fragments correspond to the piece of DNA which spans the breakpoint of the
translocated chromosome. This fragment consists of DNA from chromosome
1 as well as chromosome 11. It should be possible to recover this material by
coincidence sequence cloning (Brookes and Porteous, 1991) between
material extracted from two bands of altered size, produced by digestion of
translocation carrier DNA with two different restriction enzymes. Coincidence
sequence cloning should result in the selective recovery of the DNA at the
translocation breakpoint as, although there will be DNA from other
chromosomal regions present in both of the bands, the only DNA in common
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to the two bands should be the fragment which spans the translocation
breakpoint.
An alternative method for recovery of the breakpoint region from one or both
of the translocation chromosomes would be to generate sequence from the
chromosome 11 side of the breakpoint and to use this sequence to design
inverse PCR primers (i.e. primers which are designed to amplify out from the
cloned material in opposite directions). Digestion of DNA from a
translocation carrier with an enzyme which doesn't cut between the distal
primer and the translocation breakpoint would then be followed by ligation,
under conditions where circularisation of individual molecules is the most
likely outcome. The piece of DNA which spans the breakpoint will now exist
as a circle and thus sequence flanking the chromosome 1 translocation
breakpoint can be obtained by inverse PCR.
Once DNA fragments from the regions flanking the translocation breakpoints
have been isolated, by either of the above methods, those which are found to
originate from chromosome 1 can be used to screen cosmid and YAC
libraries, resulting in the isolation of clones from the breakpoint region on
chromosome 1.
Once clones which span the translocation breakpoints have been isolated
then the next step is the analysis of the translocated chromosomes and the
isolation of candidate genes. Again, a number of complementary methods
will be used.
1. Molecular analysis will be carried out on the translocation breakpoint
regions in various affected individuals and compared with the appropriate
normal chromosome region. Probes from the region will be hybridised to
restriction digests of DNA from normal individuals and translocation carriers.
This will determine whether the translocation involved clean breakage of the
chromosomes or whether events such as insertions, inversions or deletions
have occurred. This information will indicate the likely locations of candidate
genes.
2. Identification of the CpG islands closest to the translocation breakpoints,
by PFGE analysis of restriction digests of YACs and cosmids which span the
translocation breakpoints, will point to the locations of candidate genes.
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3. Probes which map close to a translocation breakpoint and which, by Zoo
blot analysis, show cross-species conservation will be used to screen cDNA
libraries to obtain candidate expressed sequences.
4. Coincidence sequence cloning between foetal brain cDNA and an
appropriate genomic template will be used to isolate candidate genes
(Brookes and Porteous, 1991). The appropriate genomic templates include
catch linkered PCR products from a clone which spans a translocation
breakpoint, a cosmid which spans the translocation breakpoint or the
microdissection clones which map to an appropriate region. A number of
candidate genes have already been isolated by coincidence sequence
cloning between foetal brain cDNA and a proportion of the repeat free
microdissection clones (this was carried out by Euan Slorach and Tony
Brookes).
Thus it should be possible, by using a combination of strategies, to clone
both translocation breakpoints and to isolate genes which are likely to be
affected by this rearrangement.
Once candidate genes have been identified, their location, with respect to the
translocation breakpoints, will be determined. If one of the breakpoints
interrupts the gene, then this would indicate that it is involved in the
phenotype in this family. The expression of the candidate genes will be
studied, in order to detect any differences between translocation carriers and
control individuals. Expression of candidate genes will also be examined in
archival and autopsy material, from schizophrenics (without the
t(1;11)(q42.2;q21) translocation) and from control individuals. Other
individuals with schizophrenia will be tested for mutations in the candidate
gene. Having a candidate gene (or genes) would allow a variety of
experiments into the likely role of the gene to be designed. Any genes which
are isolated in this way will also be used to identify biochemically or
evolutionarily related genes or proteins which may be mutated in other cases
of schizophrenia, or related mental illnesses.
Thus the molecular analysis of the translocation promises not only to provide
insight into the cause of the disorder in this family, but also to provide a route
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ABSTRACT
Olfactory marker protein (OMP) shows olfactory neuron-
specific expression in rodents [1,2,3]. We recently reported
tight linkage on mouse chromosome 7 of OMP to the shaker-1
deafness mutant, between the tyrosinase and globin loci [4].
Here we isolate and map the human homologue. Our results
show that OMP maps immediately centromeric to tyrosinase
on the long arm of human chromosome 11. Genetic linkage
to this region has recently been established for Usher
Syndrome Type I [5], an autosomal recessive blindness and
deafness disorder and a putative homologue of the shaker-1
mutant. OMP is thus a candidate gene for both congenital
deafness defects.
■INTRODUCTION
Olfactory marker protein (OMP) is of unknown biological
function. It is found in a wide variety of vertebrates and is
expressed predominantly in mature, functioning olfactory receptor
neurons where it is present as a highly abundant cytoplasmic
.protein [1,2,3]. Molecular genetic mapping of the mouse Omp
-gene to a series of radiation induced albino deletion chromosomes
established that it mapped distal to both tyrosinase and mod-2
and proximal to the globin locus, in an interval of approximately
2cM [6]. This analysis placed Omp in the same minimal deletion
interval as the mouse mutant shaker-1. Shaker-1 is an autosomal
recessive deafness mutant which shows associated circling and
-head-tossing behaviour and hyperactivity [7]. Homozygotes have
abnormalities in eighth-nerve and cochlear potentials, in the
■absence of detectable structural changes in the cochlea.
•Electrophysiological observations suggest that the inner hair cells
or afferent innervations are the primary site of the defect and
likely site of sh-1 gene expression [8]. As a prelude to positional
cloning of the defect, we previously undertook to refine the
■genetic location by RFLV analysis of an extensive intraspecific
hackcross segregating for the shaker-1 mutation. Typing for Omp,
we observed a single recombinant in one thousand progeny [4].
This result suggested that Omp maps within 200kbp of sh-1 and
-might in fact constitute the locus.
Similarities between a number of hereditary deafness
syndromes in mice and humans have been noted [9]. New insights
may come from further comparative studies of orthologous
chromosomal regions [10]. We therefore undertook to isolate the
human OMP homologue and establish its map location. Previous
comparative studies of genes on mouse chromosome 7 have
established extensive homology with human chromosome 19q,
1 lp and 1 lq and to a lesser extent 15q [11]. Mod-2 is exceptional
in that the human homologue, ME2, has been assigned to 6p [ 12].
The mouse map for the sub-region of current interest, with the
corresponding human chromosome locations in parenthesis, can
be summarised as follows: Fes (15q) — Tyr (11q21) —Mod-2
(6p) —Calc 1/ Hbb (lip 15). Our genetic linkage studies in the
mouse place Omp and sh-1 5.36cM distal to Tyr and 1.2cM
proximal to Hbb [4]. Taken together with the complementary
deletion mapping studies [6], our a priori expectation was that
OMP in the human would most likely map to 1 lpl5, or possibly
6p. Interestingly, recent studies have indicated linkage of Usher
Syndrome I (an autosomal recessive disorder characterised by
profound congenital deafness, vestibular areflexia and progressive
retinitis pigmentosa) close to TYR on 1 lq [5], the region to which
we now localise OMP.
RESULTS
Isolation of the human OMP homologue
In the mouse, like the rat [2], OMP is a single-copy gene encoded
by one exon of 490bp [4]. Primers derived from the rat sequence
were used successfully in cross-species PCR to amplify an
intraexonic fragment of identical size from human genomic DNA
(data not shown). This was used as a hybridization probe to screen
a human cosmid library. A single recombinant was colony
purified and confirmed to correspond to the probe by sequence
analysis of an appropriately amplified fragment (data not shown).
Mapping of the human OMP homologue
a) Segregation in somatic cell hybrids carrying derived hutnan
chromosomes 11. A single-copy sub-fragment of the human
cosmid which encompassed the OMP gene was used to probe
a panel of somatic cell hybrids carrying various portions of human
chromosome 11. Figure 1 shows the results which localise the
gene on the long arm of chromosome 11 close to TYR. MIS
7.4 and 39.8 carry the t( 1; 11 )(q43;q21) reciprocal translocation
chromosomes we have described previously segregating with
* To whom correspondence should be addressed
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:;ure 1. Mapping of human OMP to translocation, X-irradiation, and CMGT
.ntnan-rodent somatic cell hybrids carrying portions of human chromosome 11,
The Bglll digests (5/rg per track) loaded from left to right in Tracks I to 13 were,
MIS 1~A ( -ve), MIS 39.8 ( + ve), X63 (-vc), E67-1 (-ve), E67-4 (+ve), CF52
( + ve). MAFLI ( + ve), J1 ( + ve), WG3H (-ve), WJX 3.4 ( + ve). WJX 7.4
( + ve). WJX 5.4 (-ve), WJX 11.2 (-ve). A Molecular Dynamics Phopholmager
was used to detect the hybridization. Human specific hybridization is at - I.6Kbp
(scored above as +ve or -ve for each sample tested) while the rodent specific
hybridization is at ~ 5Kbp. MAFLI is a lymphoblastoid cell line established from
a patient with schizophrenia [13] and a reciprocal t( 1; 1I)(q43;q21) translocation
which has been segregated in the MIS 7.4 and 39.8 hybrids [ 15], J1 is a human
chromosome 11 only hamster hybrid [26]. X63 and WG3H are mouse and hamster
.v: lines, respectively. CF52 is an t(l I; 16)(q 13;p 11) translocation hybrid [14],
I'he WJX series are radiation reduced hybrids derived from J1 [15], while E67-1
and E6~-4 are HRAS1-CMGT reduced hybrids [16].
major mental illness, comprising schizophrenia and
schizoaffective disorder, in a large Scottish pedigree [13]. CF52
carries a well characterised t(l 1; 16)(q 13;p 11) translocation
breakpoint [ 14], The four radiation fusion hybrids (WJX series)
[15] and two HRAS1-CMGT hybrids (E67-1 and E67-4) [16]
each retain one or more sub-fragment of human chromosome
11 and help to accurately place each marker tested. The mapping
results with OMP place the human gene on the long arm of
chromosome 11 telomeric to FGF4 (and therefore also FGF3.
see later), close to TYR and centromeric to the schizophrenia
translocation breakpoint. Table 1 shows a full comparison of the
OMP mapping result with other markers tested previously [ 15].
h) DNA in situ hybridization. To confirm and refine the OMP
map location, we carried out DNA in situ hybridization with
fluorescently labelled cosmids to banded human metaphase
chromosomes, as previously described [15,17], Figures 2a and
b show the results of hybridization with a cosmid clone for
tyrosinase [18] and the OMP cosmid respectively, analysed by
scanning fluorescent confocal microscopy. Seventeen R banded
chromosomes showing hybridization were examined for each
cosmid: we conclude that tyrosinase maps to 1 lq 14.3 and that
OMP maps to 11 q 13.5. Fractional length measurements from
the tip of the short arm to the site of hybridization, determined
on the same set of images, gave FLPTER measurements of 0.6
(range 0.58-0.64) for OMP and 0.68 (range 0.64 — 0.71) for
tyrosinase. To confirm the more centromeric location of OMP,
we performed a double hybridization experiment. OMP and the
chromosome 11 specific alphoid repeat probe PLC 11A [19] were
both labelled with biotin and visualised with avidin-texas red.
Tyrosinase was labelled with digoxygenin and visualised with
ITC-iabelled anti-digoxygenin. The results are shown in
: .re 2c. High resolution mapping to interphase chromosomes
under otherwise identical hybridization conditions is shown in
Figure 2d. The relative positions of hybridization is unchanged,
but the absolute distance separating the hybridization signals is
altered, reflecting differential chromosome (de)condensation.




Figure 2. hi situ localisation of TYR and OMP. a: Representative fluorescence
in situ hybridization with OMP. Hybridization and detection was as described
in the Materials and Methods. The site of OMP hybridization on each of the
two human chromosomes 11 is arrowed, b: Representative fluorescence in situ
hybridization with TYR. Hybridization and detection was as described in the
Materials and Methods. The site of TYR hybridization on each of the two human
chromosomes 11 is arrowed, c: Dual hybridization of metaphase chromosomes
with TYR and with OMP plus PLC 11A. Hybridization and detection was as
described in the Materials and Methods. The site of OMP hybridization on each
of the two human chromosomes 11 is arrowed. The strong red signal corresponds
to the hybridization of PLC 11A to the centromere and the green signal to TYR.
d: Dual hybridization of inteiphase chromosomes with TYR and with OMP plus
PLC 11A. Hybridization and detection was as described in the Mater J < and
Methods. The hybridization of OMP to each of the two human chronica les
11 is arrowed. The strong red signal corresponds to the hybridization of PlC
11A to the centromere and the green signal to TYR.
DISCUSSION
The albino locus in the mouse, which encodes tyrosinase, has
been extensively studied. The availability of a number of
experimental and spontaneous deletion mutants has allowed the
fine mapping of flanking genes. Comparative studies show that
the region shares homology with at least three human
chromosome segments represented by Tyr (1 lq21), Mod-2 (6p)
and Hbb (11 p 15) [11], As murine Omp maps between Mod-2
and Hbb [4,6], our a priori expectation was that human OMP
would map to 6p or 11 p15. However, our present study excludes
linkage to HBB and clearly shows that human OMP maps at
11 q 13.5 in the human, close to TYR. The present result adds
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ible 1. Marker analysis of translocation, X-irradiation, and CMGT human-rodent somatic cell hybrids carrying portions of human chromosome 11
)cus mis 7.4 mis 39.8 cf 52 wjx 3.4 wjx7.4 wjx5.4 wjx11.2 e67.1 e67.4
3b _ + nd — _ + _ + _
- + nd - - - - nd nd
{r li - + - + - + - - +
}a - + - + + - - + -
du 1 - + - + + - - - -
stfi - + - + — - - - -
st 3 - + - + - - - + +
11s527 - + + + - - - - —
11s533 - + + + + - - - +
vip — + + + + - - - +
fr — + + - + - + - +
11s388 + - + - - - + - -
'my + - + - - + + - +
_g + - + - - + + - +
11s385 + - + - - + + - +
:am + - + - + - + - +
*d2 + - + - + — + - -
11s351 + - + - - + + - -
jy1 + - + - - + + - -
ic 9 + - + — - + + - -
e legend to Figure 1 for details of DNA's. Marker analysis for OMP was as described in Figure 1. All other markers were mapped by Southern blot analysis
d/or PCR analysis, as described and published in detail elsewhere [15], with the exception of D11S527 for which the original PCR conditions [22], with slight
xiification, were used.
the comparative map and suggests that the divergent evolution
: this region between mouse and man is even more complex
an thought previously; we must now account for the presence
"
a second region of homology to 1 lq on mouse chromosome
in the region between Mod-2 (6p in human) and Hbb/Calc I
lp 15 in human). Equally, it should be possible to use this new
imparative map information to further define the transcription
ap of the region and therefore the shaker-1 locus, as any
insition from one syntenic region in the human to another will
lly occur between rather than within homologous genes.
Usher Syndrome I is the most common combined cause of
afness and blindness in the developed world [5], Recent genetic
idies have provided evidence for linkage of Usher Syndrome
o 14q in French families from the Poitou-Charentes region [20],
1 lp in an isolated Louisiana Acadian population [21], and to
q in other families from the USA, Sweden, Ireland and South
ffica [5], The 1 lq linkage studies place the latter Usher I locus
;tal to FGF3 (and therefore also FGF4) and almost certainly
oximal to TYR [5], The highest LOD score was observed with
; polymorphic marker D11S527 [22] (Z=4.15, @=0.1).
US527 was isolated from a cosmid 'contig' which has been
ipped by fluorescence in sim hybridization to 11 q 13.5 [23].
lis matches closely our localisation of OMP. It is of note that
; observe discordance between OMP and D11S527 and between
TP and TYR each in two (different) reduced hybrids, whereas
;re is complete concordance between OMP and another closely
■ked and highly polymorphic marker, D11S533 [24]. This
-servation suggests that D11S533 will be a useful marker in
ther genedc linkage studies in Usher Syndrome Type I families
■1 at the same time illustrates the power of fragmentation hybrids
■ high resolution physical mapping.
■We estimate from our previous genetic studies of mouse OMP
t the gene lies within 200kbp of the shaker-1 deafness mutant
. The similarities in the mode of inheritance, penetrance and
ic pathology of the hearing defect in shaker-1 mice and Usher
ldrome I patients are provocative. We have examined mice
rying several independent sh-1 alleles by electroretinography




Figure 3. Summary of hybridisation results with TYR and with OMP on R-banded
chromosomes. Hybridization and detection was as described in the Materials and
Methods. The site of hybridization of TYR (17 metaphases) and of OMP (18
metaphases) is shown.
in young adult mice (Steel and Brown, unpublished), a careful
study of ageing mice for evidence of eye degeneration is justified.
The function of OMP is unknown, but expression studies
suggest an involvement in olfaction and a direct or indirect role
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in neurotransmission is possible [1,2,3]. Some Usher Syndrome
patients show increased numbers of compound nasal cilia with
abnormal arrangements of the axonemal microtubules [25], Since
the outer limbs of the photoreceptors are modified cilia and the
sensory epithelium of the inner ear is derived from ciliated
epithelial cells, a unifying hypothesis would be that the spectrum
of sensory abnormalities in Usher Syndrome I stem from a single
basic defect in cilial development. Taken together with the genetic
linkage in Usher Syndrome I and in sh-1, it is tempting to
speculate that these defects are true homologues and that OMP
is either directly implicated in or very closely linked to both
disorders. We are carrying out further molecular cloning and
mutation screening experiments to test both hypotheses.
MATERIALS AND METHODS
Isolation of a human OMP cosmid
A PCR reaction was performed on total human DNA using primers and conditions
as described previously for the mouse [4]. The resultant 490bp product was
radiolabelled by random priming and used to screen a total genomic DNA library
(generous gift of DrW Bickmore) prepared by partial digestion with Sau3A and
insertion at the BamHI site of the Lawrist cloning vector. A single positive
hybridising colony was identified, purified and confirmed as being human OMP
by PCR amplification using the above protocol and direct sequencing of the product
(data not shown).
Hybrid cell culture, DNA analysis and marker analysis
Somatic cell hybrids were maintained and characterised, and DNA prepared for
Southern blot and PCR analysis as described previously [15,16]. A ~900bp PstI
fragment encompassing the OMP gene was subcloned from the OMP cosmid
and used as a hybridization probe under standard conditions to 5/j.g aliquots of
Bgtll digested human, rodent and human-rodent somatic cell hybrid DNA. A
Molecular Dynamics Phospholmager was used for hybridization detection.
In situ hybridization
Metaphase spreads were prepared from human peripheral lymphocyte cultures
and hybridised to biotin labelled cosmids; the signals were detected using alternate
layers of avidin-FITC, biotinylated anti-avidin, and avidin-FITC as described
previously [15,17], The slides were mounted in antifadent containing propidium
iodide and DAPI to produce an R banded propidium iodide pattern. Images were
obtained and analysed with a Biorad MRC 600 scanning confocal microscope.
In double hybridization experiments, the tyrosinase cosmid was labelled with
digoxygenin and detected with FITC-conjugated sheep anti-digoxigenin Fab
fragments (Boehringer-Mannheim) while the OMP cosmid and the chromosome
11 specific centromere probe PLC 11A were labelled with biotin and detected
with alternate layers of avidin-Texas red, biotinylated anti-avidin and avidin-Texas
red.
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Schizophrenia-associated Chromosome Iiq2l Translocation:
Identification of Flanking Markers and Development
of Chromosome I Iq Fragment Hybrids as Cloning
and Mapping Resources
Judy M. Fletcher,* Kathryn Evans,* David Baillie,* Philip Byrd,*1' Diane Hanratty,*
Suzanne Leach,* Cecile Julier,t John R. Gosden,* Walter Muir,* David J. Porteous,*
David St. Clair,* and Veronica van Heyningen*
•Medical Research Council Human Genetics Unit, Western General Hospital, Edinburgh; and |Centre d'Etude du Polymorphisme Humaln, Paris
Summary
Genetic linkage, molecular analysis, and in situ hybridization have identified TYR and D11S388 as markers
Banking the chromosome 11 breakpoint in a large pedigree where a balanced translocation, t(l;llXq43;q21),
segregates with schizophrenia and related affective disorders. Somatic cell hybrids, separating the two
translocation chromosomes from each other and from the normal homologues, have been produced with the aid
of immunomagnetic sorting for chromosome 1- and chromosome 11-encoded cell-surface antigens. The genes
for two of these antigens map on either side of the llq breakpoint. Immunomagnetic bead sorting was also used
to isolate two stable X-irradiation hybrids for each cell-surface antigen. Each hybrid carries only chromosome
11 fragments. Translocation and X-irradiation hybrids were analyzed, mainly by PCR, for the presence of 19
chromosome 11 and 4 chromosome 1 markers. Ten newly designed primers are reported. The X-irradiation
hybrids were also studied cytogenetically, for human DNA content, by in situ Cotl DNA hybridization and by
painting the Alu-PCR products from these four lines back onto normal human metaphases. The generation of
the translocation hybrids and of the chromosome llq fragment hybrids is a necessary preliminary to
determining whether a schizophrenia-predisposition gene SCZD2 is encoded at this site.
Introduction
A large Scottish pedigree (K26) has been described (St.
Clair et al. 1990) in which major mental illness, classifi¬
able as schizoaffective disorder, was seen to segregate
with a balanced translocation, t(l;ll)(q43;q21). The
family had been initially ascertained through a cytoge¬
netic survey of mental hospitals and borstals (Jacobs et
al. 1970). Subsequently (St. Clair et al. 1990) it was
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found that 23 members of this family had psychiatric
diagnoses conforming to the details set out in Research
Diagnostic Criteria for mental and/or behavioral dis¬
orders (Spitzer et al. 1987). Thirty-four of the 77 indi¬
viduals karyotyped carried the translocation. Sixteen of
the 23 family members who had psychiatric diagnoses
had majormental illness; two others, not analyzed cyto¬
genetically, had committed suicide. The five remaining
cases with psychiatric diagnoses but without the trans¬
location did not have major mental illness (one had
generalized anxiety, one had minor depressive disorder,
and three were alcoholics). No physical dysmorphism
or mental handicap had been observed in this carefully
studied family.
Pedigrees with familial aggregations of common dis¬
eases, with both genetic and environmental compo¬
nents, are now used to unravel the specific genetic con¬
tributions to such disease, in the hope of gaining insight
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into the biochemical pathways affected, thus allowing
us to think about therapy and prevention. A large pedi¬
gree where the disease segregates tightly with a cytoge¬
netic abnormality is an ideal starting point for identify¬
ing the genetic component implicated at least in that
family. Obviously, a coscgregating translocation may
result in functional inactivation of a particular gene at
or near the breakpoint site, but we arc aware that the
breakpoint may only be a closely linked marker for a
dominantly acting disease-predisposing allele that hap¬
pens to be present in this family, at a nearby locus. Two
other, smaller families have been described with less
clear-cut cosegregation of mental illness with two inde¬
pendent chromosome 11 q translocations, one with
chromosome 9 and one with chromosome 6 (Smith et
al. 1989; Holland and Gosden 1990). The breakpoints
were not accurately defined. However, their existence
strengthened our interest in defining the exact site of
the translocation breakpoint in pedigree K26.
Cytogenetic banding analysis was carried out on pe¬
ripheral blood chromosomes from selected individuals,
to confirm and refine the position of the breakpoint.
Lymphoblastoid cell lines were set up from key family
members, both translocation carriers and noncarriers.
Genetic linkage analysis was carried out with available
polymorphic markers in the region of the translocation,
by using markers both from chromosome 1 and from
chromosome 11. We expected to see suppression of
recombination in the vicinity of the translocation but
hoped to define more accurately the site of the break¬
point. Using markers which showed little or no recom¬
bination with the disease and the translocation in this
family, we used chromosomal in situ hybridization to
determine the position of the breakpoint, with the aid
of suitable large insert markers. However, with a view
to defining the breakpoint much more closely by posi¬
tional cloning strategies, we also embarked on segregat¬
ing the two translocation-derived chromosomes into
separate somatic cell hybrids, using cell-surface marker
selection strategies which we had developed for our
work on the short arm of chromosome 11 (Seawright et
al. 1988). The two independent pairs of mouse-human
hybrids so produced showed TYR to be above the
breakpoint and showed STMY1 to be below it. In situ
hybridization confirmed the tyrosinase assignment to
the derived chromosome 11 and showed the next most
closely linked distal llq marker, D11S388 (cosmid
CJ52.4) (Julier et al. 1990), to be below the breakpoint.
The chromosome 1 breakpoint was also defined with
available markers and was found to be between D1S103
and D1S8. We then used DNA from the reciprocal
translocation hybrids MIS" and M1S39 to set up and
refine PCR-hascd analyses tor a number of chromo¬
some 1 Iq loci.
Cell-surface marker analysis revealed early on that
the two chromosome llq markers MDU1 and M1C9
were, respectively, above and below the translocation
breakpoint. Therefore we set out to produce stable
chromosome-fragment hybrids, by X irradiation of the
chromosome 11-only hybrid J1C14 (Jones et al. 1984),
selecting for each marker separately. These were des¬
tined to be both a mapping and a cloning resource, for
the production of new markers in regions defined by
earlier markers.
Material and Methods
Genetic Analysis of Selected Family Members
DNA was available for linkage analysis, from 10
translocation carriers and 5 noncarriers in the pedigree.
Individuals came from five branches of the family, each
separated by several meiotic events. Analysis was
carried out either by DNA blotting using informative
restriction digests or by PCR followed by sizing of dinu-
cleotide repeats on sequencing gels. Suitable markers
were chosen above and below the breakpoint positions
suggested by cytogenetic banding analysis on both
translocation chromosomes: on chromosome 11—
D11S97 (Jeffreys et al. 1988), TYR (Spritz et al. 1990;
Giebel et al. 1991), D11S388 (Julier et al. 1990), and
D11S35 (Litt et al. 1990); on chromosome 1—D1S81
(Nakamura et al. 1988), D1S103 (Weber et al. 1990),
and D1S8 (Royle et al. 1988). Of these, D11S35,
D1S103, and, latterly, TYR (Morris et al. 1991) were
analyzed as dinucleotide repeats.
Cell Culture and Fusion
Peripheral blood lymphocytes were isolated from a
number of cytogenetically normal and translocation-
carrying members of the pedigree. In most cases, perma¬
nent B lymphoblastoid cell lines were produced by Ep-
stein-Barr virus (EBV) transformation (van Heyningen,
in press). Two cell lines, MAFLI and ROMAR, from
translocation individuals with majormental illness have
been used for most of the marker analyses. Culture of
peripheral lymphocytes and EBV cell lines was in RPMI
1640 medium with 10% FCS. Preexisting cell hybrids
were grown in appropriate medium: CF37, carrying an
X-ll translocation chromosome (Mohandas et al.
1980) was grown in HAT medium; CF52 has an 11-16
translocation chromosome as its sole human chromo¬
some complement and was grown in medium selective
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for Al'RT (Koetfler et al. 1981). CF37 and CF52 were
the gift of Dr. T. Mohandas. The CMGT hybrids F.67.1
and F67.4 have been described elsewhere (Porteous ct
al. 1986) and have been analyzed in detail for short-arm
markers (Portcous et al. 1987). They were grown in
RPMI 1640 with 10% FCS.
The thioguanine-resistant, HPRT" mouse ceil lines
used for fusion were Sp2/0-Ag4 (Shulman et a!. 1978)
and RAG (Klebc et al. 1970). Polyethylene glycol
(PEG)-induced fusion, with MAFL1 as the human par¬
ent, was carried out according to a method described
elsewhere (van Heyningen, in press). The Sp2/0 hy¬
brids, MIS series, grew in suspension and were sub-
cloned by limiting dilution. The attached cell hybrids,
MAR series, derived from RAG were subcloned by
seeding about 100 cells into small Falcon flasks and
transferring cell-surface marker-positive colonies into
2-ml wells 10-14 d after plating.
J1CI4 (a gift from Dr. Carol Jones; Jones et al. 1984)
is a hamster cell hybrid carrying an intact chromosome
11 as its only human component. WG3H is an HPRT-
hamster cell line used as the recipient in X-irradiation
fusions (Westerveld et al. 1971). Both of these cells
were routinely grown in RPM1 1640 with 10% FCS.
Cell-Surface Marker Selection and Analysis
Hybrid cell selection for the expression of cell-sur¬
face markers expected on each "half' of the transloca¬
tion chromosome was carried out under sterile condi¬
tions by using magnetic beads. The monoclonal
antibodies used were in the form of sterile culture su¬
pernatant produced in our laboratory from hybridoma
cells which we had bought or received as gifts. The
hybridomas to detect MICIO (on chromosome 1),
MIC11, MIC4 (=CD44), MDU1, and MIC9 were, re¬
spectively, TRA2.10 (Andrews et al. 1985), from Dr.
Peter Andrews; 163A5 (Woodroofe et al. 1984), from
Dr. Frank Walsh; F10.44.2 (Goodfellow et al. 1982),
from Dr. John Fabre; 4F2, from ATCC (HB-22); and
4D12 (Jones et al. 1984), from Dr. Peter Goodfellow.
Dynabeads M450 (sheep anti-mouse immunoglobu¬
lin conjugated) were used. The stock suspension is 4
X 108 beads/ml (30 mg/ml). The most efficient separa¬
tion is expected if all the available second antibody sites
are saturated with specific monoclonal antibody. One-
milligram (33 pi = 1.3 X 107) aliquots of beads were
washed three times in sterile buffer (PBS and 1% BSA).
They were then incubated with end-over-end rotation
in 1 ml of each antibody in separate Eppendorf tubes
for 10 min. The antibody was discarded after the beads
were separated using the Dynabeads magnetic separa¬
tor, and the coated beads were washed three times in
buffer, to remove any unbound antibody.
A very small number (1-2 beads/cell) of coated
beads were gently added to the cells suspended in PBS
and incubated at room temperature with rotation of
the samples, for 30 min. The beads, some with cells
attached, were then separated magnetically and were
washed three times in sterile serum-free medium and
finally were gently rcsuspended in culture medium and
were transferred to 2-ml wells.
For attached cells (the MAR hybrids) direct antigen-
positive clone selection of attached cells is possible in a
Falcon flask. The 30-min incubation of a 25-cm2 flask
with 104 coated bcads/1 ml PBS is followed, without
washing but with gentle rocking of the flask, by inspec¬
tion, under the microscope, for bead-binding clones
which can then be transferred into a 2-ml well by using
separate sterile bacterial loops for each.
Cells with beads attached are handled as little as pos¬
sible, to prevent mechanical damage. They continue to
proliferate, and the beads are diluted out. Selection can
be repeated and may be alternated with subcloning and
quantitative fluorescence-activated cell sorter (FACS)
analysis.
FACS analysis was carried out according to a method
described elsewhere (Seawright et al. 1988; van Heynin¬
gen, in press), except that the cell sorter used was a
Becton Dickinson FACSCAN. Anti-AFP monoclonal
antibody was used as a negative control. The propor¬
tion of cell-surface marker-positive cells was estimated
from the machine-derived plot of cell number against
the log of fluorescence intensity.
Production of Cell-Surface Marker-selected
X-lrradiation Hybrids
The chromosome 11-only hybrid J1CI4 (Jones et al.
1984) was used as the potential fragment donor, and
the HPRT- Chinese hamster cell line WG3H was used
as the rodent fusion partner. A total of 2 X 107 log-
phase J1CI4 cells were harvested by gentle trypsiniza-
tion and were washed and resuspended in 2 ml of fresh
medium containing 10% FCS in a bijou bottle which
fits our gamma-irradiating cobalt source. A total of
16,000 rads were delivered to these cells. The cells were
then washed in serum-free medium and fused with 1.7
X 107 freshly harvested and washed WG3H cells, by
using our routine PEG fusion protocol. The fusion
products were plated into 8 X 75-cm2 flasks. HAT se¬
lection was implemented 16 h later. Two weeks after
fusion, MDU1-positive and MIC9-positive clones were
sought in the flasks, initially by using Dynabeads coated
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with both antibodies. The positive colonies were
picked with bacterial loops, were grown up as clones in
25-cm2 flasks, and were rcsclected with the two anti¬
bodies separately and sequentially. Clones were FACS
analyzed for all four chromosome 11-encoded cell-sur¬
face markers, and samples were cryoprcserved at every
stage. After repeated subcloning we obtained four rela¬
tively stable independent hybrid clones, two carrying
each cell-surface marker in the absence of the others:
WJX3 and WJX7are 100% MDU1 positive; and WJX5
and WJX11 are 100% MIC9 positive.
Mitotic Chromosome Preparation
The techniques used for both lymphoid cells and so¬
matic cell hybrids were essentially as described else¬
where (Fletcher, in press). For chromosome analysis by
in situ hybridization, cell synchronization with fluoro-
deoxyuridine is recommended. Mitotic cell prepara¬
tions can be stored in methanohacetic acid (3:1) for at
least 6 mo at —20°C. Spreads on slides were made as
required.
Chromosomal In Situ Hybridization
The markers used for this analysis were suggested by
preliminary linkage and hybrid cell results on determin¬
ing flanking markers. Probes were labeled with biotin
by nick-translation using routine methods (described in
detail in Gosden 1990).
Slides were prepared 3-4 d before the hybridization
was carried out. The hybridization protocol was as de¬
scribed by Gosden (1990).
Detection was essentially as described by Pinkel et al.
(1986), using (a) avidin-FlTC (Vector Labs) as reporter
and (b) linking layers of FITC with biotinylated anti-
avidin. The slides were counterstained with propidium
iodide and were mounted in Citifluorantifade:glycerol.
They were examined on a Leitz Ortholux II microscope
equipped with Ploemopak fluorescence filters, and suit¬
able metaphase spreads were scanned and stored with
the BioRad Lasersharp MRC 600 confocal laser scan¬
ning system attached to the same microscope.
The markers used to define the breakpoint were a
lambda phage clone of tyrosinase and the next distal
marker, cosmid CJ52.4. The latter defines the locus
D11S388 (Julieret al. 1990).
Cytogenetic Analysis ofX Irradiation-Fragment Hybrids
The human DNA content of these hybrids was ana¬
lyzed in several different ways. Mitotic chromosome
preparations from the subcloned stabilized hybrids
were hybridized with biotinylated human Cotl DNA
(GIBCO BRL), and signal was developed with a single
layer of avidin-FITC and was countcrstained with pro¬
pidium iodide in Citifluor by the method above. Hy-
bridization conditions used were as described by Gos¬
den and Hanratty (1991/?).
The origin of the human fragments in these hybrids
was also determined by chromosome painting. For this
the hybrid cell DNA was subjected to interrepeat se¬
quence (IRS)-PCR using several primers for the human
Alu and LI interspersed repeated sequences (table 1;
Gosden and Hanratty 1991a; Dorin et al. 1992). The
PCR products were labeled with biotin by nick-transla¬
tion and were used as a probe for in situ hybridization
back onto normal human mitotic spreads of relatively
extended chromosomes. Considerable suppression, by
adding 500 ng of unlabeled human Cotl DNA to 50 ng
labeled IRS-PCR product for each slide, was required
to give chromosome-specific results. Hybridization and
detection were essentially as described above for spe¬
cific marker in situ analysis.
Marker Analysis
DNA was prepared, by standard procedures de¬
scribed elsewhere (van Heyningen, in press), from fro¬
zen cell pellets, for all of the cell lines. Most marker
analysis was by PCR, and the products were analyzed
on agarose (1.5% for fragments of 500 bp). DNA blot
analysis was carried out for the chromosome 1 probes
D1S8 and D1S81.
Designing and Setting Up PCR Assays
for Chromosome 11 Markers
The aim was to set up PCR-based assays to quickly
analyze somatic cell hybrids for the presence of human
chromosome 11 markers on both mouse and hamster
backgrounds. Except for a few short-arm markers, we
concentrated on well-spaced long-arm markers. Where
no published primer sequences were available, we de¬
signed our own, either from published gene sequences
or, in the case of D11S388, D11S385, and D11S351,
from data obtained by sequencing a fragment of the
insert from cloned probes. In order to try to keep the
PCR human-specific, primers were designed from un¬
translated regions or introns, wherever such informa¬
tion was available. Theoretical conditions were calcu¬
lated for each primer pair and then were refined by
experimentation. Final primer sequences and annealing
temperatures are shown in table 1. For chromosome 1
markers—renin (REN) (Theune et al. 1991) and
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Table I
PCR Primers Used to Detect Genes in Somatic Cell Hybrids and for IRS-PCR for Painting Human DNA Content




















5' ATG GTG CAC CTG ACT CCT GAG G 3'
5' GCC ATC ACT AAA GGC ACC GAG C 3'
5' CCC TGG AAA CAC TTT CTG CC 3'
5' GGC TGG GTT GGA GGC AAG G 3'
5' ACA ATA TGT TTC TTA CTC TG 3'
5' TGG TAA CAC TAG ATT CAG C 3'
5' GCA TCT CTG ACA CCA ATC AG 3'
5' TGG AGA AGA GAC AGA TGG AG 3'
5' TCT TCA AAG CCT CTG CAG TAC C 3'
5' CTC ATC TCC AAC CTG TCT AAC C 3'
5' GAT GAG TGC ACG TTC AAG GAG 3
5' CAG AGA TGC TCC ACG CCA TAC
■* 3'J: 3'j
D1S103
5' GGG AGG GAT GAG ACT AGG ATG 3'
5' GGA GGT TCA CGT ACT CAG GGG 3'
5' GCA AGT TTG GCT TTT GGG GA 3'
5' CTG CCA AGA GGA GAA GAA TG 3'
5' CAT CCA CGC TGT TGG TCT GC 3' 1
5' CAG TAA GAA CCA AAG AAA GGT TAC 3'j
5' CAG TTT TCT CCT CTA CCA AGA C 3'
5' ACT GGC TTT ACT TAG CTC TAT G 3'
5' AGT CAG TAC AGG AGC CGA ACA G 3'1
5' GGA GAA AAG CTG TGC ATA CTG G 3'J
5' TTT TAT AGG GAC AGG ATC TTG C 3'
5' GGC TGT ATA ATC TTG TGT TCT C 3'
5' TGG AAA TCT CTT CCA AAC ATC CGA G 3'
5' AAT TAG AAC TTT GGA GAG GGA TGG G 3'
5' GAG GCC CTC TCA CTG ACA C 3'
5' AGT GCA CGG CCC TCC TGG A 3'
5' CTT GGG TAG CTG GTA CTA CAG G 3'
5' AGG TCA CTA CAC ATC AAA ACA GC 3'
5' CAG AAG GTG ACC AGC CTA ACG 3'
5' CTG AGC ACT GTG ACG TTC TGG 3'
5' ACG AAC ATT CTA CAA GTT AC 3'
5' TTT CAG AGA AAC TGA CAT GT 3'
65 355 In-house design
65 120 Lewis ct al. 1988; in-house
sequence and design
51 260 Giebel et al. 1991 (exon 4
oligos PI and P2; MspI
to distinguish from
TYR)
54 188 W. Cookson, personal
communication
57 859 Gottesdicner et al. 1988;
in-house design
(nt -1023 to -174)
62 542 Yoshida et al. 1987; in-
house design (nt 4161
to 4703)
60 450 Cowell et al. 1988; in-
house design (exons 5-7)
55 512 Giebel and Spritz 1990
(exon 1 oligos)
51 118 Julier et al. 1990; in-house
(variable) sequence and design
50 300 Sirum and Brinkerhoff
1989; in-house design
(nt -300 to —4)
59 517 Angel et al. 1987; in-house
design (nt —434 to +83)
54 286 Julier et al. 1990; in-house
sequence and design
55 179 Barton et al. 1990
(nt —848 to —663;
designed by G. Gillett)
55 390 R. Todd, personal
communication (exon 2)
59 209 Julier et al. 1990;
in-house sequence and
design
40 324 Cotter et al. 1989 (with
slight modification)
55 >85 Weber et al. 1990
(variable)
(continued)





























D1S103 (Weber et al. 1990)—published PCR condi¬
tions were used.
A problem which had to be overcome in the tyrosin¬
ase analysis was the existence of the tyrosinase-like
gene (TYRL1), which was described in detail while the
present work was in progress (Giebel et al. 1991). This
allowed us to resolve TYRL1 from TYR by using
primers to TYR exon 4, which is common to both loci;
but, after Mspl or HpaU digestion of the PCR product,
TYR gives rise to 120-bp and 140-bp fragments, while
the TYRL1 products are 29 bp, 91 bp, and 149 bp (data
not shown). For the detection of TYR alone, primers
for exon 1 were used (table 1).
Results
Genetic Analysis
With the more distant but highly informative chro¬
mosome 11 breakpoint-flanking markers D11S97 and
D11S35, two and three obligate recombinants, respec¬
tively, were found among the 10 translocation carriers.
For the closer but less informative flanking markers
TYR and D11S388, no recombinants were found, even
when DNA was reanalyzed for the recently described
TYR dinucleotide-repeat polymorphism (Morris et al.
1991). On chromosome 1 several recombinants are seen
with the highly informative distal marker D1S8, but
none was found with the proximal markers D1S103 or
D1S81—both of which are highly polymorphic refer¬
ence markers. These results were emerging as the cell
hybrid analysis and the in situ hybridization were get¬
ting under way and gave us an idea of the markers to
study, especially for the latter technique.
Marker Analysis of the Hybrid Cell Panel
The stabilized, repeatedly subcloned, cell-surface
marker-selected translocation hybrids were analyzed
mainly by PCR, once segregation of the two derived
chromosomes from their normal homologues had been
ascertained by cell-surface marker expression (fig. 1).
The X irradiation-fragment hybrids were screened in
the same way. Included in the panel for analysis, both
by PCR and for cell-surface markers, were potentially
useful preexisting translocation hybrids and earlier
CMGT fragment hybrids. High-molecular-weight
DNA was used for all analyses.
The PCR primers shown in table 1 were used to ana¬
lyze the complete hybrid cell panel, including some ear¬
lier CMGT chromosome-fragment hybrids. The com¬
plete data set is shown in table 2, where the position of
the translocation breakpoint is clearly defined by hy¬
brids MIS7 (=MAR12) and MIS39 (=MAR1), and the
marker analysis of the fragment hybrids gives an idea of
what chromosome 11 q regions are present for future
marker isolation.
Molecular Cytogenetic Analysis of the X Irradiation-
Fragment Hybrids
The human DNA content of the WJX hybrids was
analyzed by in situ hybridization using human Cotl
DNA. Figure 2 shows the distribution of the chromo¬
some 11 fragments in each hybrid. In three of four cases
there appears to be a single block of human DNA, but
in WJX7 three separate blocks are seen, although all
three are located on the same recipient chromosome.
The appearance of the single extended region in WJX5
is nonuniform.
DISTINGUISHING NORMAL & ABNORMAL
CHROMOSOMES 1 & 11























"Lire I Strategy for distinguishing hybrid cells carrying normal and derivative chromosomes I and 11, using cell-surface marker
;tion.
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Table 2










CF52 WJX3 \V|X5 WJX7 WJX11 F.67.1 F.67.4
CHR 11 markers:
HBB - + ND - + - - + -
D11S87 - + ND - - - - ND ND
MIC11 - + - - - - - + +
CD44 - + - - - - - - +
TYRL1 - + - + + - - - +
PGA - + - + - + - + -
MDU1 - + - + - + - - -
FGF4 - + - + - - - - -
GST3 - + - + - - - + +
TYR - + + - - + + - +
D11S388 + - + - - - + - -
STMY1 + - + - + + + - +
CLG + - + - + + + - +
D11S385 + + - + + + - +
NCAM + - ND - - + + ND ND
DRD2 + - ND - - + + ND ND
D11S351 + - + - -- + - + - -
THY1 + - + - + - + ND ND
MIC9 (+) - + - ' + - + - -
CHR 1 markers:
MIC10 + - ND ND ND ND ND ND ND
REN + - ND ND ND ND ND ND ND
D1S103 + - ND ND ND ND ND ND ND
D1S8 - + ND ND ND ND ND ND ND
* A plus sign (+) denotes presence of marker, and a minus sign (—) denotes absence of marker. ND = not determined.
Chromosome painting onto a normal human meta-
phase spread was also carried out to study directly the
chromosome 11 regions from which the human frag¬
ments were derived. Figure 3 reveals an apparently sin¬
gle contiguous region of chromosome 11 q in WJX3,
WJX7, and WJX11. Three distinct regions, two on the
short arm and one on the long arm, are seen only in
WJX5, as expected on the basis of marker analysis (ta¬
ble 2). Marker analysis would suggest the presence of
discontinuity in WJX7 too. Cotl analysis of the hybrid
showed three separate blocks of human DNA in WJX7,
and the results in table 2 reveal two gaps—first, in the
HSTF1,GST3 region and, second, around D11S388.
This suggests that two small interstitial deletions have
interrupted contiguity, and the three separate blocks of
human DNA seen in the hybrid cell line may represent
the separate insertion of each contiguous segment.
However, as the gaps are small, the human DNA con¬
tent of WJX7 appears as a single block when painted
back onto normal human chromosomes.
In Situ Hybridization to Determine the Site
of the Translocation Breakpoint
Figure 4 shows the results with the flanking markers
on mitotic chromosomes prepared from peripheral leu¬
kocytes of translocation carrier and affected patient
ROMAR. Figure 4a shows the breakpoint-distal
marker D11S388 hybridizing to the large derived chro¬
mosome 1 and to the normal chromosome 11 homo-
logue, and figure 4h shows the TYR signal on the nor¬
mal chromosome 11 and on the visibly smaller, derived
chromosome 11.
Discussion
Schizophrenia and related major mental illness are
very common in the general population (Gottesman
I letcher ci ai.
Figure 2 Human DNA content ot the WJX hybrids, revealed by in situ hybridization with C'otl fraction of human \Y'|XA. h,
WJX5. <\ WJX7. </. \\ |X11. for each cell line a representative mitotic spread is shown on the right, with an enlarged \iew ot the human
fragment-bearing chromosome in the left panel.
and Shields 1982). 1 he etiology of these diseases is not
understood hut is almost certainly heterogeneous. So¬
cial, environmental, and genetic components interact
to cause disease. Twin studies point to a major genetic
contribution (Gottcsnun and Shields 1982), which is,
however, likely to he due to several different interact¬
ing genes. Any insight into the physiological/biochemi¬
cal abnormalities which arc invoked in the onset ol
disease may give a lead in designing improved therapy
and, perhaps, in devising preventive measures. Under¬
standing the underlying pathology in one form of the
disease may lead to other candidate genes or to environ¬
mentally alterable targets.
With this philosophy in mind, we set out to identity,
as a pointer to one candidate genetic component, the
translocation breakpoint which cosegregates closely
with schizophrenic illness in this large kindred. We
have succeeded in showing that the breakpoint lies be¬
tween two adjacent genetically linked markers, I'YR
and DIIS488, initially placed 4 cM apart (G. Julicr,
unpublished results) but most recently estimated to be
about 7.8 cM apart at I Iql4-q2l NIH '( KPH Collab¬
orative Mapping Group 1992'. The DNA distance be¬
tween two such markers is impossible to predict, since
the relationship between genetic and phvsical distance
is not constant, so that in part ot the ncarhv I lq 14
Mb.N I region I cM corresponds to onk 4<)0 kb ( Ian-
son et al. 1991). 1 he next step is to idcntitv the exact
site of the breakpoint, with the atsi ot further markers
in the I ^ R-I)l IS488 interval. With this in mind we
segregated the reciprocal translocation chromosomes
into stable mouse-human hybrids, for quick assignment
ot any newly isolated markers. We have also produced
the lour W JX series ol X-irradiation hvhrids earning
I 1 q fragments selected with ccll-surtacc markers
known to map above anil below the I lq2i breakpoint.
()l these, WJX I I in particular rev eals a contiguous
block ol markers which appear to cross the transloca-
1 I q2 I I iaiishk.11 a hi in S, Inzophrenin ■1
Figure 3 Human DNA from each WJX hybrid, isolated by Alu-I'CR and painted back onto normal human mitotic spreads, it, WJX3,
showing a subccntromcric block ot DNA on I Iq. /t, WJX5, revealing the presence ot three distinct blocks. :rom I Ipter, 11pI l-pl2, and
I Iq2.1-q24 (the degree of ('ot I suppression was not quite sufficient in this ease, showing hybridization to some other chromosomes), c, WJX7,
showing a single relatively centromere-proximal block on llq. i/. WJXII, with a more distal I Iq block o: I'X \. b.ach chromosome II
homologuc is shown enlarged separately in a small panel.
tion breakpoint. We cannot be certain ot the integrity
of the DNA without PICK analysis, since, for example,
in CMGT hybrids (of w hich 1-.67.1 and b.67.4 are repre¬
sentative), wc almost invariably find the human DNA
components to be rearranged when looked at by long-
range techniques (Bickmorc et al. 19X9). Alu-I'CR
painting similarly reveals discontinuity in some chro¬
mosome-fragment hybrids {Dorin et al. 1992). Never¬
theless, such hybrids provide an excellent source ot
new markers tor the chromosome regions indicated to
be present bv the preexisting markers (I'orteous et al.
1987; Bickmore et al. 1989). However, to narrow
marker isolation more closely to the region ol interest,
we propose to try coincidence sequence cloning
(Brookes and I'orteous 1901t—for example, between
MIS.39 (= M AR I : and \V|XII, which carry overlapping
human tragmenis on a mouse cell background and
hamster cell background, respectively. Using this tech¬
nique should allow us to isolate new markers solely for
the human region which the two cells have in common,
which is around the translocation breakpoint. Other
approaches in progress that are seeking to produce
markers for the region ol interest include (u) the produc¬
tion ot microdissection libraries and (/>) the isolation of
TYR and Dl IS3XX yeast artificial chromosome (YAC)
clones, followed by YAC walking between these
clones. New markers produced are quickly mapped
onto the translocation hybrids MIS7, MIS39, and
CI 27. Markers present in both MIS39 and CI 37 or
W|Y1 I are automatically m the region ol interest. Can¬
didate YAC clones lor crossing the breakpoint can be
identified bv in situ hvbridi/ution (Breen et al. 1992)
onto the translocation cell line MAI I.I.
In the process ot producing and analyzing the so-
4X8
Figure 4 In situ hybridization of the two adjacent flanking
markers on mitotic spreads from an affected translocation carrier, a,
D11S388, which hybridizes to the derived 1 (upper left) and to the
normal 11 homologue (lower left), b, TYR signals, seen on the normal
11 homologue (upper left) and on the truncated-looking derived 11
(lower left).
matic cell hybrids described, we have contributed to
the mapping effort on chromosome 1 lq. We have de¬
vised human-specific PCR assays for a number of gene-
specific markers and have developed new sequence-
tagged sites for the D11S351, D11S385, and D11S388
(Julier et al. 1990) loci. The localization of the FACS-
selectable cell-surface marker MDU1 (Seawright et al.
1988), which is also the cloned gene 4F2 (Gottesdiener
et al. 1988), has been refined to the region proximal to
TYR but deleted in J1 -44 on 11 q (Jones ct al. 1984;
Tanigami et al. 1992). It is interesting to note that,
although there is considerable fragmentation of the re¬
tained chromosome fragments in WJX5 and WJX7,
markers known to be closely linked, such as the
CLG/STjMY1/D11S385 complex and NCAM/DRD2
(McConville et al. 1990), arc not separated. These rc-
I Ictcher et al.
suits suggest that such fragment hybrids will be useful
for short-range mapping.
Linkage studies of chromosome 11 q markers with
schizophrenia have recently been carried out (Muir ct
al. 1991). Interest in a possible disease association with
this chromosomal region has been influenced by (1) the
finding of three 1 Iq21-q23 translocations (Smith ct al.
1989; Holland and Gosden 1990; St. Clair et al. 1990),
(2) the existence of several published cases of schizo¬
phrenia in albino patients, implicating the tyrosinase
region (Baron 1976; Clarke and Buckley 1989), and (3)
the presence of possible candidate loci, such as the do¬
pamine D2 receptor (Grandy et al. 1989; Seeman et al.
1989). Although the results of these studies generally
have been negative, it is not possible to exclude the
involvement of a major locus SCZD2 in this region, in
as many as 20% of cases, making the isolation of genes
from the breakpoint region an important approach for
identifying specific schizophrenia-predisposition genes
which may be implicated in only a proportion of cases.
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at the human olfactory marker
protein (OMP) locus on
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description: The gene mutated in Friedreich's ataxia
has been localized on chromosome 9ql3-q21.1 within
'in the polymorphic DNA segments D9S15 and D9S5.
ttly determined gene order is D9S15-D9S5-FRDA (1,2).
ined YAC clones extending to 330 kb beyond D9S5
he candidate FRDA region, and we isolated DNA
s containing GT repeats from these YACs by polymerase
ction (PCR). A (TG)12TA(TG)4A(GT)5 repeat (MLS1)











I heterozygosity = 0.50.
omal Localization: The D9S15/D9S5/FRDA region is
on chromosome 9q 13 —q21.1.
tn Inheritance: Co-dominant inheritance was
ated in 30 informative families.
ditions/Comments: PCR was performed on 100 — 200
lomic DNA in a 20 p\ volume with 10 pmoles of 32P
xl MLS1 F primer, 10 picomoles cold MLS1 R primer,
Mg2 + , and consisted of 25 cycles of denaturation at
1 minute, annealing at 57°C for 1 minute, and extension
or 1 minute. Amplification products were separated on
crylamide-urea gels, and detected by autoradiography,
'ely, PCR was performed for 35 cycles with cold
ind detection was obtained by chemiluminescence after
le amplification products from the polyacrylamide-urea
t nylon membrane, which was then hybridized with a
led amplification product (manuscript in preparation).
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Source/Description: The human OMP gene was isolated and
subcloned into an 02/B cosmid (1,2). A 717 bp Sau3A 1 fragment
was selected by hybridization to poly(dC-dA) poly(dG-dT) and
subcloned into the BamHl site of pBS(+/-) phagemid.
Sequencing revealed a (CA)5GA(CA)I? DNR.
Primer Sequences:
CTG AAA GGT AAA ACA ATA ATG C (22-mcr) CA slrand
TGT CCT CCT ACC ACT AAT GC (20-mer) GT strand
Polymorphism: Oligonucleotide primers were constructed from
OMP sequences flanking the repeat region. These primers were
used to amplify a 254 bp fragment. Four alleles were observed
in genotypes of 54 unrelated persons. Heterozygosity =0.62.
Genotypes of CEPH individuals K-1331 GMO6990 and K-1331
GMO7057 are A2,A3 and A3,A3, respectively.
Allele frequencies:
Al (254 bp) = 0.12; A2 (250 bp) = 0.45: A3 (248 bp) =0.41; A4 (244 bp)
= 0.02
Chromosomal Localization: Human OMP has been localized to
11 q 13.5 (immediately centromeric to TYR) by somatic cell
hybrid panel and fluorescent in situ hybridization (2). Linkage
analysis places OMP near D11S527 ($ = .001, Zmax=9.414).
Mendelian Inheritance: Co-dominant segregation was observed
in 17 multigenerational informative families.
PCR Conditions: PCRs were done in 25 g\ with 20 ng genomic
DNA, 1.5 mM MgCl2, 10 mM Tris-Cl pH 8.3, 50 mM KC1,
0.01 % gelatin (Promega 10 X Taq polymerase buffer), 200 )tM
each of dCTP,dGTP, dTTP, and 2.5 pM dATP, 1 ^Ci a P32
dATP (NEN Du Pont, 800 Ci/mmol, 10 pC\/p\), 10 ng each
oligonucleotide primer, 1 unit of Taq DNA polymerase
(Promega). PCR conditions were set at denaturation at 94°C for
1 min., annealing at 55°C for 1 min., and extension at 72°C
for 2 min. for 29 cycles. A final cycle ended with 10 min. of
extension at 72°C. Fragments were separated on 6%
polyacrylanride denaturing gels. Dideoxy sequencing ladders of
M13mpl8 DNA were used as fragment size standards.
Other Comments: The human OMP sequence has been assigned
EMBL accession number Z18943.
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